FILENAME	SEQ	COMPOUND_NAME	MOLECULEMASS	INSTRUMENT	IONSOURCE	EXTRACTSCAN	SMILES	INCHI	INCHIAUX	CHARGE	IONMODE	PUBMED	ACQUISITION	EXACTMASS	DATACOLLECTOR	ADDUCT	INTEREST	LIBQUALITY	GENUS	SPECIES	STRAIN	CASNUMBER	PI
1_2-dehydroaspidospermidine.mgf	*..*	1,2-dehydroaspidospermidine	281.2013	qTof	LC-ESI	1	CC[C@@]12CCCN3CC[C@]4([C@@]23[H])C(CC1)=NC5=C4C=CC=C5	InChI=1S/C19H24N2/c1-2-18-9-5-12-21-13-11-19(17(18)21)14-6-3-4-7-15(14)20-16(19)8-10-18/h3-4,6-7,17H,2,5,8-13H2,1H3/t17-,18-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	280.1939	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
10_hydroxygeissoschizol.mgf	*..*	10-hydroxygeissoschizol	313.1911	qTof	LC-ESI	7	OC1=CC=C(NC2=C3CCN4C2CC(CCO)/C(C4)=C\C)C3=C1	InChI=1S/C19H24N2O2/c1-2-12-11-21-7-5-15-16-10-14(23)3-4-17(16)20-19(15)18(21)9-13(12)6-8-22/h2-4,10,13,18,20,22-23H,5-9,11H2,1H3/b12-2-	N/A	1	Positive	N/A	Isolated	312.1838	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	6870-18-4	Mehdi Beniddir
10_hydroxyusambarine.mgf	*..*	10-hydroxyusambarine	467.2805	qTof	LC-ESI	8	[H][C@@]1(N(C)CCC2=C1NC3=C2C=CC=C3)C[C@@]4([H])C[C@]5([H])N(CCC6=C5NC7=C6C=C(O)C=C7)C[C@@H]4C=C	InChI=1S/C30H34N4O/c1-3-18-17-34-13-11-23-24-16-20(35)8-9-26(24)32-30(23)28(34)15-19(18)14-27-29-22(10-12-33(27)2)21-6-4-5-7-25(21)31-29/h3-9,16,18-19,27-28,31-32,35H,1,10-15,17H2,2H3/t18-,19-,27+,28-/m0/s1	N/A	1	Positive	N/A	Isolated	466.2733	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	42814-43-7	Mehdi Beniddir
10-hydroxy-lanciferine.mgf	*..*	10-hydroxylanciferine	561.2228	qTof	LC-ESI	2	O=C(O1)C[C@]2(C3(COC(/C=C/C4=CC=CC=C4)=O)C(OC)=O)[C@@]1([C@]5([H])C[C@H]3[C@@]6(C(O6)C)CN5C)NC7=CC=C(O)C=C72	InChI=1S/C31H32N2O8/c1-18-29(40-18)16-33(2)24-14-23(29)28(27(37)38-3,17-39-25(35)12-9-19-7-5-4-6-8-19)30-15-26(36)41-31(24,30)32-22-11-10-20(34)13-21(22)30/h4-13,18,23-24,32,34H,14-17H2,1-3H3/b12-9+/t18?,23?,24-,28?,29-,30?,31-/m0/s1	N/A	1	Positive	N/A	Isolated	560.2159	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
10-hydroxypericyclivine-N-oxide.mgf	*..*	10-hydroxypericyclivine-N-oxide	355.167	qTof	LC-ESI	3	C/C=C(C1)\[C@@H]2C[C@@]([N@@+]1([O-])[C@H]([C@H]2C(OC)=O)C3)([H])C4=C3C5=CC(O)=CC=C5N4	InChI=1S/C20H22N2O4/c1-3-10-9-22(25)16-8-14-13-6-11(23)4-5-15(13)21-19(14)17(22)7-12(10)18(16)20(24)26-2/h3-6,12,16-18,21,23H,7-9H2,1-2H3/b10-3-/t12-,16-,17-,18-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	354.158	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
10-hydroxyusambarensine.mgf	*..*	10-hydroxyusambarensine	449.234	qTof	LC-ESI	4	[H][@@]12C[C@@]([H])(/C(CN1CCC3=C2NC4=C3C=CC=C4)=C\C)CC5=NC=CC6=C5NC7=C6C=C(C=C7)O	InChI=1S/C29H28N4O/c1-2-17-16-33-12-10-22-20-5-3-4-6-24(20)32-29(22)27(33)14-18(17)13-26-28-21(9-11-30-26)23-15-19(34)7-8-25(23)31-28/h2-9,11,15,18,27,31-32,34H,10,12-14,16H2,1H3/b17-2-/t18-,27-/m0/s1	N/A	1	Positive	N/A	Isolated	448.2263	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
10MeOaffinisine.mgf	*..*	10-methoxyaffinisine	339.2065	qTof	LC-ESI	6	C/C=C1CN2[C@H]3C[C@H]/1[C@@H](CO)[C@@H]2CC4=C3N(C)C5=CC=C(OC)C=C45	InChI=1S/C21H26N2O2/c1-4-12-10-23-19-9-16-15-7-13(25-3)5-6-18(15)22(2)21(16)20(23)8-14(12)17(19)11-24/h4-7,14,17,19-20,24H,8-11H2,1-3H3/b12-4-/t14-,17-,19+,20+/m1/s1	N/A	1	Positive	N/A	Isolated	338.19943	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
10-methoxy-pericyclivine-N-oxide.mgf	*..*	10-methoxy-pericyclivine-N-oxide	369.185	qTof	LC-ESI	5	COC1=CC=C2NC([C@@]3(C[C@H]4/C5=C\C)[H])=C(C[C@H]([N@+]3(C5)[O-])[C@H]4C(OC)=O)C2=C1	InChI=1S/C21H24N2O4/c1-4-11-10-23(25)17-9-15-14-7-12(26-2)5-6-16(14)22-20(15)18(23)8-13(11)19(17)21(24)27-3/h4-7,13,17-19,22H,8-10H2,1-3H3/b11-4-/t13-,17-,18-,19-,23-/m0/s1	N/A	1	Positive	N/A	Isolated	368.1736	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
11_hydroxyusambarine.mgf	*..*	11-hydroxyusambarine	467.2805	qTof	LC-ESI	11	[H][C@@]1(N(C)CCC2=C1NC3=C2C=CC=C3)C[C@@]4([H])C[C@]5([H])N(CCC6=C5NC7=C6C=CC(O)=C7)C[C@@H]4C=C	InChI=1S/C30H34N4O/c1-3-18-17-34-13-11-24-22-9-8-20(35)16-26(22)32-30(24)28(34)15-19(18)14-27-29-23(10-12-33(27)2)21-6-4-5-7-25(21)31-29/h3-9,16,18-19,27-28,31-32,35H,1,10-15,17H2,2H3/t18-,19-,27+,28-/m0/s1	N/A	1	Positive	N/A	Isolated	466.2733	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	67658-00-8	Mehdi Beniddir
11_methoxyyohimbine.mgf	*..*	11-methoxyyohimbine	385.2122	qTof	LC-ESI	12	[H][C@](N1CC2)(C[C@@]([C@@H](C(OC)=O)[C@@H](O)CC3)([H])[C@]3([H])C1)C4=C2C5=C(N4)C=C(OC)C=C5	InChI=1S/C22H28N2O4/c1-27-13-4-5-14-15-7-8-24-11-12-3-6-19(25)20(22(26)28-2)16(12)10-18(24)21(15)23-17(14)9-13/h4-5,9,12,16,18-20,23,25H,3,6-8,10-11H2,1-2H3/t12-,16-,18-,19-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	384.2049	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	65025-21-0	Mehdi Beniddir
11-hydroxytabersonine.mgf	*..*	11-hydroxytabersonine	353.183	qTof	LC-ESI	9	O=C(C1=C(NC2=C3C=CC(O)=C2)[C@]43[C@@]5([C@](CC)(C1)C=CCN5CC4)[H])OC	InChI=1S/C21H24N2O3/c1-3-20-7-4-9-23-10-8-21(19(20)23)15-6-5-13(24)11-16(15)22-17(21)14(12-20)18(25)26-2/h4-7,11,19,22,24H,3,8-10,12H2,1-2H3/t19-,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
11-methoxy-tabersonine.mgf	*..*	11-methoxy-tabersonine	366.194	qTof	LC-ESI	10	O=C(C1=C(NC2=C3C=CC(OC)=C2)[C@]43[C@@]5([C@](CC)(C1)C=CCN5CC4)[H])OC	InChI=1S/C22H26N2O3/c1-4-21-8-5-10-24-11-9-22(20(21)24)16-7-6-14(26-2)12-17(16)23-18(22)15(13-21)19(25)27-3/h5-8,12,20,23H,4,9-11,13H2,1-3H3/t20-,21-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
12MeO_voaphylline.mgf	*..*	12-methoxyvoaphylline	327.2075	qTof	LC-ESI	13	CC[C@]12CCC3=C(C4=CC=CC(OC)=C4N3)CCN(C[C@@H]5[C@H]2O5)C1	InChI=1S/C20H26N2O2/c1-3-20-9-7-15-13(8-10-22(12-20)11-17-19(20)24-17)14-5-4-6-16(23-2)18(14)21-15/h4-6,17,19,21H,3,7-12H2,1-2H3/t17-,19-,20+/m1/s1	N/A	1	Positive	N/A	Isolated	326.19943	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
14_15_dehydrovincamine.mgf	*..*	14-dehydro-vincamine	353.1868	qTof	LC-ESI	15	CC[C@@]12C=CCN3[C@]1([H])C4=C(C5=C(C=CC=C5)N4[C@](C(OC)=O)(O)C2)CC3	InChI=1S/C21H24N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-8,10,18,25H,3,9,11-13H2,1-2H3/t18-,20+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	352.17869	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
14-15-Dehydrovincine.mgf	*..*	14,15-Dehydrovincine	383.1975874	qTof	LC-ESI	14	CC[C@@]12C=CCN3[C@]1([H])C4=C(C5=C(C=C(OC)C=C5)N4[C@](C(OC)=O)(O)C2)CC3	InChI=1S/C22H26N2O4/c1-4-21-9-5-10-23-11-8-16-15-7-6-14(27-2)12-17(15)24(18(16)19(21)23)22(26,13-21)20(25)28-3/h5-7,9,12,19,26H,4,8,10-11,13H2,1-3H3/t19-,21+,22+/m1/s1	N/A	1	Positive	N/A	Isolated	382.18926	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16-Demethoxy-20-epi-serpentinine.mgf	*..*	16-demethoxy-20-epi-serpentinine	671.321	qTof	LC-ESI	16	C/C=C1CN(CCC2=C3NC4=CC=CC=C24)[C@@]3([H])CC/1([H])[C@H](CC5=C[N+]6=C(C7=C5C8=C(N7)C=CC=C8)C[C@@]([H])(C9(C6)[H])C(C(OC)=O)=CO[C@H]9C)C(O)=O	InChI=1S/C41H42N4O5/c1-4-23-18-44-14-13-26-25-9-5-7-11-33(25)42-38(26)35(44)16-28(23)30(40(46)47)15-24-19-45-20-31-22(2)50-21-32(41(48)49-3)29(31)17-36(45)39-37(24)27-10-6-8-12-34(27)43-39/h4-12,19,21-22,28-31,35,42H,13-18,20H2,1-3H3,(H,46,47)/p+1/b23-4-/t22-,28?,29-,30-,31?,35-/m0/s1	N/A	1	Positive	N/A	Isolated	671.3228	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16-epi-14-dehydrovincamine.mgf	*..*	16-epi-14-dehydrovincamine	353.1868	qTof	LC-ESI	17	CC[C@@]12C=CCN3[C@]1([H])C4=C(C5=C(C=CC=C5)N4[C@@](C(OC)=O)(O)C2)CC3	InChI=1S/C21H24N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-8,10,18,25H,3,9,11-13H2,1-2H3/t18-,20+,21-/m1/s1	N/A	1	Positive	N/A	Isolated	352.17869	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16-epi-dregamine.mgf	*..*	16-epi-dregamine	355.2015	qTof	LC-ESI	18	CN1[C@@]([C@]2([H])C(OC)=O)([H])CC3=C(C(CC2[C@H](CC)C1)=O)NC4=CC=CC=C43	InChI=1S/C21H26N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h5-8,12,14,17,19,22H,4,9-11H2,1-3H3/t12-,14?,17+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16epiochropamine.mgf	*..*	16-epiochropamine	367.2017	qTof	LC-ESI	19	C/C=C1CN(C)[C@@H]2CC(C3=CC=CC=C3N4C)=C4C(C[C@@H]/1[C@H]2C(OC)=O)=O	InChI=1S/C22H26N2O3/c1-5-13-12-23(2)18-10-16-14-8-6-7-9-17(14)24(3)21(16)19(25)11-15(13)20(18)22(26)27-4/h5-9,15,18,20H,10-12H2,1-4H3/b13-5-/t15-,18+,20+/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16epiperivine.mgf	*..*	16-epiperivine	339.1701	qTof	LC-ESI	20	C/C=C1CN[C@@H]2CC(C3=CC=CC=C3N4)=C4C(C[C@@H]/1[C@H]2C(OC)=O)=O	InChI=1S/C20H22N2O3/c1-3-11-10-21-16-8-14-12-6-4-5-7-15(12)22-19(14)17(23)9-13(11)18(16)20(24)25-2/h3-7,13,16,18,21-22H,8-10H2,1-2H3/b11-3-/t13-,16+,18+/m0/s1	N/A	1	Positive	N/A	Isolated	338.163	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
16epivobasine.mgf	*..*	16-epivobasine	353.1861	qTof	LC-ESI	21	C/C=C1CN(C)[C@@H]2CC(C3=CC=CC=C3N4)=C4C(C[C@@H]/1[C@H]2C(OC)=O)=O	InChI=1S/C21H24N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h4-8,14,17,19,22H,9-11H2,1-3H3/b12-4-/t14-,17+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
18_19_dihydrousambarine.mgf	*..*	18,19-dihydrousambarine	453.3013	qTof	LC-ESI	22	[H][C@@]12C[C@@](C[C@]3([H])N(C)CCC4=C3NC5=C4C=CC=C5)([H])[C@@H](CC)CN1CCC6=C2NC7=C6C=CC=C7	InChI=1S/C30H36N4/c1-3-19-18-34-15-13-24-22-9-5-7-11-26(22)32-30(24)28(34)17-20(19)16-27-29-23(12-14-33(27)2)21-8-4-6-10-25(21)31-29/h4-11,19-20,27-28,31-32H,3,12-18H2,1-2H3/t19-,20-,27-,28-/m0/s1	N/A	1	Positive	N/A	Isolated	452.294	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	67657-99-2	Mehdi Beniddir
18_hydroxyisosungucine.mgf	*..*	18-hydroxyisosungucine	651.333	qTof	LC-ESI	23	O=C1C([C@@]2([H])C[C@]34C5=CC=CC=C5N(C(C=C6)=O)[C@@]3([H])[C@]6([H])[C@H]7C[C@@H]4N2C/C7=C/C)C=C([C@H](/C(C8)=C\CO)C[C@@H]9N8CC%10)[C@@]%11([H])[C@]9%10C%12=CC=CC=C%12N%111	InChI=1S/C42H42N4O3/c1-2-23-22-44-34(20-42-31-8-4-5-9-32(31)45-37(48)12-11-25(38(42)45)26(23)19-36(42)44)29-17-28-27-18-35-41(14-15-43(35)21-24(27)13-16-47)30-7-3-6-10-33(30)46(39(28)41)40(29)49/h2-13,17,25-27,29,34-36,38-39,47H,14-16,18-22H2,1H3/b23-2-,24-13-/t25-,26-,27-,29?,34+,35-,36-,38-,39-,41+,42+/m0/s1	N/A	1	Positive	N/A	Isolated	650.3257	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	279258-78-5	Mehdi Beniddir
19_20_dehydroervatamine.mgf	*..*	19,20-dehydroervatamine	353.186	qTof	LC-ESI	27	CN(C1)C/C([C@]([C@]1(C(OC)=O)C2)([H])CC(C3=C2C4=CC=CC=C4N3)=O)=C\C	InChI=1S/C21H24N2O3/c1-4-13-11-23(2)12-21(20(25)26-3)10-15-14-7-5-6-8-17(14)22-19(15)18(24)9-16(13)21/h4-8,16,22H,9-12H2,1-3H3/b13-4+/t16-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	33228-82-9	Mehdi Beniddir
19_20_dihydrousambarensine.mgf	*..*	19,20-dihydrousambarensine	435.2543	qTof	LC-ESI	28	[H][C@@]12C[C@@](CC3=NC=CC4=C3NC5=C4C=CC=C5)([H])C(CC)CN1CCC6=C2NC7=C6C=CC=C7	InChI=1S/C29H30N4/c1-2-18-17-33-14-12-23-21-8-4-6-10-25(21)32-29(23)27(33)16-19(18)15-26-28-22(11-13-30-26)20-7-3-5-9-24(20)31-28/h3-11,13,18-19,27,31-32H,2,12,14-17H2,1H3/t18?,19-,27-/m0/s1	N/A	1	Positive	N/A	Isolated	432.2314	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	144548-37-8	Mehdi Beniddir
19_20_epoxynovacine.mgf	*..*	19,20-epoxynovacine	441.202	qTof	LC-ESI	29	O=C1C[C@@](OC[C@@H]2[C@]3(O2)CN(C)CC4)([H])[C@@]([C@@]3([H])CC5=O)([H])[C@@]6([H])[C@]54C7=CC(OC)=C(OC)C=C7N61	InChI=1S/C24H28N2O6/c1-25-5-4-23-12-6-15(29-2)16(30-3)8-14(12)26-20(28)9-17-21(22(23)26)13(7-18(23)27)24(11-25)19(32-24)10-31-17/h6,8,13,17,19,21-22H,4-5,7,9-11H2,1-3H3/t13-,17+,19-,21+,22+,23-,24+/m1/s1	N/A	1	Positive	N/A	Isolated	440.1947	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	19879-54-0	Mehdi Beniddir
19-20-dihydro-gelsemine.mgf	*..*	19,20-Dihydro-gelsemine	325.1903	qTof	LC-ESI	24	CC[C@]12C3CC4[C@]5(C1[C@@H](C3CO4)C(N2)C)C6=CC=CC=C6NC5=O	InChI=1S/C20H24N2O2/c1-3-19-13-8-15-20(12-6-4-5-7-14(12)21-18(20)23)17(19)16(10(2)22-19)11(13)9-24-15/h4-7,10-11,13,15-17,22H,3,8-9H2,1-2H3,(H,21,23)/t10?,11?,13?,15?,16-,17?,19+,20+/m1/s1	N/A	1	Positive	N/A	Isolated	324.1838	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
19-acetyl-tabersonine.mgf	*..*	19-acetyltabersonine	395.193	qTof	LC-ESI	25	O=C(C1=C(NC2=C3C=CC=C2)[C@]43[C@@]5([C@]([C@H](OC(C)=O)C)(C1)C=CCN5CC4)[H])OC	InChI=1S/C23H26N2O4/c1-14(29-15(2)26)22-9-6-11-25-12-10-23(21(22)25)17-7-4-5-8-18(17)24-19(23)16(13-22)20(27)28-3/h4-9,14,21,24H,10-13H2,1-3H3/t14-,21+,22+,23+/m1/s1	N/A	1	Positive	N/A	Isolated	394.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
19-hydroxytabersonine.mgf	*..*	19-hydroxytabersonine	353.184	qTof	LC-ESI	26	O=C(C1=C(NC2=C3C=CC=C2)[C@]43[C@@]5([C@]([C@H](O)C)(C1)C=CCN5CC4)[H])OC	InChI=1S/C21H24N2O3/c1-13(24)20-8-5-10-23-11-9-21(19(20)23)15-6-3-4-7-16(15)22-17(21)14(12-20)18(25)26-2/h3-8,13,19,22,24H,9-12H2,1-2H3/t13-,19+,20+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
2_7_dihydroxyapogeissoschizine.mgf	*..*	2,7-dihydroxyapogeissoschizine	369.1809	qTof	LC-ESI	32	C/C=C1[C@]2([H])C[C@@]3([H])[C@@]4(O)N(C=C2C(OC)=O)C5=CC=CC=C5[C@@]4(O)CCN3C\1	InChI=1S/C21H24N2O4/c1-3-13-11-22-9-8-20(25)16-6-4-5-7-17(16)23-12-15(19(24)27-2)14(13)10-18(22)21(20,23)26/h3-7,12,14,18,25-26H,8-11H2,1-2H3/b13-3-/t14-,18-,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	368.1736	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	154850-61-0	Mehdi Beniddir
20_epi_serpentinine.mgf	*..*	20'-episerpentinine	685.3384	qTof	LC-ESI	31	C/C=C(C1)\[C@]([C@@H](C(OC)=O)CC2=C[N+]3=C(C[C@@](C(C(OC)=O)=CO[C@H]4C)([H])[C@@]4([H])C3)C5=C2C(C=CC=C6)=C6N5)([H])C[C@@](N1CC7)([H])C8=C7C9=CC=CC=C9N8	InChI=1S/C42H44N4O5/c1-5-24-19-45-15-14-27-26-10-6-8-12-34(26)43-39(27)36(45)17-29(24)31(41(47)49-3)16-25-20-46-21-32-23(2)51-22-33(42(48)50-4)30(32)18-37(46)40-38(25)28-11-7-9-13-35(28)44-40/h5-13,20,22-23,29-32,36,43H,14-19,21H2,1-4H3/p+1/b24-5-/t23-,29-,30-,31-,32-,36-/m0/s1	N/A	1	Positive	N/A	Isolated	685.3384	Alexander Fox Ramos	M+	N/A	3	Picralima	Picralima nitida	N/A	N/A	Mehdi Beniddir
20_epi-ervatamine.mgf	*..*	20-epiervatamine	355.2025	qTof	LC-ESI	30	CC[C@H]1CN(C)C[C@]2(C(OC)=O)[C@H]1CC(C3=C(C4=CC=CC=C4N3)C2)=O	InChI=1S/C21H26N2O3/c1-4-13-11-23(2)12-21(20(25)26-3)10-15-14-7-5-6-8-17(14)22-19(15)18(24)9-16(13)21/h5-8,13,16,22H,4,9-12H2,1-3H3/t13-,16-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	354.19434	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
3_4_5_6_tetradehydrogeissoschizol.mgf	*..*	3,4,5,6-tetradehydrogeissoschizol	293.1648	qTof	LC-ESI	33	C/C=C(C1)\C(CCO)CC2=[N+]1C=CC3=C2NC4=CC=CC=C43	InChI=1S/C19H20N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h2-7,9,14,22H,8,10-12H2,1H3/p+1/b13-2-	N/A	1	Positive	N/A	Isolated	293.1648	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
3_4_5_6_tetradehydrogeissospermine.mgf	*..*	3',4',5',6'-tetradehydrogeissospermine	629.3486	qTof	LC-ESI	34	C/C=C(C1)\[C@]([C@](C(OC)=O)([H])[C@]2([H])OC[C@]3([H])[C@]4([H])N2C5=C(C=CC=C5)[C@]46[C@]7([H])C[C@@]3([H])[C@H](CC)CN7CC6)([H])CC8=[N+]1C=CC9=C8NC%10=C9C=CC=C%10	InChI=1S/C40H44N4O3/c1-4-23-21-43-17-15-40-30-11-7-9-13-32(30)44-37(40)29(27(23)19-34(40)43)22-47-38(44)35(39(45)46-3)28-18-33-36-26(14-16-42(33)20-24(28)5-2)25-10-6-8-12-31(25)41-36/h5-14,16,23,27-29,34-35,37-38H,4,15,17-22H2,1-3H3/p+1/b24-5-/t23-,27+,28+,29+,34+,35-,37+,38+,40-/m1/s1	N/A	1	Positive	N/A	Isolated	629.3486	Alexander Fox Ramos	M+	N/A	3	Geissospermum	Geissospermum laeve	N/A	N/A	Mehdi Beniddir
3_4_5_6_tetradehydrolongicaudatine_Y.mgf	*..*	3',4',5',6'-tetradehydrolongicaudatine Y	567.3118	qTof	LC-ESI	35	[H][C@]12[C@]3(CCN4C/5)C6=CC=CC=C6N1C=C([C@]7([H])/C(C[N+](C=CC8=C9NC%10=CC=CC=C8%10)=C9C7)=C\C)[C@@H](O)[C@]2([H])[C@@](C5=C/C)([H])C[C@@]34[H]	InChI=1S/C38H38N4O/c1-3-22-19-40-15-13-25-24-9-5-7-11-30(24)39-35(25)32(40)17-26(22)28-21-42-31-12-8-6-10-29(31)38-14-16-41-20-23(4-2)27(18-33(38)41)34(36(28)43)37(38)42/h3-13,15,21,26-27,33-34,36-37,43H,14,16-20H2,1-2H3/p+1/b22-3-,23-4-/t26-,27-,33-,34-,36+,37-,38+/m0/s1	N/A	1	Positive	N/A	Isolated	567.3118	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
3_epimeloscine.mgf	*..*	3-epimeloscine	293.1648	qTof	LC-ESI	36	C=C[C@]12C[C@@]([C@@]3(CC4)[C@@]1([H])N4CC=C2)([H])C(NC5=C3C=CC=C5)=O	InChI=1S/C19H20N2O/c1-2-18-8-5-10-21-11-9-19(17(18)21)13-6-3-4-7-15(13)20-16(22)14(19)12-18/h2-8,14,17H,1,9-12H2,(H,20,22)/t14-,17-,18-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	292.1576	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	24314-58-7	Mehdi Beniddir
3_oxotabernaelegantine_B.mgf	*..*	3'-oxotabernaelegantine B	721.396	qTof	LC-ESI	37	CN1C(C2C(OC)=O)CC3=C([C@@H](C4=CC5=C(NC6=C5CC[N@@](C7=O)[C@]8([H])[C@@]6(C(OC)=O)C[C@H]7C[C@@H]8CC)C=C4OC)CC2[C@H](CC)C1)NC9=C3C=CC=C9	InChI=1S/C43H52N4O6/c1-7-22-15-24-20-43(42(50)53-6)38-26(13-14-47(39(22)43)40(24)48)28-17-29(35(51-4)19-33(28)45-38)30-16-27-23(8-2)21-46(3)34(36(27)41(49)52-5)18-31-25-11-9-10-12-32(25)44-37(30)31/h9-12,17,19,22-24,27,30,34,36,39,44-45H,7-8,13-16,18,20-21H2,1-6H3/t22-,23+,24+,27?,30+,34?,36-,39-,43+/m0/s1	N/A	1	Positive	N/A	Isolated	720.3887	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
3_R_S_hydroxytabernaelegantine_A.mgf	*..*	3-R,S-hydroxytabernaelegantine A	721.396	qTof	LC-ESI	38	CN1C(C2C(OC)=O)CC3=C([C@](C4=CC5=C(NC6=C5CC[N@](C7)[C@@]8([H])[C@]6(C(OC)=O)C[C@@]7([H])C[C@H]8CC)C=C4OC)(O)CC2[C@H](CC)C1)NC9=C3C=CC=C9	InChI=1S/C43H54N4O6/c1-7-24-15-23-19-42(41(49)53-6)37-27(13-14-47(21-23)39(24)42)28-16-31(35(51-4)18-33(28)45-37)43(50)20-30-25(8-2)22-46(3)34(36(30)40(48)52-5)17-29-26-11-9-10-12-32(26)44-38(29)43/h9-12,16,18,23-25,30,34,36,39,44-45,50H,7-8,13-15,17,19-22H2,1-6H3/t23-,24-,25-,30+,34+,36?,39-,42+,43+/m1/s1	N/A	1	Positive	N/A	Isolated	722.4043	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
6_7_dihydroflavopereirine.mgf	*..*	6,7-dihydroflavopereirine	249.1386	qTof	LC-ESI	41	CCC1=C[N+](CC2)=C(C=C1)C3=C2C4=CC=CC=C4[N-]3	InChI=1S/C17H16N2/c1-2-12-7-8-16-17-14(9-10-19(16)11-12)13-5-3-4-6-15(13)18-17/h3-8,11H,2,9-10H2,1H3	N/A	1	Positive	N/A	Isolated	248.1313	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	42281-83-4	Mehdi Beniddir
6-7-didehydroleuconoxine.mgf	*..*	6,7-didehydroleuconoxine	309.1594	qTof	LC-ESI	39	CC[C@]1(CCC2=O)CCCN3C(C=C4C5=CC=CC=C5N2C413)=O	InChI=1S/C19H20N2O2/c1-2-18-9-5-11-20-17(23)12-14-13-6-3-4-7-15(13)21(19(14,18)20)16(22)8-10-18/h3-4,6-7,12H,2,5,8-11H2,1H3/t18-,19?/m1/s1	N/A	1	Positive	N/A	Isolated	308.1525	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
6oxosilicine.mgf	*..*	6-oxosilicine	311.1756	qTof	LC-ESI	40	CN1C[C@@]2([H])C(C3=C(C(C[C@@]2([H])[C@@H](CC)C1)=O)NC4=CC=CC=C43)=O	InChI=1S/C19H22N2O2/c1-3-11-9-21(2)10-14-13(11)8-16(22)18-17(19(14)23)12-6-4-5-7-15(12)20-18/h4-7,11,13-14,20H,3,8-10H2,1-2H3/t11-,13-,14+/m0/s1	N/A	1	Positive	N/A	Isolated	310.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
9MeO_ellipticine.mgf	*..*	9-methoxyellipticine	277.1343	qTof	LC-ESI	42	CC1=C2C=CN=CC2=C(C)C3=C1NC4=CC=CC(OC)=C43	InChI=1S/C18H16N2O/c1-10-13-9-19-8-7-12(13)11(2)18-16(10)17-14(20-18)5-4-6-15(17)21-3/h4-9,20H,1-3H3	N/A	1	Positive	N/A	Isolated	276.12626	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
acetoxyreserpiline.mgf	*..*	Acetoxyreserpiline	471.2116	qTof	LC-ESI	43	C[C@@]1([H])[C@]2([H])CN3CCC4(OC(C)=O)C5=CC(OC)=C(OC)C=C5N=C4[C@@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C25H30N2O7/c1-13-16-11-27-7-6-25(34-14(2)28)18-9-21(30-3)22(31-4)10-19(18)26-23(25)20(27)8-15(16)17(12-33-13)24(29)32-5/h9-10,12-13,15-16,20H,6-8,11H2,1-5H3/t13-,15-,16-,20+,25?/m0/s1	N/A	1	Positive	N/A	Isolated	470.2053	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Acetyl_splendoline.mgf	*..*	Acetyl-splendoline	413.2071	qTof	LC-ESI	45	C[C@H]1OC[C@@]2([H])[C@]3([H])N(C(C(O)C(C)=O)=O)C4=CC=CC=C4[C@]35[C@]6(O)C[C@@]2([H])[C@@]1([H])CN6CC5	InChI=1S/C23H28N2O5/c1-12(26)19(27)21(28)25-18-6-4-3-5-17(18)22-7-8-24-10-15-13(2)30-11-16(20(22)25)14(15)9-23(22,24)29/h3-6,13-16,19-20,27,29H,7-11H2,1-2H3/t13-,14+,15+,16-,19?,20+,22+,23-/m1/s1	N/A	1	Positive	N/A	Isolated	412.1998	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
acetyl-epi-voacangarine.mgf	*..*	Acetyl-epi-voacangarine	427.2217	qTof	LC-ESI	44	COC([C@@]12CC3C[C@@H](C1[N@@](CCC4=C2NC5=C4C=C(OC)C=C5)C3)[C@H](OC(C)=O)C)=O	InChI=1S/C24H30N2O5/c1-13(31-14(2)27)18-9-15-11-24(23(28)30-4)21-17(7-8-26(12-15)22(18)24)19-10-16(29-3)5-6-20(19)25-21/h5-6,10,13,15,18,22,25H,7-9,11-12H2,1-4H3/t13-,15?,18-,22?,24-/m1/s1	N/A	1	Positive	N/A	Isolated	426.2154	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
afrocurarine.mgf	*..*	Afrocurarine	291.1675	qTof	LC-ESI	46	CCC1=C[N+]2=C(C=C1C3=CN4[C@H]5[C@@H]([C@H]3O)[C@H]\6C[C@H]7[C@@]5(CC[N+]7(C/C6=C\C)C)C8=CC=CC=C84)C9=C(CC2)C1=CC=CC=C1N9	InChI=1S/C39H41N4O/c1-4-23-20-41-16-14-26-25-10-6-8-12-31(25)40-36(26)33(41)18-27(23)29-21-42-32-13-9-7-11-30(32)39-15-17-43(3)22-24(5-2)28(19-34(39)43)35(37(29)44)38(39)42/h5-13,18,20-21,28,34-35,37-38,44H,4,14-17,19,22H2,1-3H3/q+1/p+1/b24-5+/t28-,34-,35+,37-,38-,39+,43?/m0/s1	N/A	2	Positive	N/A	Isolated	582.3358	Sarah Szwarc	M2+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Ajmaline.mgf	*..*	Ajmaline	327.2067	qTof	LC-ESI	47	CC[C@H]1[C@@H]2C[C@@]3([H])[C@]([C@@]4([C@H](O)[C@H]52)C[C@@H]5N3[C@@H]1O)([H])N(C)C6=C4C=CC=C6	InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1	N/A	1	Positive	N/A	Isolated	326.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
Akagerine.mgf	*..*	Akagerine	325.1911	qTof	LC-ESI	48	O[C@@H](C[C@H](/C(C=O)=C\C)C1)N2C([C@@]1([H])N(CC3)C)=C3C4=CC=CC=C24	InChI=1S/C20H24N2O2/c1-3-13(12-23)14-10-18-20-16(8-9-21(18)2)15-6-4-5-7-17(15)22(20)19(24)11-14/h3-7,12,14,18-19,24H,8-11H2,1-2H3/b13-3-/t14-,18?,19+/m1/s1	N/A	1	Positive	N/A	Isolated	324.1838	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	56519-07-4	Mehdi Beniddir
Akuammicine.mgf	*..*	Akuammicine	323.1754	qTof	LC-ESI	49	O=C(OC)C1=C2NC3=CC=CC=C3[C@]24[C@@H]5C[C@@]1([H])/C(CN5CC4)=C\C	InChI=1S/C20H22N2O2/c1-3-12-11-22-9-8-20-14-6-4-5-7-15(14)21-18(20)17(19(23)24-2)13(12)10-16(20)22/h3-7,13,16,21H,8-11H2,1-2H3/b12-3-/t13-,16-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	639-43-0	Mehdi Beniddir
Akuammidine.mgf	*..*	Akuammidine	353.186	qTof	LC-ESI	50	C/C=C(C1)\[C@@H]2C[C@@](N1[C@H](C2(CO)C(OC)=O)C3)([H])C4=C3C5=CC=CC=C5N4	InChI=1S/C21H24N2O3/c1-3-12-10-23-17-9-15(12)21(11-24,20(25)26-2)18(23)8-14-13-6-4-5-7-16(13)22-19(14)17/h3-7,15,17-18,22,24H,8-11H2,1-2H3/b12-3-/t15-,17-,18-,21?/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	639-36-1	Mehdi Beniddir
Akuammigine.mgf	*..*	Akuammigine	353.186	qTof	LC-ESI	51	O=C(OC)C1=CO[C@@H](C)[C@@](C2)([H])[C@]1([H])C[C@](N2CC3)([H])C4=C3C5=C(N4)C=CC=C5	InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	642-17-1	Mehdi Beniddir
Akuammiline.mgf	*..*	Akuammiline	395.1965	qTof	LC-ESI	52	[H][C@]1(C[C@@H]/2C3(COC(C)=O)C(OC)=O)C([C@@]43CCN1CC2=C\C)=NC5=C4C=CC=C5	InChI=1S/C23H26N2O4/c1-4-15-12-25-10-9-22-16-7-5-6-8-18(16)24-20(22)19(25)11-17(15)23(22,21(27)28-3)13-29-14(2)26/h4-8,17,19H,9-13H2,1-3H3/b15-4-/t17-,19-,22+,23?/m0/s1	N/A	1	Positive	N/A	Isolated	394.1893	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	1897-26-3	Mehdi Beniddir
Akuammine.mgf	*..*	Akuammine	383.1965	qTof	LC-ESI	53	OC1=CC2=C(N(C)[C@]3(OC[C@]45C(OC)=O)[C@@]24CCN6[C@@]3([H])C[C@H]5/C(C6)=C\C)C=C1	InChI=1S/C22H26N2O4/c1-4-13-11-24-8-7-21-16-9-14(25)5-6-17(16)23(2)22(21)18(24)10-15(13)20(21,12-28-22)19(26)27-3/h4-6,9,15,18,25H,7-8,10-12H2,1-3H3/b13-4-/t15-,18-,20-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	382.1893	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	3512-87-6	Mehdi Beniddir
Alloyohimbine.mgf	*..*	Alloyohimbine	355.2016	qTof	LC-ESI	54	[H][C@](N1CC2)(C[C@@]([C@@H](C(OC)=O)[C@@H](O)CC3)([H])[C@@]3([H])C1)C4=C2C5=C(N4)C=CC=C5	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15+,17+,18+,19-/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	522-94-1	Mehdi Beniddir
Alpha_colubrine.mgf	*..*	Alpha-colubrine	365.186	qTof	LC-ESI	56	O=C1C[C@@]2([H])[C@@]([C@@]3([H])C[C@@H]4N(CC5)CC3=CCO2)([H])[C@@]6([H])[C@]45C7=CC=C(OC)C=C7N61	InChI=1S/C22H24N2O3/c1-26-13-2-3-15-16(8-13)24-19(25)10-17-20-14-9-18-22(15,21(20)24)5-6-23(18)11-12(14)4-7-27-17/h2-4,8,14,17-18,20-21H,5-7,9-11H2,1H3/t14-,17-,18-,20-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	364.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	509-44-4	Mehdi Beniddir
Alpha_methylyohimbine.mgf	*..*	Alpha-methylyohimbine	369.2173	qTof	LC-ESI	57	[H][C@](N1CC2)(C[C@@]([C@H](C(OC)=O)[C@@H](O)CC3)([H])[C@@]3([H])C1)C4=C2C5=CC(C)=CC=C5N4	InChI=1S/C22H28N2O3/c1-12-3-5-17-16(9-12)14-7-8-24-11-13-4-6-19(25)20(22(26)27-2)15(13)10-18(24)21(14)23-17/h3,5,9,13,15,18-20,23,25H,4,6-8,10-11H2,1-2H3/t13-,15+,18+,19+,20?/m1/s1	N/A	1	Positive	N/A	Isolated	368.21	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
alphayohimbine.mgf	*..*	Alpha-yohimbine	355.2038	qTof	LC-ESI	55	COC([C@@H]1[C@H](CC[C@@]2([H])CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=C4C=CC=C5)O)=O	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15+,17+,18+,19+/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
alstofolinine-A.mgf	*..*	Alstofolinine A	297.1589	qTof	LC-ESI	58	CN1[C@@]2([H])CC(C3=CC=CC=C3N4C)=C4[C@]1([H])C[C@]5([H])[C@@]2([H])COC5=O	InChI=1S/C18H20N2O2/c1-19-15-7-11-10-5-3-4-6-14(10)20(2)17(11)16(19)8-12-13(15)9-22-18(12)21/h3-6,12-13,15-16H,7-9H2,1-2H3/t12-,13-,15+,16+/m1/s1	N/A	1	Positive	N/A	Isolated	296.1525	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	466-85-4	Beniddir/Le Pogam
alstolactone.mgf	*..*	Alstolactone	323.1747	qTof	LC-ESI	59	C/C=C1C(OC[C@@]([C@@]/1([H])C2)([H])[C@@](C3)([H])N[C@]2([H])C4=C3C5=CC=CC=C5N4C)=O	InChI=1S/C20H22N2O2/c1-3-11-13-8-17-19-14(12-6-4-5-7-18(12)22(19)2)9-16(21-17)15(13)10-24-20(11)23/h3-7,13,15-17,21H,8-10H2,1-2H3/b11-3+/t13-,15+,16-,17-/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
alstonerine.mgf	*..*	Alstonerine	337.1906	qTof	LC-ESI	60	CC(C1=COC[C@]2([H])[C@@]1([H])C[C@@]3([H])C4=C(C5=CC=CC=C5N4C)C[C@]2([H])N3C)=O	InChI=1S/C21H24N2O2/c1-12(24)16-10-25-11-17-14(16)8-20-21-15(9-19(17)22(20)2)13-6-4-5-7-18(13)23(21)3/h4-7,10,14,17,19-20H,8-9,11H2,1-3H3/t14-,17+,19-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	336.1838	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
alstonine.mgf	*..*	Alstonine	349.1545	qTof	LC-ESI	62	C[C@H]1[C@@H]2CN3C=CC4=C5C=CC=CC5=NC4=C3C[C@@H]2C(=CO1)C(=O)OC	InChI=1S/C21H20N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-8,11-12,15-16H,9-10H2,1-2H3/t12-,15-,16-/m0/s1	N/A	1	Positive	N/A	Isolated	348.1473	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
alstonine-6-methylpropionate.mgf	*..*	Alstonine-6-methylpropionate	435.19	qTof	LC-ESI	61	O=C(C1=CO[C@@H](C)[C@@]2([H])C[N+](C=C(CCC(OC)=O)C3=C4NC5=C3C=CC=C5)=C4C[C@@]21[H])OC	InChI=1S/C25H26N2O5/c1-14-18-12-27-11-15(8-9-22(28)30-2)23-16-6-4-5-7-20(16)26-24(23)21(27)10-17(18)19(13-32-14)25(29)31-3/h4-7,11,13-14,17-18H,8-10,12H2,1-3H3/p+1/t14-,17-,18+/m0/s1	N/A	1	Positive	N/A	Isolated	435.1914	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
alstophylline.mgf	*..*	Alstophylline	367.2008	qTof	LC-ESI	63	O=C(C)C1=COC[C@@]([C@@]1([H])C2)([H])[C@@](C3)([H])N(C)[C@]2([H])C4=C3C(C=C5)=C(C=C5OC)N4C	InChI=1S/C22H26N2O3/c1-12(25)17-10-27-11-18-15(17)8-21-22-16(9-20(18)23(21)2)14-6-5-13(26-4)7-19(14)24(22)3/h5-7,10,15,18,20-21H,8-9,11H2,1-4H3/t15-,18+,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Andrangine.mgf	*..*	Andrangine	297.1968	qTof	LC-ESI	64	CC[C@]12CC[C@]34[C@H]1N(C[C@@H]5[C@H]2O5)CC[C@H]3C6=CC=CC=C6N4	InChI=1S/C19H24N2O/c1-2-18-8-9-19-13(12-5-3-4-6-14(12)20-19)7-10-21(17(18)19)11-15-16(18)22-15/h3-6,13,15-17,20H,2,7-11H2,1H3/t13-,15+,16+,17-,18+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
andranginine.mgf	*..*	Andranginine	335.1754	qTof	LC-ESI	65	O=C([C@@]12[C@](C3=CCC2)([H])N(CC=C3)CCC4=C1NC5=CC=CC=C54)OC	InChI=1S/C21H22N2O2/c1-25-20(24)21-11-4-6-14-7-5-12-23(19(14)21)13-10-16-15-8-2-3-9-17(15)22-18(16)21/h2-3,5-9,19,22H,4,10-13H2,1H3/t19-,21-/m1/s1	N/A	1	Positive	N/A	Isolated	334.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
angustilobineB.mgf	*..*	Angustilobine B	339.1704	qTof	LC-ESI	66	COC([C@@]12COCC=C3CN(Cc(c2[nH]4)c5c4cccc5)CC[C@]13[H])=O	InChI=1S/C20H22N2O3/c1-24-19(23)20-12-25-9-7-13-10-22(8-6-16(13)20)11-15-14-4-2-3-5-17(14)21-18(15)20/h2-5,7,16,21H,6,8-12H2,1H3/t16-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	338.163	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
angustilongineA.mgf	*..*	Angustilongine A	707.4141	qTof	LC-ESI	67	CN([C@@]([C@@]1([H])[C@@]([C@@]([C@H](C)C2=C(OC)C=C3C([C@@]4([C@@H]5C(OC)=O)C([C@@](C[C@]5([H])/C(C6)=C\C)([H])N6CC4)N3C)=C2)([H])[C@@H](O)OC1)([H])C7)([H])C8)[C@]7([H])C9=C8C%10=CC=CC=C%10N9C	InChI=1S/C43H54N4O5/c1-8-23-20-47-14-13-43-30-15-25(36(50-6)19-33(30)46(5)40(43)35(47)16-26(23)38(43)42(49)51-7)22(2)37-27-17-34-39-28(24-11-9-10-12-31(24)45(39)4)18-32(44(34)3)29(27)21-52-41(37)48/h8-12,15,19,22,26-27,29,32,34-35,37-38,40-41,48H,13-14,16-18,20-21H2,1-7H3/b23-8-/t22-,26-,27-,29-,32+,34+,35+,37+,38?,40?,41+,43+/m1/s1	N/A	1	Positive	N/A	Isolated	706.4094	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
angustilongineB.mgf	*..*	Angustilongine B	675.386	qTof	LC-ESI	68	CN([C@@]([C@@]1([H])[C@@]([C@@]2([H])[C@@](OC(C=C3C(C4([C@]5([H])C(OC)=O)[C@@]([C@@](C[C@]5([H])/C(C6)=C\C)([H])N6CC4)([H])N3C)=C7)=C7[C@H]2C)([H])OC1)([H])C8)([H])C9)[C@]8([H])C%10=C9C%11=CC=CC=C%11N%10C	InChI=1S/C42H50N4O4/c1-7-22-19-46-13-12-42-29-14-24-21(2)36-26-16-33-38-27(23-10-8-9-11-30(23)44(38)4)17-31(43(33)3)28(26)20-49-41(36)50-35(24)18-32(29)45(5)39(42)34(46)15-25(22)37(42)40(47)48-6/h7-11,14,18,21,25-26,28,31,33-34,36-37,39,41H,12-13,15-17,19-20H2,1-6H3/b22-7-/t21-,25-,26-,28-,31+,33+,34+,36+,37?,39?,41+,42?/m1/s1	N/A	1	Positive	N/A	Isolated	674.3832	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
angustilongineK.mgf	*..*	Angustilongine K	677.4045	qTof	LC-ESI	69	CN([C@@]([C@@](CO)([H])[C@@]([C@@](C(C)=O)([H])CC1=CC2=C(C3=C([C@@](C[C@]4([H])/C(C5)=C\C)([H])N5[C@H]([C@]4([H])CO)C3)N2C)C=C1OC)([H])C6)([H])C7)[C@]6([H])C8=C7C9=CC=CC=C9N8C	InChI=1S/C42H52N4O4/c1-7-23-19-46-37-17-31-29-18-40(50-6)24(13-35(29)45(5)42(31)39(46)14-27(23)32(37)20-47)12-26(22(2)49)28-15-38-41-30(16-36(43(38)3)33(28)21-48)25-10-8-9-11-34(25)44(41)4/h7-11,13,18,26-28,32-33,36-39,47-48H,12,14-17,19-21H2,1-6H3/b23-7-/t26-,27+,28-,32+,33+,36-,37-,38-,39-/m0/s1	N/A	1	Positive	N/A	Isolated	676.3989	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Angustine.mgf	*..*	Angustine	314.1288	qTof	LC-ESI	70	C=CC1=CN=CC(C2=O)=C1C=C(N2CC3)C4=C3C5=CC=CC=C5N4	InChI=1S/C20H15N3O/c1-2-12-10-21-11-16-15(12)9-18-19-14(7-8-23(18)20(16)24)13-5-3-4-6-17(13)22-19/h2-6,9-11,22H,1,7-8H2	N/A	1	Positive	N/A	Isolated	313.1215	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	40041-96-1	Mehdi Beniddir
angustoline.mgf	*..*	Angustoline	332.14	qTof	LC-ESI	71	CC(O)c1cncc2c1cc1-c3[nH]c4ccccc4c3CCn1c2=O	InChI=1S/C20H17N3O2/c1-11(24)15-9-21-10-16-14(15)8-18-19-13(6-7-23(18)20(16)25)12-4-2-3-5-17(12)22-19/h2-5,8-11,22,24H,6-7H2,1H3	N/A	1	Positive	N/A	Isolated	331.1321	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
anhydro_vinblastine_disulfate.mgf	*..*	Anhydro-vinblastine-disulfate	793.4163	qTof	LC-ESI	72	CCC1=CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC	InChI=1S/C46H56N4O8/c1-8-28-21-29-24-45(41(52)56-6,37-31(15-19-49(25-28)26-29)30-13-10-11-14-34(30)47-37)33-22-32-35(23-36(33)55-5)48(4)39-44(32)17-20-50-18-12-16-43(9-2,38(44)50)40(58-27(3)51)46(39,54)42(53)57-7/h10-14,16,21-23,29,38-40,47,54H,8-9,15,17-20,24-26H2,1-7H3	N/A	1	Positive	N/A	Isolated	792.4098	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Antirhine.mgf	*..*	Antirhine	297.1961	qTof	LC-ESI	73	C=C[C@@H](CO)[C@](CC1)([H])C[C@@](N1CC2)([H])C3=C2C4=C(N3)C=CC=C4	InChI=1S/C19H24N2O/c1-2-13(12-22)14-7-9-21-10-8-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14/h2-6,13-14,18,20,22H,1,7-12H2/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	16049-28-8	Mehdi Beniddir
Apo-delta_14_vincamine.mgf	*..*	Apo-delta-14-vincamine	335.1763	qTof	LC-ESI	74	[H][C@]12[C@]3(CC)C=C(C(OC)=O)N4C5=CC=CC=C5C(CCN2CC=C3)=C41	InChI=1S/C21H22N2O2/c1-3-21-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(18(15)19(21)22)17(13-21)20(24)25-2/h4-8,10,13,19H,3,9,11-12H2,1-2H3/t19-,21+/m1/s1	N/A	1	Positive	N/A	Isolated	334.16813	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Apparicine.mgf	*..*	Apparicine	265.1699	qTof	LC-ESI	75	C=C([C@]1([H])CCN(C2)C/C1=C/C)C3=C2C4=C(N3)C=CC=C4	InChI=1S/C18H20N2/c1-3-13-10-20-9-8-14(13)12(2)18-16(11-20)15-6-4-5-7-17(15)19-18/h3-7,14,19H,2,8-11H2,1H3/b13-3-/t14-/m0/s1	N/A	1	Positive	N/A	Isolated	264.1626	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
arboflorine.mgf	*..*	Arboflorine	308.178	qTof	LC-ESI	76	C[C@H]1NC([C@@]2([H])[C@@]3([H])N(CCC4=C2NC5=C4C=CC=C5)CCC=C13)=O	InChI=1S/C19H21N3O/c1-11-12-6-4-9-22-10-8-14-13-5-2-3-7-15(13)21-17(14)16(18(12)22)19(23)20-11/h2-3,5-7,11,16,18,21H,4,8-10H2,1H3,(H,20,23)/t11-,16-,18+/m1/s1	N/A	1	Positive	N/A	Isolated	307.1685	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arbolodinineA.mgf	*..*	Arbolodinine A	657.3432	qTof	LC-ESI	77	O=C(OC)[C@H]1[C@@]23NC4=CC=CC=C4[C@]25[C@]6([H])[C@@](CC(C7=[N+](CCC[C@]89CC[C@]%10%11[C@H](C([O-])=O)C9)[C@]8([H])[C@]%10(C%12=C(C=CC=C%12)N%11)C7)=CN6CC5)(C1)CC3	InChI=1S/C41H44N4O4/c1-49-33(48)28-21-37-13-15-41(28)38(25-7-2-4-9-29(25)43-41)16-18-44(34(37)38)23-24(19-37)31-22-39-26-8-3-5-10-30(26)42-40(39)14-12-36(20-27(40)32(46)47)11-6-17-45(31)35(36)39/h2-5	N/A	1	Positive	N/A	Isolated	656.3363	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arbolodinineB.mgf	*..*	Arbolodinine B	615.3689	qTof	LC-ESI	78	O=C(OC)[C@H]1[C@@]23N(CC4=C5[C@@](C(C=CC=C6)=C6N5)(CC7)[C@](N7C/8)([H])C[C@@]4([H])C8=C/C)C9=CC=CC=C9[C@]2%10[C@]%11([H])[C@@](CCCN%11CC%10)(C1)CC3	InChI=1S/C40H46N4O2/c1-3-25-23-43-19-16-38-28-9-4-6-11-31(28)41-34(38)27(26(25)21-33(38)43)24-44-32-12-7-5-10-29(32)39-17-20-42-18-8-13-37(36(39)42)14-15-40(39,44)30(22-37)35(45)46-2/h3-7,9-12,26,30,33,36,41H,8,13-24H2,1-2H3/b25-3-/t26-,30-,33-,36-,37+,38+,39+,40+/m0/s1	N/A	1	Positive	N/A	Isolated	614.3621	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arbophyllidine.mgf	*..*	Arbophyllidine	277.1699	qTof	LC-ESI	79	C=C([C@@]1(CC[N@@]2C/C1=C/C)[C@@]2([H])C3)C4=C3C5=CC=CC=C5N4	InChI=1S/C19H20N2/c1-3-13-11-21-9-8-19(13)12(2)18-15(10-17(19)21)14-6-4-5-7-16(14)20-18/h3-7,17,20H,2,8-11H2,1H3/b13-3-/t17-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	276.1626	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arbophyllinineA.mgf	*..*	ArbophyllinineA	327.1727	qTof	LC-ESI	80	[H][C@]([C@@]1([C@@H](O)C)C2)(C(CO1)=O)C[C@@](N2CC3)([H])C4=C3C5=CC=CC=C5N4	InChI=1S/C19H22N2O3/c1-11(22)19-10-21-7-6-13-12-4-2-3-5-15(12)20-18(13)16(21)8-14(19)17(23)9-24-19/h2-5,11,14,16,20,22H,6-10H2,1H3/t11-,14+,16-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	326.163	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arboricine.mgf	*..*	Arboricine	295.1803	qTof	LC-ESI	81	CC([C@H]1C[C@]2([H])C3=C(C4=CC=CC=C4N3)CCN2C/C1=C/C)=O	InChI=1S/C19H22N2O/c1-3-13-11-21-9-8-15-14-6-4-5-7-17(14)20-19(15)18(21)10-16(13)12(2)22/h3-7,16,18,20H,8-11H2,1-2H3/b13-3-/t16-,18-/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arboricinine.mgf	*..*	Arboricinine	295.18	qTof	LC-ESI	82	CC([C@H]1CCN2CCC(C3=CC=CC=C3N4)=C4[C@]2([H])/C1=C/C)=O	InChI=1S/C19H22N2O/c1-3-13-14(12(2)22)8-10-21-11-9-16-15-6-4-5-7-17(15)20-18(16)19(13)21/h3-7,14,19-20H,8-11H2,1-2H3/b13-3+/t14-,19+/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arboridinine.mgf	*..*	Arboridinine	295.1804	qTof	LC-ESI	83	C[C@H]([C@@]1(CC2)C([C@@]3(C)C[N@@]2C4)=NC5=CC=CC=C51)[C@@]4(O)C3=C	InChI=1S/C19H22N2O/c1-12-17(3)10-21-9-8-18(13(2)19(12,22)11-21)14-6-4-5-7-15(14)20-16(17)18/h4-7,13,22H,1,8-11H2,2-3H3/t13-,17+,18-,19+/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arborisidine.mgf	*..*	Arborisidine	281.1643	qTof	LC-ESI	84	C[C@@]1([C@@]2([H])CCN1CC3)C4=NC5=CC=CC=C5[C@@]43[C@H](C)C2=O	InChI=1S/C18H20N2O/c1-11-15(21)13-7-9-20-10-8-18(11)12-5-3-4-6-14(12)19-16(18)17(13,20)2/h3-6,11,13H,7-10H2,1-2H3/t11-,13+,17-,18-/m1/s1	N/A	1	Positive	N/A	Isolated	280.1576	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
arbornamine.mgf	*..*	Arbornamine	311.175	qTof	LC-ESI	85	[H][C@]1(C[C@@H](O)N2C3=CC=CC=C43)/C(CN5CCC4=C2[C@@]15CO)=C\C	InChI=1S/C19H22N2O2/c1-2-12-10-20-8-7-14-13-5-3-4-6-16(13)21-17(23)9-15(12)19(20,11-22)18(14)21/h2-6,15,17,22-23H,7-11H2,1H3/b12-2-/t15-,17+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	310.1681	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
ARICINE.mgf	*..*	Aricine	383.1971	qTof	LC-ESI	86	C[C@H]1[C@]2([H])CN3CCC(C4=C(N5)C=CC(OC)=C4)=C5[C@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C22H26N2O4/c1-12-17-10-24-7-6-14-16-8-13(26-2)4-5-19(16)23-21(14)20(24)9-15(17)18(11-28-12)22(25)27-3/h4-5,8,11-12,15,17,20,23H,6-7,9-10H2,1-3H3/t12-,15-,17-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	382.2893	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Aspidofractinine.mgf	*..*	Aspidofractinine	281.2012	qTof	LC-ESI	87	[H][C@]12C3(CC4)CCC54NC6=CC=CC=C6[C@@]51CCN2CCC3	InChI=1S/C19H24N2/c1-2-5-15-14(4-1)19-11-13-21-12-3-6-17(16(19)21)7-9-18(19,20-15)10-8-17/h1-2,4-5,16,20H,3,6-13H2/t16-,17?,18?,19+/m0/s1	N/A	1	Positive	N/A	Isolated	280.1939	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	6871-25-6	Mehdi Beniddir
aspidoreticulofractine.mgf	*..*	Aspidoreticulofractinine	371.1967	qTof	LC-ESI	88	O=C(OC)C(C1)[C@@]23NC4=CC=CC=C4[C@]25[C@@H]([N@@+]6([O-])CC5)[C@]1([C@@H](O)CC6)CC3	InChI=1S/C21H26N2O4/c1-27-17(25)14-12-19-7-8-21(14)20(13-4-2-3-5-15(13)22-21)9-11-23(26,18(19)20)10-6-16(19)24/h2-5,14,16,18,22,24H,6-12H2,1H3/t14?,16-,18-,19+,20+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	370.1893	Mehdi Beniddir	M+H	N/A	3	Melodinus	Melodinus reticulatus	N/A	N/A	Beniddir/Le Pogam
aspidospermidine.mgf	*..*	Aspidospermidine	283.2169	qTof	LC-ESI	89	CC[C@@]12CCCN3CC[C@]4([C@@]23[H])[C@@](NC5=C4C=CC=C5)([H])CC1	InChI=1S/C19H26N2/c1-2-18-9-5-12-21-13-11-19(17(18)21)14-6-3-4-7-15(14)20-16(19)8-10-18/h3-4,6-7,16-17,20H,2,5,8-13H2,1H3/t16-,17-,18-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	282.2096	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
betayohimbine.mgf	*..*	Beta-yohimbine	355.2041	qTof	LC-ESI	90	COC([C@H]1[C@@H](CC[C@@]2([H])CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=C4C=CC=C5)O)=O	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Bipleiophylline.mgf	*..*	Bipleiophylline	795.3388	qTof	LC-ESI	91	O=C(OC)[C@H]1N2[C@@]3(OC(C4=C(O)C(O5)=C(C=C46)[C@]78CCN(C/C9=C/C)[C@]%10([H])[C@@]75N(C%11=CC=CC=C%118)[C@H](C(OC)=O)[C@@]9([H])C%10)=O)[C@@]6(CCN(C/%12)[C@@]3([H])C[C@@]1([H])C%12=C/C)C%13=C2C=CC=C%13	InChI=1S/C47H46N4O8/c1-5-24-22-48-18-16-45-29-12-8-10-14-33(29)50-37(42(54)56-3)26(24)19-34(48)46(45,50)58-40-31(45)21-30-36(39(40)52)41(53)59-47-35-20-27-25(6-2)23-49(35)17-15-44(30,47)28-11-7-9-13-32(28)51(47)38(27)43(55)57-4/h5-14,21,26-27,34-35,37-38,52H,15-20,22-23H2,1-4H3/b24-5-,25-6-/t26-,27-,34-,35-,37-,38-,44-,45+,46-,47-/m0/s1	N/A	1	Positive	N/A	Other	794.3316	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia angustifolia	N/A	N/A	Mehdi Beniddir
Brucine.mgf	*..*	Brucine	395.1965	qTof	LC-ESI	92	O=C1C[C@@]2([H])[C@@]([C@@]3([H])C[C@@H]4N(CC5)CC3=CCO2)([H])[C@@]6([H])[C@]45C7=CC(OC)=C(OC)C=C7N61	InChI=1S/C23H26N2O4/c1-27-16-8-14-15(9-17(16)28-2)25-20(26)10-18-21-13-7-19-23(14,22(21)25)4-5-24(19)11-12(13)3-6-29-18/h3,8-9,13,18-19,21-22H,4-7,10-11H2,1-2H3/t13-,18-,19-,21-,22-,23+/m0/s1	N/A	1	Positive	N/A	Isolated	394.1893	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	357-57-3	Mehdi Beniddir
Burnamine.mgf	*..*	Burnamine	369.1809	qTof	LC-ESI	93	C/C=C1[C@@H]2C[C@@]3([H])[C@@]([C@@]4(C(CO)2C(OC)=O)C[C@H]5N3C\1)(O5)NC6=C4C=CC=C6	InChI=1S/C21H24N2O4/c1-3-12-10-23-16-8-14(12)19(11-24,18(25)26-2)20-9-17(23)27-21(16,20)22-15-7-5-4-6-13(15)20/h3-7,14,16-17,22,24H,8-11H2,1-2H3/b12-3-/t14-,16-,17-,19?,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	368.1736	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	6808-68-0	Mehdi Beniddir
C_fluorocurarine.mgf	*..*	C-Fluorocurarine	307.18	qTof	LC-ESI	138	CC=C1C[N+]2(CCC34[C@@H]2C[C@@H]1C(=C3NC5=CC=CC=C45)C=O)C	InChI=1S/C20H22N2O/c1-3-13-11-22(2)9-8-20-16-6-4-5-7-17(16)21-19(20)15(12-23)14(13)10-18(20)22/h3-7,12,14,18H,8-11H2,1-2H3/p+1/t14-,18-,20?,22?/m0/s1	N/A	1	Positive	N/A	Isolated	307.18	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
cabucine.mgf	*..*	Cabucine	383.1967	qTof	LC-ESI	94	C[C@H]1[C@@]2([H])CN3CCC(C4=C(N5)C=CC(OC)=C4)=C5[C@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C22H26N2O4/c1-12-17-10-24-7-6-14-16-8-13(26-2)4-5-19(16)23-21(14)20(24)9-15(17)18(11-28-12)22(25)27-3/h4-5,8,11-12,15,17,20,23H,6-7,9-10H2,1-3H3/t12-,15-,17+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	382.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Cadambine.mgf	*..*	Cadambine	545.2114	qTof	LC-ESI	95	O=C(OC)C1=CO[C@@H](OC2C(O)C(O)C(O)C(CO)O2)[C@@]3([H])[C@]1([H])C[C@]45N(CCC6=C5NC7=C6C=CC=C7)C[C@H]3O4	InChI=1S/C27H32N2O10/c1-35-24(34)15-11-36-25(38-26-22(33)21(32)20(31)18(10-30)37-26)19-14(15)8-27-23-13(6-7-29(27)9-17(19)39-27)12-4-2-3-5-16(12)28-23/h2-5,11,14,17-22,25-26,28,30-33H,6-10H2,1H3/t14-,17-,18?,19+,20?,21?,22?,25+,26?,27+/m1/s1	N/A	1	Positive	N/A	Isolated	544.2057	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
callichiline.mgf	*..*	Callichiline	689.3878	qTof	LC-ESI	96	COC1=CC=CC2=C1N[C@]34[C@@]25CCN6[C@H]3[C@]7(CCO[C@H]7CC6)C[C@H]4C[C@]58CN9CC[C@@]12[C@@H]9[C@@]3([C@H]8OCC3)CC(=C1NC1=CC=CC=C21)C(=O)OC	InChI=1S/C42H48N4O5/c1-48-29-9-5-7-27-31(29)44-42-24-20-37-13-18-50-30(37)10-15-45(35(37)42)17-12-41(27,42)39(21-24)23-46-16-11-40-26-6-3-4-8-28(26)43-32(40)25(33(47)49-2)22-38(34(40)46)14-19-51-36(38)39/h3-9,24,30,34-36,43-44H,10-23H2,1-2H3/t24-,30-,34-,35-,36+,37+,38-,39+,40-,41-,42-/m0/s1	N/A	1	Positive	N/A	Isolated	688.3624	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Camptothecine.mgf	*..*	Camptothecine	349.1183	qTof	LC-ESI	97	O=C1C2=C([C@@](O)(CC)C(OC2)=O)C=C(N1C3)C(C3=C4)=NC5=C4C=CC=C5	InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1	N/A	1	Positive	N/A	Commercial	348.111	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
caracurine_V.mgf	*..*	Caracurine V	585.3222	qTof	LC-ESI	98	C1CN2CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@@]16[C@H]5N([C@H]7[C@@H]8[C@H]9C[C@H]1[C@@]2([C@H]8N4C3=CC=CC=C32)CCN1CC9=CCO7)C1=CC=CC=C61	InChI=1S/C38H40N4O2/c1-3-7-27-25(5-1)37-11-13-39-19-21-10-16-44-36-31(23(21)17-29(37)39)33(37)41(27)35-32-24-18-30-38(12-14-40(30)20-22(24)9-15-43-35)26-6-2-4-8-28(26)42(36)34(32)38/h1-10,23-24,29-36H,11-20H2/t23-,24-,29-,30-,31+,32+,33-,34-,35+,36+,37+,38+/m0/s1	N/A	1	Positive	N/A	Isolated	584.3152	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Carapanaubine.mgf	*..*	Carapanaubine	429.202	qTof	LC-ESI	99	COC(C([C@]1(C2)[H])=CO[C@H]([C@@]1(CN3CCC4(C(NC(C=C5OC)=C4C=C5OC)=O)[C@]23[H])[H])C)=O	InChI=1S/C23H28N2O6/c1-12-14-10-25-6-5-23(20(25)7-13(14)15(11-31-12)21(26)30-4)16-8-18(28-2)19(29-3)9-17(16)24-22(23)27/h8-9,11-14,20H,5-7,10H2,1-4H3,(H,24,27)/t12-,13-,14-,20-,23+/m0/s1	N/A	1	Positive	N/A	Isolated	428.1947	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	1255-02-3	Mehdi Beniddir
Catharanthine.mgf	*..*	Catharanthine	337.1911	qTof	LC-ESI	100	CCC1=C[C@H]2C[C@](C1[N@@](C2)CC3)(C(OC)=O)C4=C3C5=C(N4)C=CC=C5	InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3/t13-,19?,21-/m0/s1	N/A	1	Positive	N/A	Isolated	336.1838	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2468-21-5	Mehdi Beniddir
Ceridimine.mgf	*..*	Ceridimine	497.2911	qTof	LC-ESI	101	CN1[C@@]([C@@]([C@H](C[C@@H]2C3=CC(NC=C4CCN)=C4C=C3)/C(C1)=C\C)([H])C(OC)=O)([H])CC5=C2NC6=CC=CC=C56	InChI=1S/C31H36N4O2/c1-4-18-17-35(2)28-15-25-22-7-5-6-8-26(22)34-30(25)24(14-23(18)29(28)31(36)37-3)19-9-10-21-20(11-12-32)16-33-27(21)13-19/h4-10,13,16,23-24,28-29,33-34H,11-12,14-15,17,32H2,1-3H3/b18-4-/t23-,24-,28+,29?/m1/s1	N/A	1	Positive	N/A	Isolated	496.2838	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	102719-93-7	Mehdi Beniddir
chlorhydrate-eburnamonine.mgf	*..*	Eburnamonine	295.1806	qTof	LC-ESI	102	CC[C@@]1(CC2=O)CCCN3CCC(C4=CC=CC=C4N25)=C5[C@]13[H]	InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
chlorhydrate-homovincamone.mgf	*..*	Homovincamone	309.196	qTof	LC-ESI	103	[H][C@](N1CC2)([C@@]3(CC)CCC1)C4=C2C5=CC=CC=C5N4C(CC3)=O	InChI=1S/C20H24N2O/c1-2-20-10-5-12-21-13-9-15-14-6-3-4-7-16(14)22(17(23)8-11-20)18(15)19(20)21/h3-4,6-7,19H,2,5,8-13H2,1H3/t19-,20+/m1/s1	N/A	1	Positive	N/A	Isolated	308.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
chlorhydrate-N-Me-dregamine.mgf	*..*	N-Me Dregamine	369.2169	qTof	LC-ESI	104	CC[C@H]([C@H]([C@@H]1C(OC)=O)CC2=O)CN([C@@H]1CC3=C2N(C)C4=CC=CC=C34)C	InChI=1S/C22H28N2O3/c1-5-13-12-23(2)18-10-16-14-8-6-7-9-17(14)24(3)21(16)19(25)11-15(13)20(18)22(26)27-4/h6-9,13,15,18,20H,5,10-12H2,1-4H3/t13-,15+,18+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	368.21	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Cinchonamine_HCl.mgf	*..*	Cinchonamine HCl	297.1961	qTof	LC-ESI	105	OCCC1=C([C@@]2([H])[N@@](CC3)C[C@H](C=C)[C@@H]3C2)NC4=CC=CC=C14	InChI=1S/C19H24N2O/c1-2-13-12-21-9-7-14(13)11-18(21)19-16(8-10-22)15-5-3-4-6-17(15)20-19/h2-6,13-14,18,20,22H,1,7-12H2/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	482-28-0	Mehdi Beniddir
Cinchonidine.mgf	*..*	Cinchonidine	295.1802	qTof	LC-ESI	106	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)C3=CC=NC4=CC=CC=C34	InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	294.1732	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
cinchonine.mgf	*..*	Cinchonine	295.1798	qTof	LC-ESI	107	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=CC=NC4=CC=CC=C34)O	InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18+,19-/m0/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Condylocarpine.mgf	*..*	Condylocarpine	323.1754	qTof	LC-ESI	108	C/C=C1[C@@H]2CCN3[C@H]/1[C@@]4(C5=CC=CC=C5NC4=C2C(OC)=O)CC3	InChI=1S/C20H22N2O2/c1-3-12-13-8-10-22-11-9-20(18(12)22)14-6-4-5-7-15(14)21-17(20)16(13)19(23)24-2/h3-7,13,18,21H,8-11H2,1-2H3/b12-3-/t13-,18+,20+/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Condylocarpine_N_oxyde.mgf	*..*	Condylocarpine N-oxide	339.1714	qTof	LC-ESI	109	C/C=C1C(CC2)C(C(OC)=O)=C3NC4=CC=CC=C4[C@@]35[C@@H]/1[N@+]2([O-])CC5	InChI=1S/C20H22N2O3/c1-3-12-13-8-10-22(24)11-9-20(18(12)22)14-6-4-5-7-15(14)21-17(20)16(13)19(23)25-2/h3-7,13,18,21H,8-11H2,1-2H3/b12-3-/t13?,18-,20-,22-/m1/s1	N/A	1	Positive	N/A	Isolated	338.163	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia vieillardii	N/A	74918-28-8	Mehdi Beniddir
conodiparineA.mgf	*..*	Conodiparine A	751.4065	qTof	LC-ESI	110	O[C@@H](C)[C@@]([C@@]12[H])([H])C[C@@H]3C[C@@]1(C(OC)=O)C4=C(C5=CC([C@H]6C[C@@H]([C@@]7(C(OC)=O)CO)/C(CN([C@@H]7CC8=C6NC9=CC=CC=C89)C)=C\C)=C(OC)C=C5N4)CC[N@]2C3	InChI=1S/C44H54N4O7/c1-7-25-21-47(3)37-17-32-26-10-8-9-11-34(26)45-38(32)31(16-33(25)44(37,22-49)42(52)55-6)30-15-29-27-12-13-48-20-24-14-28(23(2)50)40(48)43(19-24,41(51)54-5)39(27)46-35(29)18-36(30)53-4/h7-11,15,18,23-24,28,31,33,37,40,45-46,49-50H,12-14,16-17,19-22H2,1-6H3/b25-7-/t23-,24+,28+,31+,33+,37+,40-,43+,44-/m0/s1	N/A	1	Positive	N/A	Isolated	750.3993	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodiparineB.mgf	*..*	Conodiparine B	751.4056	qTof	LC-ESI	111	CN1[C@H](C2(C(OC)=O)CO)CC3=C([C@@]([H])(C4=C(NC5=C6CCN7[C@]8([H])[C@@]5(C(OC)=O)C[C@](C7)([H])C[C@]8([H])[C@@H](O)C)C6=CC=C4OC)C[C@@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C44H54N4O7/c1-7-25-21-47(3)35-18-30-26-10-8-9-11-33(26)45-37(30)31(17-32(25)44(35,22-49)42(52)55-6)36-34(53-4)13-12-27-28-14-15-48-20-24-16-29(23(2)50)40(48)43(19-24,41(51)54-5)39(28)46-38(27)36/h7-13,23-24,29,31-32,35,40,45-46,49-50H,14-22H2,1-6H3/b25-7-/t23-,24-,29+,31+,32-,35-,40-,43?,44?/m0/s1	N/A	1	Positive	N/A	Isolated	750.3992	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodiparineC.mgf	*..*	Conodiparine C	749.3896	qTof	LC-ESI	112	CN1[C@H](C2(C(OC)=O)CO)CC3=C([C@@]([H])(C4=C(OC)C=C(NC5=C6CCN7[C@]8([H])[C@@]5(C(OC)=O)C[C@](C7)([H])C[C@]8([H])C(C)=O)C6=C4)C[C@@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C44H52N4O7/c1-7-25-21-47(3)37-17-32-26-10-8-9-11-34(26)45-38(32)31(16-33(25)44(37,22-49)42(52)55-6)30-15-29-27-12-13-48-20-24-14-28(23(2)50)40(48)43(19-24,41(51)54-5)39(27)46-35(29)18-36(30)53-4/h7-11,15,18,24,28,31,33,37,40,45-46,49H,12-14,16-17,19-22H2,1-6H3/b25-7-/t24-,28+,31+,33-,37-,40-,43?,44?/m0/s1	N/A	1	Positive	N/A	Isolated	748.3836	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodiparineD.mgf	*..*	Conodiparine D	749.3892	qTof	LC-ESI	113	CN1[C@H](C2(C(OC)=O)CO)CC3=C([C@@]([H])(C4=C(NC5=C6CCN7[C@]8([H])[C@@]5(C(OC)=O)C[C@](C7)([H])C[C@]8([H])C(C)=O)C6=CC=C4OC)C[C@@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C44H52N4O7/c1-7-25-21-47(3)35-18-30-26-10-8-9-11-33(26)45-37(30)31(17-32(25)44(35,22-49)42(52)55-6)36-34(53-4)13-12-27-28-14-15-48-20-24-16-29(23(2)50)40(48)43(19-24,41(51)54-5)39(28)46-38(27)36/h7-13,24,29,31-32,35,40,45-46,49H,14-22H2,1-6H3/b25-7-/t24-,29+,31+,32-,35-,40-,43?,44?/m0/s1	N/A	1	Positive	N/A	Isolated	748.3836	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodiparineE.mgf	*..*	Conodiparine E	737.3904	qTof	LC-ESI	114	[H][C@@](C[C@]/1([H])C2(C(OC)=O)CO)(C3=C(OC)C=C(NC4=C5CCN6[C@]7([H])[C@@]4(C(OC)=O)C[C@](C6)([H])C[C@]7([H])[C@@H](O)C)C5=C3)C8=C(C[C@@H]2NCC1=C\C)C9=CC=CC=C9N8	InChI=1S/C43H52N4O7/c1-6-24-19-44-36-16-31-25-9-7-8-10-33(25)45-37(31)30(15-32(24)43(36,21-48)41(51)54-5)29-14-28-26-11-12-47-20-23-13-27(22(2)49)39(47)42(18-23,40(50)53-4)38(26)46-34(28)17-35(29)52-3/h6-10,14,17,22-23,27,30,32,36,39,44-46,48-49H,11-13,15-16,18-21H2,1-5H3/b24-6-/t22-,23-,27+,30+,32-,36-,39-,42?,43?/m0/s1	N/A	1	Positive	N/A	Isolated	736.3836	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodiparineF.mgf	*..*	Conodiparine F	737.3891	qTof	LC-ESI	115	[H][C@@](C[C@]/1([H])C2(C(OC)=O)CO)(C3=C(NC4=C5CCN6[C@]7([H])[C@@]4(C(OC)=O)C[C@](C6)([H])C[C@]7([H])[C@@H](O)C)C5=CC=C3OC)C8=C(C[C@@H]2NCC1=C\C)C9=CC=CC=C9N8	InChI=1S/C43H52N4O7/c1-6-24-19-44-34-17-29-25-9-7-8-10-32(25)45-36(29)30(16-31(24)43(34,21-48)41(51)54-5)35-33(52-3)12-11-26-27-13-14-47-20-23-15-28(22(2)49)39(47)42(18-23,40(50)53-4)38(27)46-37(26)35/h6-12,22-23,28,30-31,34,39,44-46,48-49H,13-21H2,1-5H3/b24-6-/t22-,23-,28+,30+,31-,34-,39-,42?,43?/m0/s1	N/A	1	Positive	N/A	Isolated	736.3836	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conodurine.mgf	*..*	Conodurine	309.1597	qTof	LC-ESI	116	CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5C6CC\7C(C(CC8=C6NC9=CC=CC=C89)N(C/C7=C\C)C)C(=O)OC)OC)C(=O)OC	InChI=1S/C43H52N4O5/c1-7-24-17-23-20-43(42(49)52-6)39-28(15-16-47(21-23)40(24)43)27-13-14-34(50-4)36(38(27)45-39)31-18-29-25(8-2)22-46(3)33(35(29)41(48)51-5)19-30-26-11-9-10-12-32(26)44-37(30)31/h8-14,23-24,29,31,33,35,40,44-45H,7,15-22H2,1-6H3/b25-8+	N/A	1	Positive	N/A	Isolated	704.3937	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conoliferine.mgf	*..*	Conoliferine	613.3267	qTof	LC-ESI	117	CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C(=C5)C[C@@H](C6=CC(=C(C=C6)O)OC)[C@@H](C7=CC(=C(C=C7)O)OC)O)OC	InChI=1S/C37H44N2O6/c1-5-21-12-20-13-28-35-25(10-11-39(19-20)36(21)28)27-18-32(43-2)24(15-29(27)38-35)14-26(22-6-8-30(40)33(16-22)44-3)37(42)23-7-9-31(41)34(17-23)45-4/h6-9,15-18,20-21,26,28,36-38,40-42H,5,10-14,19H2,1-4H3/t20-,21+,26+,28+,36+,37-/m1/s1	N/A	1	Positive	N/A	Isolated	612.3199	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conolodinineA.mgf	*..*	Conolodinine A	793.3431	qTof	LC-ESI	118	OC1=C(OC)C(OC)=C(N=C2[C@@]34[C@]5([H])[C@]([C@H](O)[C@@H](OC6=C7C=C8C(NC9=C(C(OC)=O)C[C@@]%10(CC)[C@@]%11([H])[C@]98CCN%11C[C@@H]%12[C@H]%10O%12)=C6)[C@@H]7N5CC4)(CC)C=C2C(OC)=O)C3=C1	InChI=1S/C44H48N4O10/c1-7-41-16-20(37(51)55-5)34-44(23-14-25(49)30(53-3)31(54-4)28(23)46-34)10-12-48(40(41)44)29-19-13-22-24(15-26(19)57-32(29)35(41)50)45-33-21(38(52)56-6)17-42(8-2)36-27(58-36)18-47-11-9-43(22,33)39(42)47/h13-16,27,29,32,35-36,39-40,45,49-50H,7-12,17-18H2,1-6H3/t27-,29-,32+,35-,36-,39+,40+,41-,42-,43+,44+/m1/s1	N/A	1	Positive	N/A	Isolated	792.337	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
conolutinine.mgf	*..*	Conolutinine	313.1904	qTof	LC-ESI	119	O[C@@]12[C@@]3(N4CC1)N(C5=CC=CC=C25)[C@H](O6)C(C[C@@]6(CC)C4)CC3	InChI=1S/C19H24N2O2/c1-2-17-11-13-7-8-19-18(22,9-10-20(19)12-17)14-5-3-4-6-15(14)21(19)16(13)23-17/h3-6,13,16,22H,2,7-12H2,1H3/t13?,16-,17+,18+,19+/m1/s1	N/A	1	Positive	N/A	Isolated	312.1838	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
cononusine.mgf	*..*	Cononusine	394.2487	qTof	LC-ESI	120	CC[C@H](C12)C[C@@H]3C[C@@]1([H])C4=C(C5=CC(OC)=C(C(N6)CCC6=O)C=C5N4)CC[N@]2C3	InChI=1S/C24H31N3O2/c1-3-14-8-13-9-18-23-15(6-7-27(12-13)24(14)18)16-11-21(29-2)17(10-20(16)26-23)19-4-5-22(28)25-19/h10-11,13-14,18-19,24,26H,3-9,12H2,1-2H3,(H,25,28)/t13-,14+,18+,19?,24?/m1/s1	N/A	1	Positive	N/A	Isolated	393.2416	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Conopharyngine.mgf	*..*	Conopharyngine	399.2278	qTof	LC-ESI	121	COC1=CC2=C(NC3=C2CC[N@@](C4)C5[C@@]3(C(OC)=O)C[C@@H]4C[C@@H]5CC)C=C1OC	InChI=1S/C23H30N2O4/c1-5-14-8-13-11-23(22(26)29-4)20-15(6-7-25(12-13)21(14)23)16-9-18(27-2)19(28-3)10-17(16)24-20/h9-10,13-14,21,24H,5-8,11-12H2,1-4H3/t13-,14-,21?,23+/m0/s1	N/A	1	Positive	N/A	Isolated	398.2206	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	76-98-2	Mehdi Beniddir
conophylline.mgf	*..*	Conophylline	795.3591	qTof	LC-ESI	122	O=C(C1=C(C2(C3=C4)[C@@]5([H])N(CC2)C[C@H]6O[C@H]6[C@@]5(CC)C1)NC3=CC(O[C@@H]7[C@H]8O)=C4[C@H]7N(CC9)[C@]([C@]8(CC)C%10)([H])[C@@]9(C%11=C%12)C(NC%11=C(C(OC)=C%12O)OC)=C%10C(OC)=O)OC	InChI=1S/C44H50N4O10/c1-7-41-16-20(37(51)55-5)34-44(23-14-25(49)30(53-3)31(54-4)28(23)46-34)10-12-48(40(41)44)29-19-13-22-24(15-26(19)57-32(29)35(41)50)45-33-21(38(52)56-6)17-42(8-2)36-27(58-36)18-47-11-9-43(22,33)39(42)47/h13-15,27,29,32,35-36,39-40,45-46,49-50H,7-12,16-18H2,1-6H3/t27-,29-,32+,35-,36-,39+,40+,41-,42-,43?,44+/m1/s1	N/A	1	Positive	N/A	Isolated	794.3527	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Coronaridine.mgf	*..*	Coronaridine	339.2067	qTof	LC-ESI	123	CC[C@H]1C[C@@H]2C[N@@](C1[C@@]3(C(OC)=O)C2)CCC4=C3NC5=C4C=CC=C5	InChI=1S/C21H26N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,13-14,19,22H,3,8-12H2,1-2H3/t13-,14-,19?,21?/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	467-77-6	Mehdi Beniddir
Corynantheidal.mgf	*..*	Corynantheidal	297.1961	qTof	LC-ESI	124	[H][C@](N1CC2)(C[C@H](CC=O)[C@H](CC)C1)C3=C2C4=CC=CC=C4N3	InChI=1S/C19H24N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h3-6,10,13-14,18,20H,2,7-9,11-12H2,1H3/t13-,14+,18+/m1/s1	N/A	1	Positive	N/A	Isolated	296.1889	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	483-28-3	Mehdi Beniddir
corynantheidane.mgf	*..*	Corynantheidan	283.2195	qTof	LC-ESI	125	CC[C@H]([C@H](CC)C1)C[C@@](N1CC2)([H])C3=C2C4=CC=CC=C4N3	InChI=1S/C19H26N2/c1-3-13-11-18-19-16(9-10-21(18)12-14(13)4-2)15-7-5-6-8-17(15)20-19/h5-8,13-14,18,20H,3-4,9-12H2,1-2H3/t13-,14+,18-/m0/s1	N/A	1	Positive	N/A	Isolated	282.2096	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Corynantheidine.mgf	*..*	Corynantheidine	369.2173	qTof	LC-ESI	126	[H][C@](N1CC2)(C[C@@](/C(C(OC)=O)=C\OC)([H])[C@H](CC)C1)C3=C2C4=CC=CC=C4N3	InChI=1S/C22H28N2O3/c1-4-14-12-24-10-9-16-15-7-5-6-8-19(15)23-21(16)20(24)11-17(14)18(13-26-2)22(25)27-3/h5-8,13-14,17,20,23H,4,9-12H2,1-3H3/b18-13+/t14-,17+,20+/m1/s1	N/A	1	Positive	N/A	Isolated	368.21	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	23407-35-4	Mehdi Beniddir
Corynantheidol.mgf	*..*	Corynantheidol	299.2118	qTof	LC-ESI	127	[H][C@](N1CC2)(C[C@H](CCO)[C@H](CC)C1)C3=C2C4=CC=CC=C4N3	InChI=1S/C19H26N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h3-6,13-14,18,20,22H,2,7-12H2,1H3/t13-,14+,18+/m1/s1	N/A	1	Positive	N/A	Isolated	298.2045	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	483-27-2	Mehdi Beniddir
Corynantheine.mgf	*..*	Corynantheine	367.2016	qTof	LC-ESI	128	[H][C@](N1CC2)(C[C@@](/C(C(OC)=O)=C\OC)([H])[C@@H](C=C)C1)C3=C2C4=CC=CC=C4N3	InChI=1S/C22H26N2O3/c1-4-14-12-24-10-9-16-15-7-5-6-8-19(15)23-21(16)20(24)11-17(14)18(13-26-2)22(25)27-3/h4-8,13-14,17,20,23H,1,9-12H2,2-3H3/b18-13+/t14-,17-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	18904-54-6	Mehdi Beniddir
Corynantheol.mgf	*..*	Corynantheol	297.1961	qTof	LC-ESI	129	[H][C@](N1CC2)(C[C@H](CCO)[C@@H](C=C)C1)C3=C2C4=CC=CC=C4N3	InChI=1S/C19H24N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h2-6,13-14,18,20,22H,1,7-12H2/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	23443-70-1	Mehdi Beniddir
corynanthicacid.mgf	*..*	Corynanthic acid	341.1861	qTof	LC-ESI	130	OC([C@@H]1[C@H](CCC2CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=C4C=CC=C5)O)=O	InChI=1S/C20H24N2O3/c23-17-6-5-11-10-22-8-7-13-12-3-1-2-4-15(12)21-19(13)16(22)9-14(11)18(17)20(24)25/h1-4,11,14,16-18,21,23H,5-10H2,(H,24,25)/t11?,14-,16-,17-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	340.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Corynanthine.mgf	*..*	Corynanthine	355.2016	qTof	LC-ESI	131	[H][C@](N1CC2)(C[C@@]([C@H](C(OC)=O)[C@@H](O)CC3)([H])[C@]3([H])C1)C4=C2C5=C(N4)C=CC=C5	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	483-10-3	Mehdi Beniddir
corynoxeine.mgf	*..*	Corynoxeine	383.1958	qTof	LC-ESI	132	CO/C=C(\[C@H]1C[C@H]2[C@@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	382.1892	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Corynoxine.mgf	*..*	Corynoxine	385.2118	qTof	LC-ESI	133	CC[C@@H]1CN2CC[C@]3(C4=CC=CC=C4NC3=O)[C@@H]2C[C@@H]1/C(C(OC)=O)=C\OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22+/m1/s1	N/A	1	Positive	N/A	Isolated	384.20491	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Criocerine.mgf	*..*	Criocerine	351.1711	qTof	LC-ESI	134	CC[C@]12CC3(C(OC)=O)N4C5=CC=CC=C5C6=C4[C@H]1N(C=C[C@H]2O3)CC6	InChI=1S/C21H22N2O3/c1-3-20-12-21(19(24)25-2)23-15-7-5-4-6-13(15)14-8-10-22(18(20)17(14)23)11-9-16(20)26-21/h4-7,9,11,16,18H,3,8,10,12H2,1-2H3/t16-,18-,20-,21?/m1/s1	N/A	1	Positive	N/A	Isolated	350.16304	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
criofolinine.mgf	*..*	Criofolinine	399.1553	qTof	LC-ESI	135	COC([C@@H]1[C@]2([H])[C@@](C(N3CCC4=C(C([C@@]23O)=O)NC5=C4C=CC=C5)=O)([H])CC[C@H]1O)=O	InChI=1S/C21H22N2O6/c1-29-20(27)15-14(24)7-6-12-16(15)21(28)18(25)17-11(8-9-23(21)19(12)26)10-4-2-3-5-13(10)22-17/h2-5,12,14-16,22,24,28H,6-9H2,1H3/t12-,14-,15+,16+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	398.1478	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Criophylline.mgf	*..*	Criophylline	647.3592	qTof	LC-ESI	136	[H][C@]12[C@]34NC5=CC=C([C@]6([H])N(CC7)[C@@]([C@@]7(C(C=CC=C8)=C8N9)C9=C(C(OC)=O)C%10)([H])[C@@]%10(CC)[C@H]%11[C@@H]6O%11)C=C5[C@]3([H])CCN1C[C@@H]%12[C@@H](O%12)[C@@]2(CC)CC4	InChI=1S/C40H46N4O4/c1-4-37-13-14-40-24(12-16-43(36(37)40)20-28-32(37)47-28)22-18-21(10-11-26(22)42-40)29-30-33(48-30)38(5-2)19-23(34(45)46-3)31-39(15-17-44(29)35(38)39)25-8-6-7-9-27(25)41-31/h6-11,18,24,28-30,32-33,35-36,41-42H,4-5,12-17,19-20H2,1-3H3/t24-,28+,29-,30+,32+,33+,35-,36-,37+,38+,39-,40+/m0/s1	N/A	1	Positive	N/A	Isolated	646.3519	Alexander Fox Ramos	M+H	N/A	3	Callichilia	Callichilia inaequalis	N/A	52659-53-7	Mehdi Beniddir
Cymoside.mgf	*..*	Cymoside	547.2286	qTof	LC-ESI	137	C=C[C@H]([C@H](O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1)O[C@](O2)([H])[C@@]34C(OC)=O)C3C[C@@]5([H])[C@]64NC7=CC=CC=C7C6[C@H]2CN5	InChI=1S/C27H34N2O10/c1-3-11-13-8-17-27-18(12-6-4-5-7-14(12)29-27)15(9-28-17)37-25(26(13,27)24(34)35-2)39-22(11)38-23-21(33)20(32)19(31)16(10-30)36-23/h3-7,11,13,15-23,25,28-33H,1,8-10H2,2H3/t11-,13?,15+,16-,17-,18?,19-,20+,21-,22+,23+,25+,26?,27-/m0/s1	N/A	1	Positive	N/A	Isolated	546.2213	Alexander Fox Ramos	M+H	N/A	3	Chimarrhis	Chimarrhis cymosa	N/A	N/A	Mehdi Beniddir
Deacetylvindoline.mgf	*..*	Deacetylvindoline	415.22	qTof	LC-ESI	139	CC[C@@]1([C@]23[H])C=CCN3CC[C@]2(C4([H])[C@@](C(OC)=O)(O)[C@@]1([H])O)C5=C(N4C)C=C(OC)C=C5	InChI=1S/C23H30N2O5/c1-5-21-9-6-11-25-12-10-22(17(21)25)15-8-7-14(29-3)13-16(15)24(2)18(22)23(28,19(21)26)20(27)30-4/h6-9,13,17-19,26,28H,5,10-12H2,1-4H3/t17-,18?,19+,21+,22+,23-/m1/s1	N/A	1	Positive	N/A	Isolated	414.2155	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Desacetyl_isosplendine.mgf	*..*	Desacetyl-isosplendine	327.2067	qTof	LC-ESI	140	C[C@@H]([C@@H]1CN(C)CC2)OC[C@@]([C@@]1([H])C3)([H])[C@]4([H])NC5=CC=CC=C5[C@]42C3=O	InChI=1S/C20H26N2O2/c1-12-14-10-22(2)8-7-20-16-5-3-4-6-17(16)21-19(20)15(11-24-12)13(14)9-18(20)23/h3-6,12-15,19,21H,7-11H2,1-2H3/t12-,13-,14-,15+,19-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	326.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
descarbomethoxy-criophylline.mgf	*..*	Decarbomethoxycriophylline	589.3521	qTof	LC-ESI	141	CC[C@@]1([C@@]23[H])CC=C4[C@@]2(C5=CC=CC=C5N4)CCN3C([C@@H]6[C@H]1O6)C7=CC8=C(C=C7)N[C@]9([C@@]8([H])CC%10)[C@@]%11([H])N%10C[C@H]%12O[C@H]%12[C@@]%11(CC)CC9	InChI=1S/C38H44N4O2/c1-3-35-13-11-28-37(24-7-5-6-8-26(24)39-28)16-18-42(33(35)37)29(30-32(35)44-30)21-9-10-25-22(19-21)23-12-17-41-20-27-31(43-27)36(4-2)14-15-38(23,40-25)34(36)41/h5-11,19,23,27,29-34,39-40H,3-4,12-18,20H2,1-2H3/t23-,27+,29?,30+,31+,32+,33-,34-,35+,36+,37-,38+/m0/s1	N/A	1	Positive	N/A	Isolated	588.34643	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Descarbomethoxydihydrogambirtannine.mgf	*..*	Descarbomethoxydihydrogambirtannine	275.155	qTof	LC-ESI	142	C12=C(C=C3C4=C(C5=CC=CC=C5N4)CCN3C2)CCC=C1	InChI=1S/C19H18N2/c1-2-6-14-12-21-10-9-16-15-7-3-4-8-17(15)20-19(16)18(21)11-13(14)5-1/h2-4,6-8,11,20H,1,5,9-10,12H2	N/A	1	Positive	N/A	Isolated	274.147	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
desformodeacetylakuammiline.mgf	*..*	Deformodeacetylakuammiline	323.1748	qTof	LC-ESI	143	C/C=C1[C@H]2C[C@@]3(C4=NC5=CC=CC=C5[C@]4(CCN3C\1)[C@H]2C(OC)=O)[H]	InChI=1S/C20H22N2O2/c1-3-12-11-22-9-8-20-14-6-4-5-7-15(14)21-18(20)16(22)10-13(12)17(20)19(23)24-2/h3-7,13,16-17H,8-11H2,1-2H3/b12-3-/t13-,16-,17-,20-/m1/s1	N/A	1	Positive	N/A	Isolated	322.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
desformodeacetylpicraline.mgf	*..*	Deformodeacetylpicraline	339.1696	qTof	LC-ESI	144	C/C=C1[C@@H]([C@H]2C(OC)=O)C[C@@]3([H])[C@@]4(O5)NC6=CC=CC=C6[C@]42CC5N3C\1	InChI=1S/C20H22N2O3/c1-3-11-10-22-15-8-12(11)17(18(23)24-2)19-9-16(22)25-20(15,19)21-14-7-5-4-6-13(14)19/h3-7,12,15-17,21H,8-10H2,1-2H3/b11-3-/t12?,15-,16?,17+,19?,20+/m1/s1	N/A	1	Positive	N/A	Isolated	338.163	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Desoxycabufiline.mgf	*..*	Desoxycabufiline	735.4116	qTof	LC-ESI	145	CN1C2=CC(C3=C(OC)C=C(N(C)[C@]4([H])[C@@]5([C@H]6C(OC)=O)CCN7C4C[C@H]6/C(C7)=C([H])\C)C5=C3)=C(OC)C=C2[C@@]8([C@@H]9C(OC)=O)C1%10N(C/C([C@@H]9CC%10)=C([H])\C)CC8	InChI=1S/C44H54N4O6/c1-9-24-22-47-15-13-42-30-17-28(36(52-6)21-32(30)45(3)39(42)34(47)18-27(24)37(42)40(49)53-7)29-19-33-31(20-35(29)51-5)43-14-16-48-23-25(10-2)26(38(43)41(50)54-8)11-12-44(43,48)46(33)4/h9-10,17,19-21,26-27,34,37-39H,11-16,18,22-23H2,1-8H3/b24-9-,25-10+/t26-,27-,34?,37+,38-,39-,42-,43-,44?/m0/s1	N/A	1	Positive	N/A	Isolated	734.4043	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia balansae	N/A	82841-74-5	Mehdi Beniddir
didehydro-reserpiline-perchlorate.mgf	*..*	Didehydroreserpiline-perchlorate	411.1905	qTof	LC-ESI	146	CC1=C2CN3CCC4C5=CC(OC)=C(OC)C=C5N=C4[C@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C23H26N2O5/c1-12-16-10-25-6-5-13-15-8-20(27-2)21(28-3)9-18(15)24-22(13)19(25)7-14(16)17(11-30-12)23(26)29-4/h8-9,11,13-14,19H,5-7,10H2,1-4H3/t13?,14-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	410.1842	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
dihydro-corynantheidal.mgf	*..*	Dihydro-corynantheial	297.1957	qTof	LC-ESI	147	CC[C@@H](C1)[C@@H](CC=O)C[C@@](N1CC2)([H])C3=C2C4=CC=CC=C4N3	InChI=1S/C19H24N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h3-6,10,13-14,18,20H,2,7-9,11-12H2,1H3/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
dihydrocorynantheol.mgf	*..*	Dihydrocorynantheol	299.2116	qTof	LC-ESI	148	OCC[C@@H]1[C@@H](CC)CN2[C@@](C3=C(CC2)C4=C(N3)C=CC=C4)([H])C1	InChI=1S/C19H26N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h3-6,13-14,18,20,22H,2,7-12H2,1H3/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	298.2045	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
dippinineA.mgf	*..*	Dippinine A	401.2062	qTof	LC-ESI	149	O=C([C@@]1([C@@]([C@](C2)([H])[C@@](C)([H])O)([H])NCC3)C4=C3C(C=C5)=C(C=C5OC)N4[C@H]([C@@]2([H])C1)O)OC	InChI=1S/C22H28N2O5/c1-11(25)16-8-12-10-22(21(27)29-3)18(16)23-7-6-15-14-5-4-13(28-2)9-17(14)24(19(15)22)20(12)26/h4-5,9,11-12,16,18,20,23,25-26H,6-8,10H2,1-3H3/t11-,12+,16-,18-,20-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	400.1998	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Dregamine.mgf	*..*	Dregamine	355.2016	qTof	LC-ESI	150	CN1C(C2C(OC)=O)CC3=C(C(CC2[C@H](CC)C1)=O)NC4=C3C=CC=C4	InChI=1S/C21H26N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h5-8,12,14,17,19,22H,4,9-11H2,1-3H3/t12-,14-,17-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2299-26-5	Mehdi Beniddir
eburnamine.mgf	*..*	Eburnamine	297.1963	qTof	LC-ESI	151	CC[C@@]1(C[C@H](O)N2C3=CC=CC=C43)CCCN5CCC4=C2[C@]15[H]	InChI=1S/C19H24N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,16,18,22H,2,5,8-12H2,1H3/t16-,18+,19-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Echitamidine.mgf	*..*	Echitamidine	341.186	qTof	LC-ESI	152	[H][C@]12C(C(OC)=O)=C3NC4=CC=CC=C4[C@]35[C@@H](N(C[C@@]2([H])[C@@H](O)C)CC5)C1	InChI=1S/C20H24N2O3/c1-11(23)13-10-22-8-7-20-14-5-3-4-6-15(14)21-18(20)17(19(24)25-2)12(13)9-16(20)22/h3-6,11-13,16,21,23H,7-10H2,1-2H3/t11-,12-,13-,16-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	340.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	38681-90-2	Mehdi Beniddir
Echitamine.mgf	*..*	Echitamine	385.2122	qTof	LC-ESI	153	O[C@H]1C[C@H]2C(C=C)C[N@+]3(C)[C@]([C@@]4(C2(CO)C(OC)=O)CC3)1NC5=C4C=CC=C5	InChI=1S/C22H29N2O4/c1-4-14-12-24(2)10-9-21-15-7-5-6-8-17(15)23-22(21,24)18(26)11-16(14)20(21,13-25)19(27)28-3/h4-8,14,16,18,23,25-26H,1,9-13H2,2-3H3/q+1/t14?,16-,18-,20?,21-,22-,24+/m0/s1	N/A	1	Positive	N/A	Isolated	385.2122	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	6871-44-9	Mehdi Beniddir
Ellipticine.mgf	*..*	Ellipticine	247.1235	qTof	LC-ESI	154	CC1=C2C=CN=CC2=C(C)C3=C1NC4=CC=CC=C43	InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3	N/A	1	Positive	N/A	Isolated	246.1157	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
epi-antirhine.mgf	*..*	3-epiantirhine	297.1964	qTof	LC-ESI	155	OC[C@H](C=C)[C@]1([H])C[C@@]2([H])N(CC1)CCC3=C2NC4=CC=CC=C43	InChI=1S/C19H24N2O/c1-2-13(12-22)14-7-9-21-10-8-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14/h2-6,13-14,18,20,22H,1,7-12H2/t13-,14-,18+/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Epicatechocorynantheidine.mgf	*..*	Epicatechocorynantheidine	655.275	qTof	LC-ESI	156	C[C@@H]1[C@@]([C@]2([H])OC3=C1C4=C(C[C@@H](O)[C@@H](C5=CC(O)=C(O)C=C5)O4)C(O)=C3)([H])[C@@H](/C(C(OC)=O)=C\OC)C[C@@](N2CC6)([H])C7=C6C8=CC=CC=C8N7	InChI=1S/C37H38N2O9/c1-17-31-21(23(16-45-2)37(44)46-3)13-25-33-20(19-6-4-5-7-24(19)38-33)10-11-39(25)36(31)47-30-15-27(41)22-14-29(43)34(48-35(22)32(17)30)18-8-9-26(40)28(42)12-18/h4-9,12,15-17,21,25,29,31,34,36,38,40-43H,10-11,13-14H2,1-3H3/b23-16+/t17-,21-,25+,29-,31+,34-,36+/m1/s1	N/A	1	Positive	N/A	Isolated	654.2577	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Epicatechocorynantheine-A.mgf	*..*	Epicatechocorynantheine A	657.276	qTof	LC-ESI	157	CO/C=C([C@@H](C[C@]12[H])[C@H]([C@@H](N1CCC3=C2NC4=CC=CC=C34)C(C(O[C@@H]5C(C=C6)=CC(O)=C6O)=C(C(O)=C7)C[C@H]5O)=C7O)CC)/C(OC)=O	InChI=1S/C37H40N2O9/c1-4-19-22(24(17-46-2)37(45)47-3)14-26-33-21(20-7-5-6-8-25(20)38-33)11-12-39(26)34(19)32-30(43)16-28(41)23-15-31(44)35(48-36(23)32)18-9-10-27(40)29(42)13-18/h5-10,13,16-17,19,22,26,31,34-35,38,40-44H,4,11-12,14-15H2,1-3H3/b24-17+/t19-,22+,26+,31-,34-,35-/m1/s1	N/A	1	Positive	N/A	Isolated	656.2734	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Epicatechocorynantheine-B.mgf	*..*	Epicatechocorynantheine B	657.275	qTof	LC-ESI	158	CC[C@@H]([C@@H]1C2=C(O)C(C[C@@H](O)[C@@H](C3=CC(O)=C(O)C=C3)O4)=C4C=C2O)[C@@H](/C(C(OC)=O)=C\OC)C[C@@](N1CC5)([H])C6=C5C7=CC=CC=C7N6	InChI=1S/C37H40N2O9/c1-4-19-22(24(17-46-2)37(45)47-3)14-26-33-21(20-7-5-6-8-25(20)38-33)11-12-39(26)34(19)32-29(42)16-31-23(35(32)44)15-30(43)36(48-31)18-9-10-27(40)28(41)13-18/h5-10,13,16-17,19,22,26,30,34,36,38,40-44H,4,11-12,14-15H2,1-3H3/b24-17+/t19-,22+,26+,30-,34-,36-/m1/s1	N/A	1	Positive	N/A	Isolated	656.2734	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
epivoacorine.mgf	*..*	Epivoacorine	721.3945	qTof	LC-ESI	159	C/C=C\1/CN([C@@H]2CC3=C([C@H](C[C@@H]1C2C(=O)OC)C4=C(C=C5C6=C([C@@]7(C[C@@H]8C[C@@H]([C@@H]7N(C8)CC6)[C@@H](C)O)C(=O)OC)NC5=C4)OC)NC9=CC=CC=C39)C	InChI=1S/C43H52N4O6/c1-7-24-21-46(3)35-17-32-25-10-8-9-11-33(25)44-38(32)31(15-28(24)37(35)41(49)52-5)30-16-34-29(18-36(30)51-4)26-12-13-47-20-23-14-27(22(2)48)40(47)43(19-23,39(26)45-34)42(50)53-6/h7-11,16,18,22-23,27-28,31,35,37,40,44-45,48H,12-15,17,19-21H2,1-6H3/b24-7-/t22-,23+,27-,28+,31-,35-,37?,40+,43-/m1/s1	N/A	1	Positive	N/A	Isolated	720.3887	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
eripine.mgf	*..*	Eripine	413.2073	qTof	LC-ESI	160	C/C=C(C(OC)=O)\[C@@H]1C[C@H]2[C@@]34[C@@](CCN3C)(C5=CC=CC=C5N4C)[C@]1(CO)C(O2)=O	InChI=1S/C23H28N2O5/c1-5-14(19(27)29-4)16-12-18-23-22(10-11-24(23)2,21(16,13-26)20(28)30-18)15-8-6-7-9-17(15)25(23)3/h5-9,16,18,26H,10-13H2,1-4H3/b14-5+/t16-,18-,21-,22-,23+/m0/s1	N/A	1	Positive	N/A	Isolated	412.1998	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Ervafoline.mgf	*..*	Ervafoline	645.3435	qTof	LC-ESI	161	[H][C@@]12[C@@]34CC(C(OC)=O)=C([C@@]51CC[N@@]3[C@]6([H])[C@@](CC)(O[C@@]78[C@]9(C(C=CC=C%10)=C%10N82)[C@]%11([H])[C@@](CC)([C@H]%12[C@H](O%12)CN%11CC9)C[C@@]67[H])C4)NC%13=C5C=CC=C%13	InChI=1S/C40H44N4O4/c1-4-35-19-25-30-37(5-2)21-36-18-22(32(45)46-3)29-38(14-17-43(30)36,23-10-6-8-12-26(23)41-29)34(36)44-27-13-9-7-11-24(27)39(40(25,44)48-37)15-16-42(33(35)39)20-28-31(35)47-28/h6-13,25,28,30-31,33-34,41H,4-5,14-21H2,1-3H3/t25-,28+,30-,31+,33-,34+,35+,36-,37-,38+,39+,40+/m0/s1	N/A	1	Positive	N/A	Isolated	644.3363	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	70545-44-7	Mehdi Beniddir
Ervatamine.mgf	*..*	Ervatamine	355.2016	qTof	LC-ESI	162	CN(C1)C[C@@H](CC)[C@]([C@]1(C(OC)=O)C2)([H])CC(C3=C2C4=CC=CC=C4N3)=O	InChI=1S/C21H26N2O3/c1-4-13-11-23(2)12-21(20(25)26-3)10-15-14-7-5-6-8-17(14)22-19(15)18(24)9-16(13)21/h5-8,13,16,22H,4,9-12H2,1-3H3/t13-,16+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	33257-13-5	Mehdi Beniddir
Ervitsine.mgf	*..*	Ervitsine	293.1648	qTof	LC-ESI	163	CN1[C@@](C2=C)([H])C3=C(C(CC2/C(C1)=C\C)=O)NC4=CC=CC=C34	InChI=1S/C19H20N2O/c1-4-12-10-21(3)19-11(2)14(12)9-16(22)18-17(19)13-7-5-6-8-15(13)20-18/h4-8,14,19-20H,2,9-10H2,1,3H3/b12-4-/t14-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	292.1576	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	65617-99-4	Mehdi Beniddir
flavopereirine.mgf	*..*	Flavopereirine	247.1228	qTof	LC-ESI	164	CCc1ccc2c3[n-]c4ccccc4c3cc[n+]2c1	InChI=1S/C17H14N2/c1-2-12-7-8-16-17-14(9-10-19(16)11-12)13-5-3-4-6-15(13)18-17/h3-11H,2H2,1H3	N/A	1	Positive	N/A	Isolated	246.1156	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
fluorocurarine.mgf	*..*	C-fluorocurarine	307.1805	qTof	LC-ESI	165	O=C([H])C1=C2NC3=CC=CC=C3[C@]24[C@@H]5C[C@H]1/C(C[N@+]5(C)CC4)=C\C	InChI=1S/C20H22N2O/c1-3-13-11-22(2)9-8-20-16-6-4-5-7-17(16)21-19(20)15(12-23)14(13)10-18(20)22/h3-7,12,14,18H,8-11H2,1-2H3/p+1/b13-3-/t14-,18-,20+,22-/m0/s1	N/A	1	Positive	N/A	Isolated	307.1805	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	6866-39-3	Mehdi Beniddir
Geissolaevine.mgf	*..*	Geissolaevine	367.1288	qTof	LC-ESI	166	O[C@]1(C2=NC=CC3=C2NC4=CC=CC=C34)OC(C(CC)=C1CC(OC)=O)=O	InChI=1S/C20H18N2O5/c1-3-11-14(10-16(23)26-2)20(25,27-19(11)24)18-17-13(8-9-21-18)12-6-4-5-7-15(12)22-17/h4-9,22,25H,3,10H2,1-2H3/t20-/m0/s1	N/A	1	Positive	N/A	Isolated	366.1216	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	N/A	Mehdi Beniddir
Geissolosimine.mgf	*..*	Geissolosimine	573.3588	qTof	LC-ESI	167	[H][C@@]12[C@@]3([H])CO[C@@]([H])(C4[C@H](C5)N6[C@](C[C@@H]4/C(C6)=C\C)([H])C7=C5C8=CC=CC=C8N7)N1C9=C(C=CC=C9)[C@]2%10[C@H]%11C[C@@]3([H])[C@H](CC)CN%11CC%10	InChI=1S/C38H44N4O/c1-3-21-18-40-14-13-38-28-10-6-8-12-30(28)42-36(38)27(24(21)17-33(38)40)20-43-37(42)34-25-15-32-35-26(23-9-5-7-11-29(23)39-35)16-31(34)41(32)19-22(25)4-2/h4-12,21,24-25,27,31-34,36-37,39H,3,13-20H2,1-2H3/b22-4-/t21-,24+,25-,27+,31+,32+,33-,34?,36+,37+,38-/m1/s1	N/A	1	Positive	N/A	Isolated	572.3515	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	N/A	Mehdi Beniddir
Geissoschizine.mgf	*..*	Geissoschizine	353.186	qTof	LC-ESI	168	C/C=C(C1)\C(/C(C(OC)=O)=C/O)C[C@@](N1CC2)([H])C3=C2C4=CC=CC=C4N3	InChI=1S/C21H24N2O3/c1-3-13-11-23-9-8-15-14-6-4-5-7-18(14)22-20(15)19(23)10-16(13)17(12-24)21(25)26-2/h3-7,12,16,19,22,24H,8-11H2,1-2H3/b13-3-,17-12-/t16?,19-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	439-66-7	Mehdi Beniddir
geissoschizol.mgf	*..*	Geissoschizol	297.1963	qTof	LC-ESI	169	C/C=C/1\CN2CCC3=C([C@@H]2C[C@@H]1CCO)NC4=CC=CC=C34	InChI=1S/C19H24N2O/c1-2-13-12-21-9-7-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14(13)8-10-22/h2-6,14,18,20,22H,7-12H2,1H3/b13-2+/t14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Geissoschizoline.mgf	*..*	Geissoschizoline	299.2118	qTof	LC-ESI	170	CC[C@H](C1)[C@]2([H])[C@H](CO)[C@]([C@@]34[C@@H](N1CC4)C2)([H])NC5=C3C=CC=C5	InChI=1S/C19H26N2O/c1-2-12-10-21-8-7-19-15-5-3-4-6-16(15)20-18(19)14(11-22)13(12)9-17(19)21/h3-6,12-14,17-18,20,22H,2,7-11H2,1H3/t12-,13-,14+,17+,18+,19-/m1/s1	N/A	1	Positive	N/A	Isolated	298.2045	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	18397-07-4	Mehdi Beniddir
Geissospermine.mgf	*..*	Geissospermine	633.3799	qTof	LC-ESI	171	[H][C@@]12N([C@]([H])([C@@H]([C@]3([H])/C(CN(CCC4=C5NC6=C4C=CC=C6)[C@@]5([H])C3)=C/C)C(OC)=O)OC7)C8=CC=CC=C8[C@]1(CC9)[C@](N9C[C@]%10(CC)[H])([H])C[C@]%10([H])[C@@]27[H]	InChI=1S/C40H48N4O3/c1-4-23-21-43-17-15-40-30-11-7-9-13-32(30)44-37(40)29(27(23)19-34(40)43)22-47-38(44)35(39(45)46-3)28-18-33-36-26(14-16-42(33)20-24(28)5-2)25-10-6-8-12-31(25)41-36/h5-13,23,27-29,33-35,37-38,41H,4,14-22H2,1-3H3/b24-5+/t23-,27+,28+,29+,33+,34+,35-,37+,38+,40-/m1/s1	N/A	1	Positive	N/A	Isolated	632.3726	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	427-01-0	Mehdi Beniddir
Gelsemicine.mgf	*..*	Gelsemicine	359.1965	qTof	LC-ESI	172	O=C1N(OC)C2=C(C=CC(OC)=C2)[C@@]1(CC3N[C@@H]4CC)[C@H]5OCC3[C@H]4C5	InChI=1S/C20H26N2O4/c1-4-15-12-8-18-20(9-16(21-15)13(12)10-26-18)14-6-5-11(24-2)7-17(14)22(25-3)19(20)23/h5-7,12-13,15-16,18,21H,4,8-10H2,1-3H3/t12-,13?,15-,16?,18+,20+/m1/s1	N/A	1	Positive	N/A	Isolated	358.1893	Alexander Fox Ramos	M+H	N/A	3	Mostuea	Mostuea brunonis	N/A	6887-28-1	Mehdi Beniddir
Gelsemine.mgf	*..*	Gelsemine	323.1755	qTof	LC-ESI	173	[H][C@@]1(OC[C@H]2[C@@H]3[C@]4([H])[C@@](C=C)(CN3C)C2([H])C1)[C@@]4(C5=C(N6)C=CC=C5)C6=O	InChI=1S/C20H22N2O2/c1-3-19-10-22(2)16-11-9-24-15(8-13(11)19)20(17(16)19)12-6-4-5-7-14(12)21-18(20)23/h3-7,11,13,15-17H,1,8-10H2,2H3,(H,21,23)/t11-,13?,15+,16-,17-,19+,20-/m1/s1	N/A	1	Positive	N/A	Isolated	322.1681	Alexander Fox Ramos	M+H	N/A	3	Mostuea	Mostuea brunonis	N/A	509-15-9	Mehdi Beniddir
Goniomedine_A.mgf	*..*	Goniomedine A	649.3748	qTof	LC-ESI	174	CC[C@]1(C2)CC[C@]3([C@@]4(O)CC[N@@+]23CCC1)NC5=C4C=C(C[C@]6(C7=C(N8[C@]([H])(C(OC)=O)[C@@](/C(C9)=C\C)([H])C[C@]%10([H])N9CC6)C=CC=C7)[C@@]8%10O%11)C%11=C5	InChI=1S/C40H49N4O4/c1-4-25-23-42-16-14-37-22-26-19-29-30(41-39-13-12-36(5-2)11-8-17-44(39,24-36)18-15-38(29,39)46)21-32(26)48-40(37)33(42)20-27(25)34(35(45)47-3)43(40)31-10-7-6-9-28(31)37/h4,6-7,9-10,19,21,27,33-34,41,46H,5,8,11-18,20,22-24H2,1-3H3/q+1/b25-4-/t27-,33-,34-,36+,37+,38+,39-,40+,44-/m0/s1	N/A	1	Positive	N/A	Isolated	649.3748	Alexander Fox Ramos	M+	N/A	3	Gonioma	Gonioma malagasy	N/A	N/A	Mehdi Beniddir
Goniomedine_A_N_oxyde.mgf	*..*	Goniomedine A N-oxide	665.3711	qTof	LC-ESI	175	CC[C@]1(C2)CC[C@]3([C@@]4(O)CC[N@@+]23CCC1)NC5=C4C=C(C[C@]6(C7=C(N8[C@]([H])(C(OC)=O)[C@@](/C(C9)=C\C)([H])C[C@]%10([H])[N+]9([O-])CC6)C=CC=C7)[C@@]8%10O%11)C%11=C5	InChI=1S/C40H49N4O5/c1-4-25-23-44(47)18-14-37-22-26-19-29-30(41-39-13-12-36(5-2)11-8-16-43(39,24-36)17-15-38(29,39)46)21-32(26)49-40(37)33(44)20-27(25)34(35(45)48-3)42(40)31-10-7-6-9-28(31)37/h4,6-7,9-10,19,21,27,33-34,41,46H,5,8,11-18,20,22-24H2,1-3H3/q+1/b25-4-/t27-,33-,34-,36+,37+,38+,39-,40+,43-,44?/m0/s1	N/A	1	Positive	N/A	Isolated	665.3697	Alexander Fox Ramos	M+	N/A	3	Gonioma	Gonioma malagasy	N/A	N/A	Mehdi Beniddir
Goniomedine_B.mgf	*..*	Goniomedine B	633.3799	qTof	LC-ESI	176	CC[C@]1(CN(CC2)CCC1)CCC3=C2C4=C(N3)C=C5C(C[C@]6(C7=C(N8[C@H](C(OC)=O)[C@](/C(C9)=C\C)([H])C[C@@]%10([H])N9CC6)C=CC=C7)[C@@]8%10O5)=C4	InChI=1S/C40H48N4O3/c1-4-25-23-43-18-15-39-22-26-19-29-27-12-17-42-16-8-13-38(5-2,24-42)14-11-31(27)41-32(29)21-34(26)47-40(39)35(43)20-28(25)36(37(45)46-3)44(40)33-10-7-6-9-30(33)39/h4,6-7,9-10,19,21,28,35-36,41H,5,8,11-18,20,22-24H2,1-3H3/b25-4-/t28-,35-,36+,38-,39-,40-/m1/s1	N/A	1	Positive	N/A	Isolated	632.3726	Alexander Fox Ramos	M+H	N/A	3	Gonioma	Gonioma malagasy	N/A	N/A	Mehdi Beniddir
Goniomedinone.mgf	*..*	Goniomedinone	663.3541	qTof	LC-ESI	177	CC[C@]1(C2)CC[C@]3([C@@]4(O)CC[N@@+]23CCC1)NC5=C4C=C(C([C@]6(C7=C(N8[C@]([H])(C(OC)=O)[C@@](/C(C9)=C\C)([H])C[C@]%10([H])N9CC6)C=CC=C7)[C@@]8%10O%11)=O)C%11=C5	InChI=1S/C40H46N4O5/c1-4-24-22-42-16-14-37-27-9-6-7-10-30(27)43-33(35(46)48-3)25(24)20-32(42)40(37,43)49-31-21-29-28(19-26(31)34(37)45)38(47)15-18-44-17-8-11-36(5-2,23-44)12-13-39(38,44)41-29/h4,6-7,9-10,19,21,25,32-33,47H,5,8,11-18,20,22-23H2,1-3H3/p+1/b24-4-/t25-,32-,33-,36+,37-,38+,39-,40+,44-/m0/s1	N/A	1	Positive	N/A	Isolated	663.3541	Alexander Fox Ramos	M+	N/A	3	Gonioma	Gonioma malagasy	N/A	N/A	Mehdi Beniddir
goniomine.mgf	*..*	Goniomine	311.1755	qTof	LC-ESI	178	C=C(C1=O)[C@H]2CCN3CC[C@@]1([C@@]3([H])[C@@]42O)C5=CC=CC=C5N[C@H]4C	InChI=1S/C19H22N2O2/c1-11-13-7-9-21-10-8-18(16(11)22)14-5-3-4-6-15(14)20-12(2)19(13,23)17(18)21/h3-6,12-13,17,20,23H,1,7-10H2,2H3/t12-,13+,17-,18+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	310.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Goniomitine.mgf	*..*	Goniomitine	299.2118	qTof	LC-ESI	179	OCCC1=C2CC[C@]3(CC)[C@](NCCC3)([H])N2C4=C1C=CC=C4	InChI=1S/C19H26N2O/c1-2-19-10-5-12-20-18(19)21-16-7-4-3-6-14(16)15(9-13-22)17(21)8-11-19/h3-4,6-7,18,20,22H,2,5,8-13H2,1H3/t18-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	298.2045	Alexander Fox Ramos	M+H	N/A	3	Gonioma	Gonioma malagasy	N/A	135355-89-4	Mehdi Beniddir
Grandilodine_B.mgf	*..*	Grandilodine B	455.1813	qTof	LC-ESI	180	O=C1C=C[C@@]23CC(C(OC)=O)[C@@]4(CC3)N(C(OC)=O)C5=CC=CC=C5[C@@]4(C(OC)=O)CCN21	InChI=1S/C24H26N2O7/c1-31-19(28)16-14-22-9-8-18(27)25(22)13-12-23(20(29)32-2)15-6-4-5-7-17(15)26(21(30)33-3)24(16,23)11-10-22/h4-9,16H,10-14H2,1-3H3/t16?,22-,23?,24-/m1/s1	N/A	1	Positive	N/A	Other	454.174	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
Grandilodine_C.mgf	*..*	Grandilodine C	381.1445	qTof	LC-ESI	181	O=C1C=C[C@@]23C[C@H]4[C@@]5(CC3)N(C(OC)=O)C6=CC=CC=C6C5(OC4=O)CCN21	InChI=1S/C21H20N2O5/c1-27-18(26)23-15-5-3-2-4-13(15)21-10-11-22-16(24)6-7-19(22)8-9-20(21,23)14(12-19)17(25)28-21/h2-7,14H,8-12H2,1H3/t14-,19-,20-,21?/m1/s1	N/A	1	Positive	N/A	Other	380.1372	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
guianensine.mgf	*..*	Guianensine	625.2799	qTof	LC-ESI	182	CCC1=CN2C=CC3=C4C(C=CC=C4OC)=NC3=C2C=C1C5=CN6C7=CC=CC=C7C89CCN%10C/C(C(C(C96)C5O)CC8%10)=C([H])\C(O)=O	InChI=1S/C39H36N4O4/c1-3-21-18-41-13-11-23-34-28(8-6-10-31(34)47-2)40-36(23)30(41)16-24(21)26-20-43-29-9-5-4-7-27(29)39-12-14-42-19-22(15-33(44)45)25(17-32(39)42)35(37(26)46)38(39)43/h4-11,13,15-16,18,20,25,32,35,37-38,46H,3,12,14,17,19H2,1-2H3,(H,44,45)/b22-15+	N/A	1	Positive	N/A	Isolated	624.2736	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
hemitheion.mgf	*..*	Hemitheion	371.179	qTof	LC-ESI	183	SC1C(NC2=C3C=CC=C2)=C3CC(N(C)C/C4=C/C)([H])[C@]([H])(C(OC)=O)[C@]4([H])C1	InChI=1S/C21H26N2O2S/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(26)10-14(12)19(17)21(24)25-3/h4-8,14,17-19,22,26H,9-11H2,1-3H3/b12-4-/t14-,17-,18-,19?/m1/s1	N/A	1	Positive	N/A	Isolated	370.1715	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Holstiine.mgf	*..*	Holstiine	383.1965	qTof	LC-ESI	184	O=C1C[C@]2([H])[C@]3([H])[C@]4([H])N(C([C@@H](O)OC3)=O)C5=CC=CC=C5[C@@]41CCN(C)C/C2=C/C	InChI=1S/C22H26N2O4/c1-3-13-11-23(2)9-8-22-16-6-4-5-7-17(16)24-19(22)15(14(13)10-18(22)25)12-28-21(27)20(24)26/h3-7,14-15,19,21,27H,8-12H2,1-2H3/b13-3-/t14-,15+,19-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	382.1893	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	11053-97-7	Mehdi Beniddir
Holstiline.mgf	*..*	Holstiline	397.2122	qTof	LC-ESI	185	O=C1C[C@]2([H])[C@]3([H])[C@]4([H])N(C([C@@H](OC)OC3)=O)C5=CC=CC=C5[C@@]41CCN(C)C/C2=C/C	InChI=1S/C23H28N2O4/c1-4-14-12-24(2)10-9-23-17-7-5-6-8-18(17)25-20(23)16(15(14)11-19(23)26)13-29-22(28-3)21(25)27/h4-8,15-16,20,22H,9-13H2,1-3H3/b14-4-/t15-,16+,20-,22-,23+/m0/s1	N/A	1	Positive	N/A	Isolated	396.2049	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	57103-48-7	Mehdi Beniddir
Horhammericine.mgf	*..*	Horhammericine	369.181	qTof	LC-ESI	186	O=C(C1=C(NC2=C3C=CC=C2)[C@]43[C@@]5([C@]([C@H](O)C)(C1)[C@@H]6O[C@@H]6CN5CC4)[H])OC	InChI=1S/C21H24N2O4/c1-11(24)21-9-12(18(25)26-2)16-20(13-5-3-4-6-14(13)22-16)7-8-23(19(20)21)10-15-17(21)27-15/h3-6,11,15,17,19,22,24H,7-10H2,1-2H3/t11-,15-,17-,19-,20+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	368.1736	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
hydrogenosulfatecriophylline.mgf	*..*	14'-hydrogenosulfatecriophylline	745.3245	qTof	LC-ESI	187	[H][C@@]1(C2=CC([C@H]([C@@H]3C4O3)N(CC[C@]56C7=CC=CC=C7NC5=C(C(OC)=O)C8)[C@H]6C84CC)=CC=C2N9)CCN%10CC(OS(=O)(O)=O)[C@@H](O)[C@]%11(CC)[C@H]%10[C@@]19CC%11	InChI=1S/C40H48N4O8S/c1-4-37-13-14-40-24(12-16-43(36(37)40)20-28(32(37)45)52-53(47,48)49)22-18-21(10-11-26(22)42-40)29-30-33(51-30)38(5-2)19-23(34(46)50-3)31-39(15-17-44(29)35(38)39)25-8-6-7-9-27(25)41-31/h6-11,18,24,28-30,32-33,35-36,41-42,45H,4-5,12-17,19-20H2,1-3H3,(H,47,48,49)/t24-,28+,29+,30+,32+,33?,35-,36-,37+,38?,39-,40+/m0/s1	N/A	1	Positive	N/A	Isolated	744.3193	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
hydroxy-criophylline.mgf	*..*	14'-hydroxycriophylline	665.3673	qTof	LC-ESI	188	[H][C@@]1(C2=CC([C@H]([C@@H]3C4O3)N(CC[C@]56C7=CC=CC=C7NC5=C(C(OC)=O)C8)[C@H]6C84CC)=CC=C2N9)CCN%10CC(O)[C@@H](O)[C@]%11(CC)[C@H]%10[C@@]19CC%11	InChI=1S/C40H48N4O5/c1-4-37-13-14-40-24(12-16-43(36(37)40)20-28(45)32(37)46)22-18-21(10-11-26(22)42-40)29-30-33(49-30)38(5-2)19-23(34(47)48-3)31-39(15-17-44(29)35(38)39)25-8-6-7-9-27(25)41-31/h6-11,18,24,28-30,32-33,35-36,41-42,45-46H,4-5,12-17,19-20H2,1-3H3/t24-,28-,29+,30+,32+,33+,35-,36-,37+,38?,39-,40+/m0/s1	N/A	1	Positive	N/A	Isolated	664.3625	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Ibogaine.mgf	*..*	Ibogaine	311.2118	qTof	LC-ESI	189	COC1=CC2=C(NC3=C2CC[N@@](C4)C5[C@H]3C[C@@H]4CC5CC)C=C1	InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13?,17-,20?/m0/s1	N/A	1	Positive	N/A	Isolated	310.2045	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	83-74-9	Mehdi Beniddir
Ibogamine.mgf	*..*	Ibogamine	281.2012	qTof	LC-ESI	190	CC[C@@H](C[C@H]1C2)C([N@](C1)CC3)[C@@H]2C4=C3C5=C(N4)C=CC=C5	InChI=1S/C19H24N2/c1-2-13-9-12-10-16-18-15(7-8-21(11-12)19(13)16)14-5-3-4-6-17(14)20-18/h3-6,12-13,16,19-20H,2,7-11H2,1H3/t12-,13-,16-,19?/m0/s1	N/A	1	Positive	N/A	Isolated	280.1939	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	481-87-8	Mehdi Beniddir
Iboxygaine.mgf	*..*	Iboxygaine	327.2067	qTof	LC-ESI	191	COC1=CC2=C(NC3=C2CC[N@@](C4)[C@]5([H])[C@@]3([H])C[C@@H]4C[C@@]5([H])[C@@H](O)C)C=C1	InChI=1S/C20H26N2O2/c1-11(23)15-7-12-8-17-19-14(5-6-22(10-12)20(15)17)16-9-13(24-2)3-4-18(16)21-19/h3-4,9,11-12,15,17,20-21,23H,5-8,10H2,1-2H3/t11-,12-,15-,17-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	326.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	82-55-3	Mehdi Beniddir
Icajine.mgf	*..*	Icajine	365.186	qTof	LC-ESI	192	O=C1C[C@@](OCC=C2CN(C)CC3)([H])[C@@]([C@@]2([H])CC4=O)([H])[C@@]5([H])[C@]43C6=CC=CC=C6N51	InChI=1S/C22H24N2O3/c1-23-8-7-22-15-4-2-3-5-16(15)24-19(26)11-17-20(21(22)24)14(10-18(22)25)13(12-23)6-9-27-17/h2-6,14,17,20-21H,7-12H2,1H3/t14-,17-,20-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	364.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	5525-31-5	Mehdi Beniddir
Inaequalisine-A.mgf	*..*	Inaequalisine A	443.267	qTof	LC-ESI	193	CC[C@]1(C2)CC[C@]34[N@+]2(CC[C@@]3(C/C=C/C5=CC=C(O)C(OC)=C5)C6=CC=CC=C6N4)CC=C1	InChI=1S/C29H34N2O2/c1-3-27-13-7-18-31(21-27)19-17-28(14-6-8-22-11-12-25(32)26(20-22)33-2)23-9-4-5-10-24(23)30-29(28,31)16-15-27/h4-13,20,30H,3,14-19,21H2,1-2H3/p+1/b8-6+/t27-,28+,29+,31+/m1/s1	N/A	1	Positive	N/A	Isolated	443.2693	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Inaequalisine-B.mgf	*..*	Inaequalisine B	473.279	qTof	LC-ESI	194	CC[C@]1(C2)CC[C@]34[N@+]2(CC[C@@]3(C/C=C/C5=CC=C(O)C(OC)=C5)C6=CC=CC(OC)=C6N4)CC=C1	InChI=1S/C30H36N2O3/c1-4-28-13-7-18-32(21-28)19-17-29(14-6-8-22-11-12-24(33)26(20-22)35-3)23-9-5-10-25(34-2)27(23)31-30(29,32)16-15-28/h5-13,20,31H,4,14-19,21H2,1-3H3/p+1/b8-6+/t28-,29+,30+,32+/m1/s1	N/A	1	Positive	N/A	Isolated	473.2799	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
iodomethylate-acetoxy-reserpiline.mgf	*..*	Iodomethylate-acetoxy-reserpiline	485.2287	qTof	LC-ESI	195	C[C@H]1[C@]2([H])C[N+]3(C)CCC4(OC(C)=O)C5=CC(OC)=C(OC)C=C5N=C4[C@@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C26H33N2O7/c1-14-17-12-28(3)8-7-26(35-15(2)29)19-10-22(31-4)23(32-5)11-20(19)27-24(26)21(28)9-16(17)18(13-34-14)25(30)33-6/h10-11,13-14,16-17,21H,7-9,12H2,1-6H3/q+1/t14-,16-,17-,21+,26?,28?/m0/s1	N/A	1	Positive	N/A	Isolated	485.2282	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
iodomethylate-de-desacetyl-desformo-akuammiline.mgf	*..*	N4-methyldeformodeacetylakuammiline	337.1902	qTof	LC-ESI	196	C/C=C1[C@@H]2C[C@@]3([H])C4=NC5=CC=CC=C5[C@]4([C@@H]2C(OC)=O)CC[N+]3(C)C\1	InChI=1S/C21H25N2O2/c1-4-13-12-23(2)10-9-21-15-7-5-6-8-16(15)22-19(21)17(23)11-14(13)18(21)20(24)25-3/h4-8,14,17-18H,9-12H2,1-3H3/q+1/b13-4-/t14?,17-,18-,21?,23?/m0/s1	N/A	1	Positive	N/A	Isolated	337.1911	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
iodomethylate-de-reserpiline.mgf	*..*	N4-methylreserpiline	447.2218	qTof	LC-ESI	197	C[C@H]1[C@]2([H])C[N+]3(C)CCC(C4=CC(OC)=C(OC)C=C4N5)=C5[C@@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C24H31N2O5/c1-13-17-11-26(2)7-6-14-16-9-21(28-3)22(29-4)10-19(16)25-23(14)20(26)8-15(17)18(12-31-13)24(27)30-5/h9-10,12-13,15,17,20,25H,6-8,11H2,1-5H3/q+1/t13-,15-,17-,20+,26?/m0/s1	N/A	1	Positive	N/A	Isolated	308.189	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isocarapanaubine.mgf	*..*	Isocarapanaubine	429.2015	qTof	LC-ESI	198	[H][C@@]([C@]1(C2=C3)C(O)=NC2=CC(OC)=C3OC)(C4)N(CC1)C[C@@]5([C@]4(C(C(OC)=O)=CO[C@]5(C)[H])[H])[H]	InChI=1S/C23H28N2O6/c1-12-14-10-25-6-5-23(20(25)7-13(14)15(11-31-12)21(26)30-4)16-8-18(28-2)19(29-3)9-17(16)24-22(23)27/h8-9,11-14,20H,5-7,10H2,1-4H3,(H,24,27)	N/A	1	Positive	N/A	Isolated	428.19474	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isocorynoxine.mgf	*..*	Isocorynoxine	385.212	qTof	LC-ESI	199	O=C1NC2=CC=CC=C2C13[C@@](C[C@H](/C(C(OC)=O)=C\OC)[C@H](CC)C4)([H])N4CC3	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22?/m1/s1	N/A	1	Positive	N/A	Isolated	384.20491	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isomalindine.mgf	*..*	Isomalindine	304.1808	qTof	LC-ESI	200	C[N@+]1(CC2)[C@](CC(C=CN=C3)=C3[C@H]1C)([H])C4=C2C5=CC=CC=C5N4	InChI=1S/C20H22N3/c1-13-17-12-21-9-7-14(17)11-19-20-16(8-10-23(13,19)2)15-5-3-4-6-18(15)22-20/h3-7,9,12-13,19,22H,8,10-11H2,1-2H3/q+1/t13-,19+,23-/m1/s1	N/A	1	Positive	N/A	Isolated	304.1808	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	91739-07-0	Mehdi Beniddir
isomethuenine.mgf	*..*	Isomethuenine	295.1805	qTof	LC-ESI	201	C/C=C1CN(C[C@]2([H])CC(C3=CC=CC=C3N4)=C4C(C[C@@]/12[H])=O)C	InChI=1S/C19H22N2O/c1-3-12-10-21(2)11-13-8-16-14-6-4-5-7-17(14)20-19(16)18(22)9-15(12)13/h3-7,13,15,20H,8-11H2,1-2H3/b12-3-/t13-,15-/m0/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isomitraphylline.mgf	*..*	Isomitraphylline	369.1804	qTof	LC-ESI	202	C[C@H]1[C@H]2CN3CC[C@]4(C5=CC=CC=C5NC4=O)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14+,18-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isoreserpiline.mgf	*..*	Isoreserpiline	413.2063	qTof	LC-ESI	203	C[C@H]1[C@@H]2CN3CCC4=C(NC5=CC(OC)=C(OC)C=C45)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C23H28N2O5/c1-12-16-10-25-6-5-13-15-8-20(27-2)21(28-3)9-18(15)24-22(13)19(25)7-14(16)17(11-30-12)23(26)29-4/h8-9,11-12,14,16,19,24H,5-7,10H2,1-4H3/t12-,14-,16-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	412.19982	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isoretuline.mgf	*..*	Isoretuline	339.2067	qTof	LC-ESI	204	C/C=C(CN1CC2)\[C@H]3[C@@H](CO)[C@]4([H])N(C(C)=O)C5=CC=CC=C5[C@]42[C@@H]1C3	InChI=1S/C21H26N2O2/c1-3-14-11-22-9-8-21-17-6-4-5-7-18(17)23(13(2)25)20(21)16(12-24)15(14)10-19(21)22/h3-7,15-16,19-20,24H,8-12H2,1-2H3/b14-3-/t15-,16+,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	10388-62-2	Mehdi Beniddir
Isorhynchophylline.mgf	*..*	Isorhynchophylline.mgf	385.2116	qTof	LC-ESI	205	CC[C@H]1CN2CC[C@]3(C4=CC=CC=C4NC3=O)[C@@H]2C[C@@H]1/C(C(OC)=O)=C\OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	384.20491	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isorotundifoline.mgf	*..*	Isorotundifoline	401.2066	qTof	LC-ESI	206	CC[C@H]1CN2CC[C@@]3(C4=C(NC3=O)C=CC=C4O)[C@@H]2C[C@@H]1/C(C(OC)=O)=C\OC	InChI=1S/C22H28N2O5/c1-4-13-11-24-9-8-22(19-16(23-21(22)27)6-5-7-17(19)25)18(24)10-14(13)15(12-28-2)20(26)29-3/h5-7,12-14,18,25H,4,8-11H2,1-3H3,(H,23,27)/b15-12+/t13-,14-,18-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	400.19982	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Isostrychnine.mgf	*..*	Isostrychnine	335.1754	qTof	LC-ESI	207	O=C1CCC2=C(/C(C3)=C\CO)C[C@H](N3CC4)[C@@]54C6=CC=CC=C6N1[C@]52[H]	InChI=1S/C21H22N2O2/c24-10-7-13-12-22-9-8-21-16-3-1-2-4-17(16)23-19(25)6-5-14(20(21)23)15(13)11-18(21)22/h1-4,7,18,20,24H,5-6,8-12H2/b13-7-/t18-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	334.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	467-16-3	Mehdi Beniddir
Isostrychnopentamine_A.mgf	*..*	Isostrychnopentamine A	550.354	qTof	LC-ESI	208	[H][C@](N1CC2)(C[C@@](C[C@@]3([H])C4=C(C(C=CC=C5)=C5N4)CCN3C)([H])[C@](C=C)([H])C1)C6=C2C7=CC=C(O)C([C@@]8([H])N(C)CCC8)=C7N6	InChI=1S/C35H43N5O/c1-4-21-20-40-17-14-26-24-11-12-31(41)32(28-10-7-15-38(28)2)35(24)37-34(26)30(40)19-22(21)18-29-33-25(13-16-39(29)3)23-8-5-6-9-27(23)36-33/h4-6,8-9,11-12,21-22,28-30,36-37,41H,1,7,10,13-20H2,2-3H3/t21-,22-,28-,29-,30-/m0/s1	N/A	1	Positive	N/A	Isolated	549.3468	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
Isosungucine.mgf	*..*	Isosungucine	635.3381	qTof	LC-ESI	209	C/C=C(C1)\[C@H](C[C@@H]2N1CC3)C([C@@]4([H])[C@]23C5=CC=CC=C5N46)=CC([C@@]7([H])C[C@]89C%10=CC=CC=C%10N(C(C=C%11)=O)[C@@]8([H])[C@]%11([H])[C@H]%12C[C@@H]9N7C/C%12=C/C)C6=O	InChI=1S/C42H42N4O2/c1-3-23-21-43-16-15-41-30-9-5-8-12-33(30)46-39(41)28(27(23)18-35(41)43)17-29(40(46)48)34-20-42-31-10-6-7-11-32(31)45-37(47)14-13-25(38(42)45)26-19-36(42)44(34)22-24(26)4-2/h3-14,17,25-27,29,34-36,38-39H,15-16,18-22H2,1-2H3/b23-3-,24-4-/t25-,26-,27-,29?,34+,35-,36-,38-,39-,41+,42+/m0/s1	N/A	1	Positive	N/A	Isolated	634.3308	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	279684-12-7	Mehdi Beniddir
jerantinineA.mgf	*..*	Jerantinine A	383.1968	qTof	LC-ESI	210	CC[C@]1([C@@]23[H])C=CCN3CC[C@]42C5=CC(O)=C(OC)C=C5NC4=C(C(OC)=O)C1	InChI=1S/C22H26N2O4/c1-4-21-6-5-8-24-9-7-22(20(21)24)14-10-16(25)17(27-2)11-15(14)23-18(22)13(12-21)19(26)28-3/h5-6,10-11,20,23,25H,4,7-9,12H2,1-3H3/t20-,21-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	382.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
jerantiphyllineA.mgf	*..*	Jerantiphylline A	415.1855	qTof	LC-ESI	211	CC[C@]1(C=O)CC(C(OC)=O)=C2NC3=CC(OC)=C(O)C=C3[C@]24[C@@]1([H])N(C(C)=O)CC4	InChI=1S/C22H26N2O6/c1-5-21(11-25)10-13(19(28)30-4)18-22(6-7-24(12(2)26)20(21)22)14-8-16(27)17(29-3)9-15(14)23-18/h8-9,11,20,23,27H,5-7,10H2,1-4H3/t20-,21?,22-/m0/s1	N/A	1	Positive	N/A	Isolated	414.1791	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
jerantiphyllineB.mgf	*..*	Jerantiphylline B	417.202	qTof	LC-ESI	212	CC[C@@]1(/C=C(C(OC)=O)\O)CCCN2CC[C@]3(C(Nc4c3cc(O)c(OC)c4)=O)[C@]12[H]	InChI=1S/C22H28N2O6/c1-4-21(12-16(26)18(27)30-3)6-5-8-24-9-7-22(19(21)24)13-10-15(25)17(29-2)11-14(13)23-20(22)28/h10-12,19,25-26H,4-9H2,1-3H3,(H,23,28)/b16-12-/t19-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	416.1945	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsanone.mgf	*..*	Kopsanone	307.1806	qTof	LC-ESI	213	O=C1[C@@H](C2)[C@@]34[C@@](CC[C@]56C4N2CCC5)([C@@H]1C6)NC7=CC=CC=C73	InChI=1S/C20H22N2O/c23-16-13-10-18-6-3-9-22-11-14(16)20(17(18)22)12-4-1-2-5-15(12)21-19(13,20)8-7-18/h1-2,4-5,13-14,17,21H,3,6-11H2/t13-,14-,17?,18-,19-,20+/m1/s1	N/A	1	Positive	N/A	Isolated	306.1732	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsidineA.mgf	*..*	Kopsidine A	487.2064	qTof	LC-ESI	214	[H][C@]12[C@@]34CC[C@]5(C(O)(C(OC)=O)[C@@]46[H])N(C(OC)=O)C7=C(OC)C=CC=C7[C@@]51CCN2C(O6)([H])C[C@@H]3OC	InChI=1S/C25H30N2O8/c1-31-14-7-5-6-13-17(14)27(21(29)34-4)24-9-8-22-15(32-2)12-16(26-11-10-23(13,24)18(22)26)35-19(22)25(24,30)20(28)33-3/h5-7,15-16,18-19,30H,8-12H2,1-4H3/t15-,16?,18-,19+,22+,23+,24-,25+/m0/s1	N/A	1	Positive	N/A	Isolated	486.2002	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsidineC.mgf	*..*	Kopsidine C	473.1931	qTof	LC-ESI	215	COC(N1C2=C([C@]34CCN5[C@@]3([H])[C@]67CC[C@]14[C@@]([C@]6([H])O[C@]5([H])C[C@@H]7O)(C(OC)=O)O)C=CC=C2OC)=O	InChI=1S/C24H28N2O8/c1-31-13-6-4-5-12-16(13)26(20(29)33-3)23-8-7-21-14(27)11-15(25-10-9-22(12,23)17(21)25)34-18(21)24(23,30)19(28)32-2/h4-6,14-15,17-18,27,30H,7-11H2,1-3H3/t14-,15+,17-,18+,21+,22+,23-,24+/m0/s1	N/A	1	Positive	N/A	Isolated	472.1846	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsidineD.mgf	*..*	Kopsidine D	473.1956	qTof	LC-ESI	216	COC(N1C2=C([C@]34CCN5[C@@]3([H])[C@]67CC[C@]14[C@@]([C@]6([H])O[C@]5([H])C[C@H]7O)(C(OC)=O)O)C=CC=C2OC)=O	InChI=1S/C24H28N2O8/c1-31-13-6-4-5-12-16(13)26(20(29)33-3)23-8-7-21-14(27)11-15(25-10-9-22(12,23)17(21)25)34-18(21)24(23,30)19(28)32-2/h4-6,14-15,17-18,27,30H,7-11H2,1-3H3/t14-,15-,17+,18-,21-,22-,23+,24-/m1/s1	N/A	1	Positive	N/A	Isolated	472.1846	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsifine.mgf	*..*	Kopsifine	439.1493	qTof	LC-ESI	217	[H][C@]1(N2CCC3)[C@@]34CC[C@]5([C@]6(O)C4)N(C(OC)=O)C7=C8C(OCO8)=CC=C7[C@@]51[C@@H](C6=O)C2=O	InChI=1S/C23H22N2O7/c1-30-19(28)25-14-11(3-4-12-15(14)32-10-31-12)23-13-16(26)21(29)9-20(6-7-22(21,23)25)5-2-8-24(17(13)27)18(20)23/h3-4,13,18,29H,2,5-10H2,1H3/t13-,18-,20+,21-,22+,23-/m0/s1	N/A	1	Positive	N/A	Isolated	438.1427	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsinarine.mgf	*..*	Kopsinarine	455.1845	qTof	LC-ESI	218	COC(N1C2=C([C@]34[C@@]5([H])N6CCC[C@]57CC[C@]13[C@@](C7)(C([C@H]4C6=O)=O)O)C=CC(OC)=C2OC)=O	InChI=1S/C24H26N2O7/c1-31-13-6-5-12-15(16(13)32-2)26(20(29)33-3)23-9-8-21-7-4-10-25-18(28)14(24(12,23)19(21)25)17(27)22(23,30)11-21/h5-6,14,19,30H,4,7-11H2,1-3H3/t14-,19-,21+,22+,23+,24-/m0/s1	N/A	1	Positive	N/A	Isolated	454.174	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsinine.mgf	*..*	Kopsinine	339.2066	qTof	LC-ESI	219	COC([C@@H]1C[C@@]2([C@@]34[H])CCCN4CC[C@]53C6=CC=CC=C6N[C@]15CC2)=O	InChI=1S/C21H26N2O2/c1-25-17(24)15-13-19-7-4-11-23-12-10-20(18(19)23)14-5-2-3-6-16(14)22-21(15,20)9-8-19/h2-3,5-6,15,18,22H,4,7-13H2,1H3/t15-,18-,19+,20+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
kopsinitarineB.mgf	*..*	Kopsinitarine B	365.1507	qTof	LC-ESI	220	COC1=CC=CC2=C1N[C@@]3([C@]4(O)[C@@H]5O6)CC[C@@]75C=CCN8C6C(C4=O)C23[C@]78[H]	InChI=1S/C21H20N2O4/c1-26-11-5-2-4-10-13(11)22-19-8-7-18-6-3-9-23-15-12(20(10,19)16(18)23)14(24)21(19,25)17(18)27-15/h2-6,12,15-17,22,25H,7-9H2,1H3/t12?,15?,16-,17+,18-,19-,20?,21+/m0/s1	N/A	1	Positive	N/A	Isolated	364.1423	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Lanciferine.mgf	*..*	Lanciferine	545.2282	qTof	LC-ESI	221	O=C(O1)C[C@]2(C3(COC(/C=C/C4=CC=CC=C4)=O)C(OC)=O)[C@@]1([C@]5([H])C[C@H]3[C@@]6(C(O6)C)CN5C)NC7=CC=CC=C72	InChI=1S/C31H32N2O7/c1-19-29(39-19)17-33(2)24-15-23(29)28(27(36)37-3,18-38-25(34)14-13-20-9-5-4-6-10-20)30-16-26(35)40-31(24,30)32-22-12-8-7-11-21(22)30/h4-14,19,23-24,32H,15-18H2,1-3H3/b14-13+/t19?,23-,24+,28?,29+,30+,31+/m1/s1	N/A	1	Positive	N/A	Isolated	544.221	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia boulindaensis	N/A	56440-64-3	Mehdi Beniddir
larutienineA.mgf	*..*	Larutienine A	295.1797	qTof	LC-ESI	222	C[C@H](O1)[C@@]2(C[C@@]1([H])N3C4=CC=CC=C54)CCCN6CCC5=C3[C@]26[H]	InChI=1S/C19H22N2O/c1-12-19-8-4-9-20-10-7-14-13-5-2-3-6-15(13)21(16(11-19)22-12)17(14)18(19)20/h2-3,5-6,12,16,18H,4,7-11H2,1H3/t12-,16-,18+,19-/m0/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
leucolusine.mgf	*..*	Leucolusine	331.2017	qTof	LC-ESI	223	O[C@@]1(CCN2[C@@]3([H])OCC[C@@]3(CC)CCC2)C(NC4=CC=CC=C14)=O	InChI=1S/C19H26N2O3/c1-2-18-8-5-11-21(17(18)24-13-10-18)12-9-19(23)14-6-3-4-7-15(14)20-16(19)22/h3-4	N/A	1	Positive	N/A	Isolated	330.1934	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
leuconodineA.mgf	*..*	Leuconodine A	327.1704	qTof	LC-ESI	224	CCC12CCCN3C(=O)C(O)C4c5ccccc5N(C(=O)CC1)C234	InChI=1S/C19H22N2O3/c1-2-18-9-5-11-20-17(24)16(23)15-12-6-3-4-7-13(12)21(19(15,18)20)14(22)8-10-18/h3-4,6-7,15-16,23H,2,5,8-11H2,1H3/t15-,16+,18?,19+/m0/s1	N/A	1	Positive	N/A	Isolated	326.16304	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Leuconolam.mgf	*..*	Leuconolam	327.1703	qTof	LC-ESI	225	O=C1C=C2C3=C(NC(CC[C@]4(CC)[C@@]2(O)N1CCC4)=O)C=CC=C3	InChI=1S/C19H22N2O3/c1-2-18-9-5-11-21-17(23)12-14(19(18,21)24)13-6-3-4-7-15(13)20-16(22)8-10-18/h3-4,6-7,12,24H,2,5,8-11H2,1H3,(H,20,22)/t18-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	326.163	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	93710-27-1	Mehdi Beniddir
leuconoxine.mgf	*..*	Leuconoxine	311.1749	qTof	LC-ESI	226	CC[C@]1(CCC2=O)CCCN3C(C[C@]4([H])C5=CC=CC=C5N2[C@]413)=O	InChI=1S/C19H22N2O2/c1-2-18-9-5-11-20-17(23)12-14-13-6-3-4-7-15(13)21(19(14,18)20)16(22)8-10-18/h3-4,6-7,14H,2,5,8-12H2,1H3/t14-,18-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	310.1681	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
leucophyllidine.mgf	*..*	Leucophyllidine	573.3587	qTof	LC-ESI	227	CC[C@]12CCCN(C3=NC4=C(C(C=C)=C3C2)C=C([C@]5([H])C[C@]6(CCCN7CCC8=C(N5C9=C8C=CC=C9)[C@@]67[H])CC)C(O)=C4)C1	InChI=1S/C38H44N4O/c1-4-24-27-19-28(33(43)20-30(27)39-36-29(24)21-37(5-2)14-9-17-41(36)23-37)32-22-38(6-3)15-10-16-40-18-13-26-25-11-7-8-12-31(25)42(32)34(26)35(38)40/h4	N/A	1	Positive	N/A	Isolated	572.3515	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Leucoridine_A.mgf	*..*	Leucoridine A	557.3639	qTof	LC-ESI	231	CC[C@H]1C[C@H]2C[C@]3(CC([C@H]4CC5[C@@]67CCN5C[C@@H]4CC)=C7N(C8=C6C=CC=C8)C3)C9=NC%10=CC=CC=C%10[C@]9%11C2N1CC%11	InChI=1S/C38H44N4/c1-3-23-21-40-15-13-37-29-10-6-8-12-31(29)42-22-36(20-27(34(37)42)26(23)18-32(37)40)19-24-17-25(4-2)41-16-14-38(33(24)41)28-9-5-7-11-30(28)39-35(36)38/h5-12,23-26,32-33H,3-4,13-22H2,1-2H3/t23-,24-,25-,26-,32?,33?,36+,37+,38+/m0/s1	N/A	1	Positive	N/A	Other	556.3566	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	1233498-30-0	Mehdi Beniddir
leucoridineB.mgf	*..*	Leucoridine B	555.3483	qTof	LC-ESI	228	CCC1=CN(CC2)[C@]3([H])[C@]42C([C@@](CN5C6=C7[C@]8([H])[C@H](CC)CN(CC9)[C@](C8)([H])[C@@]69C%10=CC=CC=C5%10)(C7)[C@@]1([H])C3)=NC%11=CC=CC=C4%11	InChI=1S/C38H42N4/c1-3-23-20-40-15-13-37-28-10-6-8-12-31(28)42-22-36(19-26(34(37)42)25(23)17-32(37)40)29-18-33-38(14-16-41(33)21-24(29)4-2)27-9-5-7-11-30(27)39-35(36)38/h5-12	N/A	1	Positive	N/A	Isolated	554.3409	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
leucoridineC.mgf	*..*	Leucoridine C	575.3742	qTof	LC-ESI	229	NC1=CC=CC=C1[C@@]23C([C@@](CN4C5=C6[C@]7([H])[C@H](CC)CN(CC8)[C@](C7)([H])[C@@]58C9=CC=CC=C49)(C6)[C@]%10([H])[C@H](CC)CN(CC3)[C@@]2([H])C%10)=O	InChI=1S/C38H46N4O/c1-3-23-20-40-15-13-37-28-10-6-8-12-31(28)42-22-36(19-26(34(37)42)25(23)17-32(37)40)29-18-33-38(35(36)43	N/A	1	Positive	N/A	Isolated	574.3672	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
leucoridineD.mgf	*..*	Leucoridine D	559.3796	qTof	LC-ESI	230	C=C1[C@]([C@]2(C3=CC=C4)[C@@]5([H])N(CC2)C[C@@H](CC)[C@]1([H])C5)([H])NC3=C4C[C@]6([H])C7=NC8=CC=CC=C8[C@]79[C@@]%10([H])N(CC9)C[C@@H](CC)[C@]6([H])C%10	InChI=1S/C38H46N4/c1-4-23-20-41-16-14-38-30-11-8-9-25(34(30)40-35(38)22(3)26(23)18-32(38)41)17-28-27-19-33-37(13-15-42(33)21-24(27)5-2)29-10-6-7-12-31(29)39-36(28)37/h6-12	N/A	1	Positive	N/A	Isolated	558.3722	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lirofolineA.mgf	*..*	Lirofoline A	325.1911	qTof	LC-ESI	232	CC[C@H]1CC2C[C@]3([H])[C@@]1([H])N(CN4C3=C(C5=C4C=CC(OC)=C5)C=O)C2	InChI=1S/C20H24N2O2/c1-3-13-6-12-7-16-19(13)21(9-12)11-22-18-5-4-14(24-2)8-15(18)17(10-23)20(16)22/h4-5,8,10,12-13,16,19H,3,6-7,9,11H2,1-2H3/t12?,13-,16+,19-/m0/s1	N/A	1	Positive	N/A	Isolated	324.1838	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lochnericine.mgf	*..*	Lochnericine	353.186	qTof	LC-ESI	233	O=C(C1=C(NC2=C3C=CC=C2)[C@]43[C@@]5([C@](CC)(C1)[C@@H]6[C@@H](O6)CN5CC4)[H])OC	InChI=1S/C21H24N2O3/c1-3-20-10-12(18(24)25-2)16-21(13-6-4-5-7-14(13)22-16)8-9-23(19(20)21)11-15-17(20)26-15/h4-7,15,17,19,22H,3,8-11H2,1-2H3/t15-,17-,19-,20+,21-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lonicerine.mgf	*..*	Lonicerine	371.1985	qTof	LC-ESI	234	C/C=C(CN1)\[C@@H]2C[C@@]1([H])[C@@]34NC5=C([C@]3(C2(CO)C(OC)=O)CCO4)C=CC=C5	InChI=1S/C21H26N2O4/c1-3-13-11-22-17-10-15(13)19(12-24,18(25)26-2)20-8-9-27-21(17,20)23-16-7-5-4-6-14(16)20/h3-7,15,17,22-24H,8-12H2,1-2H3/b13-3-/t15-,17-,19?,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	370.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lumusidineA.mgf	*..*	Lumusidine A	687.3886	qTof	LC-ESI	235	[H][C@](C1)([C@@]2([H])[C@@](C([C@@H](C)C3=C(OC)C=C(N(C)C4=C5C[C@]6([H])N(C)[C@@]4([H])C[C@]7([H])[C@@]6([H])COC=C7C(C)=O)C5=C3)=COC2)([H])C8)N(C)[C@]8([H])C9=C1C%10=CC=CC=C%10N9C	InChI=1S/C43H50N4O4/c1-22(31-18-50-20-33-26(31)13-39-42-29(15-36(33)44(39)3)24-10-8-9-11-35(24)46(42)5)25-12-28-30-16-37-34-21-51-19-32(23(2)48)27(34)14-40(45(37)4)43(30)47(6)38(28)17-41(25)49-7/h8-12,17-19,22,26-27,33-34,36-37,39-40H,13-16,20-21H2,1-7H3/t22-,26-,27-,33+,34+,36-,37-,39-,40-/m0/s1	N/A	1	Positive	N/A	Isolated	686.3832	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lumusidineB.mgf	*..*	Lumusidine B	705.3992	qTof	LC-ESI	236	[H][C@](C1)([C@@]2([H])[C@@](C([C@@H](C)C3=C(OC)C=C(N(C)C4=C5C[C@]6([H])N(C)[C@@]4([H])C[C@]7([H])[C@@]6([H])COC=C7C(C)=O)C5=C3)[C@H](O)OC2)([H])C8)N(C)[C@]8([H])C9=C1C%10=CC=CC=C%10N9C	InChI=1S/C43H52N4O5/c1-21(40-27-14-38-41-28(23-10-8-9-11-33(23)46(41)5)15-35(45(38)4)32(27)20-52-43(40)49)24-12-26-29-16-34-31-19-51-18-30(22(2)48)25(31)13-37(44(34)3)42(29)47(6)36(26)17-39(24)50-7/h8-12,17-18,21,25,27,31-32,34-35,37-38,40,43,49H,13-16,19-20H2,1-7H3/t21-,25-,27+,31+,32+,34-,35-,37-,38-,40?,43+/m0/s1	N/A	1	Positive	N/A	Isolated	704.3938	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lumutinineA.mgf	*..*	Lumutinine A	673.372	qTof	LC-ESI	237	[H][C@](C1)([C@@]2([H])[C@@]([C@@](CC(C=C(C(C[C@]3([H])N(C)[C@@]4([H])C[C@]5([H])[C@@]3([H])COC=C5C(C)=O)=C4N6C)C6=C7)=C7O8)([H])[C@@]8(C)OC2)([H])C9)N(C)[C@]9([H])C%10=C1C%11=CC=CC=C%11N%10C	InChI=1S/C42H48N4O4/c1-21(47)29-18-48-19-30-24(29)13-37-41-28(16-34(30)43(37)3)26-11-22-12-32-25-14-38-40-27(23-9-7-8-10-33(23)45(40)5)15-35(44(38)4)31(25)20-49-42(32,2)50-39(22)17-36(26)46(41)6/h7-11,17-18,24-25,30-32,34-35,37-38H,12-16,19-20H2,1-6H3/t24-,25+,30+,31+,32-,34-,35-,37-,38-,42-/m0/s1	N/A	1	Positive	N/A	Isolated	672.3676	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lumutinineB.mgf	*..*	Lumutinine B	673.3729	qTof	LC-ESI	238	[H][C@](C1)([C@@]2([H])[C@@]([C@@](CC3=C4C(C(C[C@]5([H])N(C)[C@@]6([H])C[C@]7([H])[C@@]5([H])COC=C7C(C)=O)=C6N4C)=CC=C3O8)([H])[C@@]8(C)OC2)([H])C9)N(C)[C@]9([H])C%10=C1C%11=CC=CC=C%11N%10C	InChI=1S/C42H48N4O4/c1-21(47)29-18-48-19-30-24(29)14-36-41-27(17-34(30)43(36)3)23-11-12-38-28(39(23)46(41)6)13-32-25-15-37-40-26(22-9-7-8-10-33(22)45(40)5)16-35(44(37)4)31(25)20-49-42(32,2)50-38/h7-12,18,24-25,30-32,34-37H,13-17,19-20H2,1-6H3/t24-,25+,30+,31+,32-,34-,35-,36-,37-,42-/m0/s1	N/A	1	Positive	N/A	Isolated	672.3676	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Lundurine_A.mgf	*..*	Lundurine A	367.1652	qTof	LC-ESI	239	O=C1C=C[C@]23CC[C@]4([C@H]5C3)N(C(OC)=O)C6=CC=C(OC)C=C6[C@]45CCN21	InChI=1S/C21H22N2O4/c1-26-13-3-4-15-14(11-13)20-9-10-22-17(24)5-6-19(22)7-8-21(20,16(20)12-19)23(15)18(25)27-2/h3-6,11,16H,7-10,12H2,1-2H3/t16-,19+,20-,21+/m0/s1	N/A	1	Positive	N/A	Other	366.158	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	162616-56-0	Mehdi Beniddir
lyaline.mgf	*..*	Lyaline	346.1548	qTof	LC-ESI	240	O=C(OC)C1=CN[C@H]2[C@](C=C)([H])[C@@H]1CC3=C4N2C5=C(C4=CC=N3)C=CC=C5	InChI=1S/C21H19N3O2/c1-3-12-15-10-17-19-14(8-9-22-17)13-6-4-5-7-18(13)24(19)20(12)23-11-16(15)21(25)26-2/h3-9,11-12,15,20,23H,1,10H2,2H3/t12-,15-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	345.1477	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
lyaloside.mgf	*..*	Lyaloside	527.2017	qTof	LC-ESI	241	C=C[C@@H]1[C@](C(C(OC)=O)=CO[C@H]1OC2C(O)C(O)C(O)C(O2)CO)([H])CC3=NC=CC4=C3NC5=CC=CC=C45	InChI=1S/C27H30N2O9/c1-3-13-16(10-19-21-15(8-9-28-19)14-6-4-5-7-18(14)29-21)17(25(34)35-2)12-36-26(13)38-27-24(33)23(32)22(31)20(11-30)37-27/h3-9,12-13,16,20,22-24,26-27,29-33H,1,10-11H2,2H3/t13-,16+,20?,22?,23?,24?,26+,27?/m1/s1	N/A	1	Positive	N/A	Isolated	526.1951	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
macralstonine.mgf	*..*	Macralstonine	705.3997	qTof	LC-ESI	242	CC(=O)C1=COC[C@@H]2[C@H]1C[C@H]3C4=C(C[C@@H]2N3C)C5=C(N4C)C=C(C(=C5)C[C@@H]6[C@@H]7C[C@H]8C9=C(C[C@@H]([C@@H]7CO[C@]6(C)O)N8C)C1=CC=CC=C1N9C)OC	InChI=1S/C43H52N4O5/c1-22(48)30-19-51-20-31-25(30)14-38-42-29(17-35(31)44(38)3)27-12-23(40(50-7)18-37(27)47(42)6)13-33-26-15-39-41-28(24-10-8-9-11-34(24)46(41)5)16-36(45(39)4)32(26)21-52-43(33,2)49/h8-12,18-19,25-26,31-33,35-36,38-39,49H,13-17,20-21H2,1-7H3/t25-,26+,31+,32+,33+,35-,36-,38-,39-,43-/m0/s1	N/A	1	Positive	N/A	Isolated	704.3938	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
macrocarpamine.mgf	*..*	Macrocarpamine	643.363	qTof	LC-ESI	243	C/C=C\1/CN2CC[C@@H]3C4=CC=CC=C4N5[C@@]3([C@@H]2C[C@@H]1[C@H]5C(=O)OC)/C=C/C6=COC[C@@H]7[C@H]6C[C@H]8C9=C(C[C@@H]7N8C)C1=CC=CC=C1N9C	InChI=1S/C41H46N4O3/c1-5-24-21-44-17-15-32-27-11-7-9-13-34(27)45-39(40(46)47-4)29(24)20-37(44)41(32,45)16-14-25-22-48-23-31-28(25)18-36-38-30(19-35(31)42(36)2)26-10-6-8-12-33(26)43(38)3/h5-14,16,22,28-29,31-32,35-37,39H,15,17-21,23H2,1-4H3/b16-14+,24-5-/t28-,29-,31+,32+,35-,36-,37-,39-,41-/m0/s1	N/A	1	Positive	N/A	Isolated	642.357	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
macrocarpineD.mgf	*..*	Macrocarpine D	327.206	qTof	LC-ESI	244	C[C@H]1[C@@H]([C@]2([H])C[C@@]3([H])C4=C(C5=CC=CC=C5N4)C[C@@](N3C)([H])[C@]2([H])CO1)CO	InChI=1S/C20H26N2O2/c1-11-15(9-23)13-7-19-20-14(12-5-3-4-6-17(12)21-20)8-18(22(19)2)16(13)10-24-11/h3-6,11,13,15-16,18-19,21,23H,7-10H2,1-2H3/t11-,13-,15-,16+,18-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	326.1994	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
macrodasine_A.mgf	*..*	Macrodasine A	455.2535	qTof	LC-ESI	245	C[C@]1(O2)[C@@]([C@]3([H])C[C@@]4([H])C5=C(C6=CC=CC=C6N5C)C[C@@](N4C)([H])[C@]3([H])CO1)([H])C[C@@]72[C@@H](O)C[C@@H](O7)CO	InChI=1S/C26H34N2O5/c1-25-19(11-26(33-25)23(30)8-14(12-29)32-26)16-9-22-24-17(10-21(27(22)2)18(16)13-31-25)15-6-4-5-7-20(15)28(24)3/h4-7,14,16,18-19,21-23,29-30H,8-13H2,1-3H3/t14-,16-,18-,19+,21+,22+,23-,25+,26-/m1/s1	N/A	1	Positive	N/A	Isolated	454.2468	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
macusine_B.mgf	*..*	Macusine B	309.1956	qTof	LC-ESI	246	C\C=C1\C[N+]2(C)C3Cc4c([nH]c5ccccc45)C2CC1C3CO	InChI=1S/C20H25N2O/c1-3-12-10-22(2)18-9-15-13-6-4-5-7-17(13)21-20(15)19(22)8-14(12)16(18)11-23/h3-7,14,16,18-19,21,23H,8-11H2,1-2H3/q+1/b12-3-	N/A	1	Positive	N/A	Isolated	309.1966	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Malindine.mgf	*..*	Malindine	304.1808	qTof	LC-ESI	247	C[N@+]1(CC2)[C@](CC(C=CN=C3)=C3[C@@H]1C)([H])C4=C2C5=CC=CC=C5N4	InChI=1S/C20H22N3/c1-13-17-12-21-9-7-14(17)11-19-20-16(8-10-23(13,19)2)15-5-3-4-6-18(15)22-20/h3-7,9,12-13,19,22H,8,10-11H2,1-2H3/q+1/t13-,19-,23+/m0/s1	N/A	1	Positive	N/A	Isolated	304.1808	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	81161-28-6	Mehdi Beniddir
mavacurine.mgf	*..*	C-mavacurine	309.1961	qTof	LC-ESI	248	C[N+]1(CC2)[C@]3([H])C4=C2C5=CC=CC=C5N4[C@@]([H])(CO)[C@@](/C(C1)=C\C)([H])C3	InChI=1S/C20H25N2O/c1-3-13-11-22(2)9-8-15-14-6-4-5-7-17(14)21-18(12-23)16(13)10-19(22)20(15)21/h3-7,16,18-19,23H,8-12H2,1-2H3/q+1/b13-3-/t16-,18?,19-,22?/m0/s1	N/A	1	Positive	N/A	Isolated	309.1961	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	6801-19-0	Mehdi Beniddir
melonine.mgf	*..*	Melonine	283.215	qTof	LC-ESI	249	CC[C@]12CC[C@@]34[C@@](C5=CC=CC=C5N4)([H])CC[N@@]([C@H]3CC2)C1	InChI=1S/C19H26N2/c1-2-18-9-7-17-19(11-10-18)15(8-12-21(17)13-18)14-5-3-4-6-16(14)20-19/h3-6,15,17,20H,2,7-13H2,1H3/t15-,17-,18-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	282.21	Tape Kouame	M+H	N/A	3	N/A	N/A	N/A	N/A	Le Pogam
Melosuavine_E.mgf	*..*	Melosuavine E	703.349	qTof	LC-ESI	250	O=C(OC)C1=C([C@@]23[C@@H]4[C@](C=CCN4CC3)(CC)C1)NC5=C2C=C([C@@]6([H])C=C[C@@]([C@@H]7N6CC8)(CC)CC(C(OC)=O)=C9[C@]78C(C=CC=C%10O)=C%10N9)C(O)=C5	InChI=1S/C42H46N4O6/c1-5-39-12-8-16-45-17-14-42(37(39)45)27-19-23(31(48)20-28(27)43-33(42)24(21-39)35(49)51-3)29-11-13-40(6-2)22-25(36(50)52-4)34-41(15-18-46(29)38(40)41)26-9-7-10-30(47)32(26)44-34/h7-13,19-20,29,37-38,43-44,47-48H,5-6,14-18,21-22H2,1-4H3/t29-,37+,38+,39+,40+,41+,42+/m1/s1	N/A	1	Positive	N/A	Isolated	702.3417	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
mersicarpine.mgf	*..*	Mersicarpine	285.1594	qTof	LC-ESI	251	O=C(CC1)N2C3=CC=CC=C3C4=NCCC[C@@]1(CC)[C@@]24O	InChI=1S/C17H20N2O2/c1-2-16-9-5-11-18-15-12-6-3-4-7-13(12)19(17(15,16)21)14(20)8-10-16/h3-4,6-7,21H,2,5,8-11H2,1H3/t16-,17-/m1/s1	N/A	1	Positive	N/A	Isolated	284.1525	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
mersidasineC.mgf	*..*	Mersidasine C	505.2179	qTof	LC-ESI	252	COC([C@]12CC[C@]([C@@]3(O)C(OC)=O)([H])[C@](C4=C(N3C(OC)=O)C(OC)=CC=C4)([C@]25[H])CCN5CC[C@@H]1O)=O	InChI=1S/C25H32N2O9/c1-33-15-7-5-6-14-18(15)27(22(31)36-4)25(32,21(30)35-3)16-8-10-24(20(29)34-2)17(28)9-12-26-13-11-23(14,16)19(24)26/h5-7,16-17,19,28,32H,8-13H2,1-4H3/t16-,17+,19-,23+,24-,25-/m1/s1	N/A	1	Positive	N/A	Isolated	504.2108	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
mersilongine.mgf	*..*	Mersilongine	445.1635	qTof	LC-ESI	253	COC(N1c2c([C@@]34CCN[C@]1(C(OC)=O)[C@]3([H])CCC(C(OC)=O)=C4)ccc5c2OCO5)=O	InChI=1S/C22H24N2O8/c1-28-18(25)12-4-7-15-21(10-12)8-9-23-22(15,19(26)29-2)24(20(27)30-3)16-13(21)5-6-14-17(16)32-11-31-14/h5-6,10,15,23H,4,7-9,11H2,1-3H3/t15-,21+,22-/m1/s1	N/A	1	Positive	N/A	Isolated	444.1533	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
mersiloscineA.mgf	*..*	Mersiloscine A	503.1697	qTof	LC-ESI	254	COC(N1C2=C([C@@]34CCN5C[C@H]6OC([C@]([C@H]6O)([C@@]45[H])CC[C@@]3([H])[C@]1(C(OC)=O)O)=O)C=CC7=C2OCO7)=O	InChI=1S/C24H26N2O10/c1-32-20(29)24(31)14-5-6-23-17(27)13(36-19(23)28)9-25-8-7-22(14,18(23)25)11-3-4-12-16(35-10-34-12)15(11)26(24)21(30)33-2/h3-4,13-14,17-18,27,31H,5-10H2,1-2H3/t13-,14-,17+,18-,22+,23-,24-/m1/s1	N/A	1	Positive	N/A	Isolated	502.1588	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
mersingineA.mgf	*..*	Mersingine A	364.168	qTof	LC-ESI	255	COC1=CC=CC2=C1N[C@@]3([C@]4(N)[C@@H]5O6)CC[C@@]75C=CCN8[C@H]6[C@H](C4=O)C23[C@]78[H]	InChI=1S/C21H21N3O3/c1-26-11-5-2-4-10-13(11)23-19-8-7-18-6-3-9-24-15-12(20(10,19)16(18)24)14(25)21(19,22)17(18)27-15/h2-6,12,15-17,23H,7-9,22H2,1H3/t12-,15+,16-,17+,18-,19-,20?,21+/m0/s1	N/A	1	Positive	N/A	Isolated	363.1583	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Methuenine.mgf	*..*	Methuenine	295.1805	qTof	LC-ESI	256	CN(C1)C/C([C@]([C@]1([H])C2)([H])CC(C3=C2C4=CC=CC=C4N3)=O)=C/C	InChI=1S/C19H22N2O/c1-3-12-10-21(2)11-13-8-16-14-6-4-5-7-17(14)20-19(16)18(22)9-15(12)13/h3-7,13,15,20H,8-11H2,1-2H3/b12-3-/t13-,15+/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	63425-00-3	Mehdi Beniddir
Methyle_reserpate.mgf	*..*	Methyle reserpate	415.2227	qTof	LC-ESI	257	[H][C@@](N1CC2)(C[C@@]([C@H](C(OC)=O)[C@@H](OC)[C@H](O)C3)([H])[C@@]3([H])C1)C4=C2C5=C(N4)C=C(OC)C=C5	InChI=1S/C23H30N2O5/c1-28-13-4-5-14-15-6-7-25-11-12-8-19(26)22(29-2)20(23(27)30-3)16(12)10-18(25)21(15)24-17(14)9-13/h4-5,9,12,16,18-20,22,24,26H,6-8,10-11H2,1-3H3/t12-,16+,18-,19-,20+,22+/m1/s1	N/A	1	Positive	N/A	Isolated	414.2155	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2901-66-8	Mehdi Beniddir
Mitrinermine.mgf	*..*	Mitrinermine	385.2122	qTof	LC-ESI	258	O=C1NC2=CC=CC=C2[C@]13C(C[C@H](/C(C(OC)=O)=C\OC)[C@@H](CC)C4)N4CC3	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19?,22+/m0/s1	N/A	1	Positive	N/A	Isolated	384.2049	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	76-66-4	Mehdi Beniddir
moandaensine_B.mgf	*..*	Moandaensine B	631.363	qTof	LC-ESI	259	C/C=C1CN(CCC2=C3NC4=CC=CC=C24)[C@@]3([H])C[C@]/1([H])[C@H](CC5=C[N+]6=C(C7=C5C8=C(N7)C=CC=C8)C[C@@]([H])([C@]([H])(C6)CC)CCO)C(OC)=O	InChI=1S/C40H46N4O3/c1-4-24-21-44-23-27(37-30-11-7-9-13-34(30)42-39(37)35(44)19-26(24)15-17-45)18-32(40(46)47-3)31-20-36-38-29(14-16-43(36)22-25(31)5-2)28-10-6-8-12-33(28)41-38/h5-13,23-24,26,31-32,36,41,45H,4,14-22H2,1-3H3/p+1/b25-5-/t24-,26-,31-,32-,36-/m0/s1	N/A	1	Positive	N/A	Isolated	631.3643	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
moandaensine_C.mgf	*..*	Moandaensine C	629.347	qTof	LC-ESI	260	C/C=C(C1)\C([C@@H](C(OC)=O)CC2=C[N+]3=C(C[C@@](CCO)([H])/C(C3)=C\C)C4=C2C(C=CC=C5)=C5N4)([H])C[C@@](N1CC6)([H])C7=C6C8=CC=CC=C8N7	InChI=1S/C40H44N4O3/c1-4-24-21-44-23-27(37-30-11-7-9-13-34(30)42-39(37)35(44)19-26(24)15-17-45)18-32(40(46)47-3)31-20-36-38-29(14-16-43(36)22-25(31)5-2)28-10-6-8-12-33(28)41-38/h4-13,23,26,31-32,36,41,45H,14-22H2,1-3H3/p+1/b24-4-,25-5-/t26-,31-,32-,36-/m0/s1	N/A	1	Positive	N/A	Isolated	629.3486	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
N4_methylantirhine.mgf	*..*	N4-methylantirhine	311.2118	qTof	LC-ESI	267	C=C[C@@H](CO)[C@](CC1)([H])C[C@@]([N@+]1(C)CC2)([H])C3=C2C4=C(N3)C=CC=C4	InChI=1S/C20H27N2O/c1-3-14(13-23)15-8-10-22(2)11-9-17-16-6-4-5-7-18(16)21-20(17)19(22)12-15/h3-7,14-15,19,21,23H,1,8-13H2,2H3/q+1/t14-,15-,19-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	311.2118	Alexander Fox Ramos	M+	N/A	3	N/A	N/A	N/A	58580-53-3	Mehdi Beniddir
n-acetylisostrychnosplendine.mgf	*..*	N-acetylisostrychnosplendine	355.201	qTof	LC-ESI	261	C[C@@H]1OC[C@@]2([H])[C@]3([H])N(C4=C([C@@]35CCN6C[C@]1([H])[C@]2([H])C[C@@]56O)C=CC=C4)C(C)=O	InChI=1S/C21H26N2O3/c1-12-15-10-22-8-7-20-17-5-3-4-6-18(17)23(13(2)24)19(20)16(11-26-12)14(15)9-21(20,22)25/h3-6,12,14-16,19,25H,7-11H2,1-2H3/t12-,14-,15-,16+,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Naucleidinal.mgf	*..*	Naucleidinal	337.1547	qTof	LC-ESI	268	O=C1C2=CO[C@H](C)[C@@H](C=O)[C@]2([H])C[C@@](N1CC3)([H])C4=C3C5=CC=CC=C5N4	InChI=1S/C20H20N2O3/c1-11-15(9-23)14-8-18-19-13(12-4-2-3-5-17(12)21-19)6-7-22(18)20(24)16(14)10-25-11/h2-5,9-11,14-15,18,21H,6-8H2,1H3/t11-,14+,15?,18+/m1/s1	N/A	1	Positive	N/A	Isolated	336.1474	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	77513-45-2	Mehdi Beniddir
Naulafine.mgf	*..*	Naulafine	312.1131	qTof	LC-ESI	269	O=C1C2=C(C3=CN=C2)C(C=C3)=C(N1CC4)C5=C4C6=CC=CC=C6N5	InChI=1S/C20H13N3O/c24-20-15-10-21-9-11-5-6-14(17(11)15)19-18-13(7-8-23(19)20)12-3-1-2-4-16(12)22-18/h1-6,9-10,22H,7-8H2	N/A	1	Positive	N/A	Isolated	311.1059	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	70503-66-1	Mehdi Beniddir
Nb_methylusambarensine.mgf	*..*	Nb-methylusambarensine	447.2543	qTof	LC-ESI	270	[H][C@@]12C[C@@](CC3=NC=CC4=C3NC5=C4C=CC=C5)([H])/C(C[N+]1(C)CCC6=C2NC7=C6C=CC=C7)=C\C	InChI=1S/C30H31N4/c1-3-19-18-34(2)15-13-24-22-9-5-7-11-26(22)33-30(24)28(34)17-20(19)16-27-29-23(12-14-31-27)21-8-4-6-10-25(21)32-29/h3-12,14,20,28,32-33H,13,15-18H2,1-2H3/q+1/b19-3-/t20-,28-,34?/m0/s1	N/A	1	Positive	N/A	Isolated	447.2543	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	36150-17-1	Mehdi Beniddir
n-demethylechitamine.mgf	*..*	N-demethylechitamine	371.1968	qTof	LC-ESI	262	COC(C1([C@H]2C[C@@H](C34NC5=C([C@@]13CCN4C/C2=C\C)C=CC=C5)O)CO)=O	InChI=1S/C21H26N2O4/c1-3-13-11-23-9-8-20-14-6-4-5-7-16(14)22-21(20,23)17(25)10-15(13)19(20,12-24)18(26)27-2/h3-7,15,17,22,24-25H,8-12H2,1-2H3/b13-3+/t15-,17-,19?,20-,21?/m0/s1	N/A	1	Positive	N/A	Isolated	370.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
N-Me-16-epi-dregamine.mgf	*..*	16-epi-N-Me Dregamine	369.2177	qTof	LC-ESI	263	CC[C@H]([C@H]([C@H]1C(OC)=O)CC2=O)CN([C@@H]1CC3=C2N(C)C4=CC=CC=C34)C	InChI=1S/C22H28N2O3/c1-5-13-12-23(2)18-10-16-14-8-6-7-9-17(14)24(3)21(16)19(25)11-15(13)20(18)22(26)27-4/h6-9,13,15,18,20H,5,10-12H2,1-4H3/t13-,15+,18+,20+/m0/s1	N/A	1	Positive	N/A	Isolated	368.21	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Nmethyl10methoxyakuammidine.mgf	*..*	N(a)-methyl-10-methoxyakuammidine	397.2121	qTof	LC-ESI	271	COC(C1([C@@H]2CC3=C(N(C4=CC=C(C=C34)OC)C)[C@]5([H])C[C@H]1/C(CN25)=C/C)CO)=O	InChI=1S/C23H28N2O4/c1-5-13-11-25-19-10-17(13)23(12-26,22(27)29-4)20(25)9-16-15-8-14(28-3)6-7-18(15)24(2)21(16)19/h5-8,17,19-20,26H,9-12H2,1-4H3/b13-5+/t17-,19-,20-,23?/m0/s1	N/A	1	Positive	N/A	Isolated	396.2049	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
N-methyl-10-methoxy-16-epi-pericyclivine_N-oxide.mgf	*..*	N-methyl-10-methoxy-16-epi-pericyclivine N-oxide	383.196	qTof	LC-ESI	264	CN1C([C@@]2(C[C@H]3/C4=C\C)[H])=C(C[C@H]([N@+]2(C4)[O-])[C@@H]3C(OC)=O)C5=CC(OC)=CC=C15	InChI=1S/C22H26N2O4/c1-5-12-11-24(26)18-10-16-15-8-13(27-3)6-7-17(15)23(2)21(16)19(24)9-14(12)20(18)22(25)28-4/h5-8,14,18-20H,9-11H2,1-4H3/b12-5-/t14-,18-,19-,20+,24-/m0/s1	N/A	1	Positive	N/A	Isolated	382.1894	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
N-methyl-16-epi-pericyclivine-N-oxide.mgf	*..*	N-methyl-16-epi-pericyclivine-N-oxide	353.185	qTof	LC-ESI	265	C/C=C(C1)\[C@@H]2C[C@@]([N@@+]1([O-])[C@H]([C@H]2C(OC)=O)C3)([H])C4=C3C5=CC=CC=C5N4C	InChI=1S/C21H24N2O3/c1-4-12-11-23(25)17-10-15-13-7-5-6-8-16(13)22(2)20(15)18(23)9-14(12)19(17)21(24)26-3/h4-8,14,17-19H,9-11H2,1-3H3/b12-4-/t14-,17-,18-,19-,23-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
normacusineB.mgf	*..*	Normacusine B	295.1804	qTof	LC-ESI	272	C/C=C1C(C2CO)CC(N(C\1)C2C3)C4=C3C5=CC=CC=C5N4	InChI=1S/C19H22N2O/c1-2-11-9-21-17-8-14-12-5-3-4-6-16(12)20-19(14)18(21)7-13(11)15(17)10-22/h2-6,13,15,17-18,20,22H,7-10H2,1H3/b11-2-	N/A	1	Positive	N/A	Isolated	294.1732	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
norpleiomutine.mgf	*..*	Norpleiomutine	617.3849	qTof	LC-ESI	273	CC[C@]1(C[C@@]2([H])C3=CC([C@@]45CCN6CCC[C@@]7([C@@]56[H])CC[C@@]48[C@H](C(OC)=O)C7)=C(N8)C=C3)CCCN9CCC(C%10=CC=CC=C%10N2%11)=C%11[C@@]19[H]	InChI=1S/C40H48N4O2/c1-3-37-13-6-18-42-20-12-27-26-8-4-5-9-31(26)44(33(27)34(37)42)32(24-37)25-10-11-30-28(22-25)39-17-21-43-19-7-14-38(36(39)43)15-16-40(39,41-30)29(23-38)35(45)46-2/h4-5,8-11,22,29,32,34,36,41H,3,6-7,12-21,23-24H2,1-2H3/t29-,32-,34-,36-,37+,38+,39+,40+/m0/s1	N/A	1	Positive	N/A	Isolated	616.3777	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Novacine.mgf	*..*	Novacine	425.2071	qTof	LC-ESI	274	O=C1C[C@@](OCC=C2CN(C)CC3)([H])[C@@]([C@@]2([H])CC4=O)([H])[C@@]5([H])[C@]43C6=CC(OC)=C(OC)C=C6N51	InChI=1S/C24H28N2O5/c1-25-6-5-24-15-9-17(29-2)18(30-3)10-16(15)26-21(28)11-19-22(23(24)26)14(8-20(24)27)13(12-25)4-7-31-19/h4,9-10,14,19,22-23H,5-8,11-12H2,1-3H3/t14-,19-,22-,23-,24+/m0/s1	N/A	1	Positive	N/A	Isolated	424.1998	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	466-64-8	Mehdi Beniddir
N-oxy-14-delta-vincamine.mgf	*..*	N-oxy_delta_14_vincamine	353.18676	qTof	LC-ESI	266	[H][C@@]12C3=C4C5=CC=CC=C5N3[C@@](O)(C(OC)=O)C[C@]1(CC)C=CC[N+]2([O-])CC4	InChI=1S/C21H24N2O4/c1-3-20-10-6-11-23(26)12-9-15-14-7-4-5-8-16(14)22(17(15)18(20)23)21(25,13-20)19(24)27-2/h4-8,10,18,25H,3,9,11-13H2,1-2H3/t18-,20+,21+,23?/m1/s1	N/A	1	Positive	N/A	Isolated	368.1736	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
O_methylgeissolaevine.mgf	*..*	O-methylgeissolaevine	381.1445	qTof	LC-ESI	282	COC(CC1=C(C(OC1(C2=NC=CC3=C2NC4=CC=CC=C34)OC)=O)CC)=O	InChI=1S/C21H20N2O5/c1-4-12-15(11-17(24)26-2)21(27-3,28-20(12)25)19-18-14(9-10-22-19)13-7-5-6-8-16(13)23-18/h5-10,23H,4,11H2,1-3H3	N/A	1	Positive	N/A	Isolated	380.1372	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	N/A	Mehdi Beniddir
O_trimethoxy_3_4_5_benzoyl_OH_vincamajine.mgf	*..*	O-trimethoxy-3,4,5-benzoyl-OH-vincamajine	577.2544	qTof	LC-ESI	283	C/C=C1[C@@H]2C[C@@]3([H])[C@@]4([H])N(C)C5=CC=C(O)C=C5C4([C@@H]6OC(C7=CC(OC)=C(OC)C(OC)=C7)=O)C[C@@H](C26C(OC)=O)N3C\1	InChI=1S/C32H36N2O8/c1-7-16-15-34-22-13-19(16)32(30(37)41-6)25(34)14-31(20-12-18(35)8-9-21(20)33(2)27(22)31)29(32)42-28(36)17-10-23(38-3)26(40-5)24(11-17)39-4/h7-12,19,22,25,27,29,35H,13-15H2,1-6H3/b16-7-/t19-,22-,25-,27+,29-,31?,32?/m0/s1	N/A	1	Positive	N/A	Isolated	576.2472	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia boulindaensis	N/A	57800-05-2	Mehdi Beniddir
O_trimethoxy_3_4_5_benzoyl_vincamajine.mgf	*..*	O-trimethoxy-3,4,5-benzoyl-vincamajine	561.2595	qTof	LC-ESI	284	C/C=C1[C@@H]2C[C@@]3([H])[C@@]4([H])N(C)C5=CC=CC=C5C4([C@@H]6OC(C7=CC(OC)=C(OC)C(OC)=C7)=O)C[C@@H](C26C(OC)=O)N3C\1	InChI=1S/C32H36N2O7/c1-7-17-16-34-22-14-20(17)32(30(36)40-6)25(34)15-31(19-10-8-9-11-21(19)33(2)27(22)31)29(32)41-28(35)18-12-23(37-3)26(39-5)24(13-18)38-4/h7-13,20,22,25,27,29H,14-16H2,1-6H3/b17-7-/t20-,22-,25-,27+,29-,31?,32?/m0/s1	N/A	1	Positive	N/A	Isolated	560.2523	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia boulindaensis	N/A	71385-80-3	Mehdi Beniddir
oacetylperhentidineA.mgf	*..*	O-Acetylperhentidine A	747.4096	qTof	LC-ESI	276	CC(C1=COC[C@]2([H])[C@@]1([H])C[C@@H]3C4=C(C5=C(N4C)C(C[C@H](C(C)=O)[C@]6([H])C[C@@H]7C8=C(C9=CC=CC=C9N8C)C[C@@H](N7C)C6COC(C)=O)=C(OC)C=C5)C[C@H]2N3C)=O	InChI=1S/C45H54N4O6/c1-23(50)28(29-16-40-44-31(26-11-9-10-12-37(26)48(44)6)18-39(47(40)5)36(29)22-55-25(3)52)15-33-42(53-8)14-13-27-32-19-38-35-21-54-20-34(24(2)51)30(35)17-41(46(38)4)45(32)49(7)43(27)33/h9-14,20,28-30,35-36,38-41H,15-19,21-22H2,1-8H3/t28-,29+,30+,35-,36?,38-,39-,40-,41-/m1/s1	N/A	1	Positive	N/A	Isolated	746.4043	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
oacvallesamine.mgf	*..*	O-Acetylvallesamine	383.1964	qTof	LC-ESI	277	COC([C@]1([C@@]2([H])CCN(CC3=C1NC4=CC=CC=C34)C/C2=C/C)COC(C)=O)=O	InChI=1S/C22H26N2O4/c1-4-15-11-24-10-9-18(15)22(21(26)27-3,13-28-14(2)25)20-17(12-24)16-7-5-6-8-19(16)23-20/h4-8,18,23H,9-13H2,1-3H3/b15-4-/t18-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	382.1893	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Ochrolifuanine_A.mgf	*..*	Ochrolifuanine A	439.2856	qTof	LC-ESI	278	[H][C@](N1CC2)(C[C@@](C[C@@]3([H])NCCC4=C3NC5=C4C=CC=C5)([H])[C@@H](CC)C1)C6=C2C7=C(N6)C=CC=C7	InChI=1S/C29H34N4/c1-2-18-17-33-14-12-23-21-8-4-6-10-25(21)32-29(23)27(33)16-19(18)15-26-28-22(11-13-30-26)20-7-3-5-9-24(20)31-28/h3-10,18-19,26-27,30-32H,2,11-17H2,1H3/t18-,19-,26+,27-/m0/s1	N/A	1	Positive	N/A	Isolated	438.2783	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	35527-46-9	Mehdi Beniddir
Ochropamine.mgf	*..*	Ochropamine	367.2016	qTof	LC-ESI	279	C/C=C1C2CC(C3=C(C[C@]([C@@H]2C(OC)=O)([H])N(C)C\1)C4=CC=CC=C4N3C)=O	InChI=1S/C22H26N2O3/c1-5-13-12-23(2)18-10-16-14-8-6-7-9-17(14)24(3)21(16)19(25)11-15(13)20(18)22(26)27-4/h5-9,15,18,20H,10-12H2,1-4H3/b13-5-/t15?,18-,20?/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2134-97-6	Mehdi Beniddir
Ochropposinine.mgf	*..*	Ochropposinine	359.2329	qTof	LC-ESI	280	COC(C(OC)=C1)=CC2=C1C3=C(N2)[C@@]4(C[C@@H]([C@H](CN4CC3)CC)CCO)[H]	InChI=1S/C21H30N2O3/c1-4-13-12-23-7-5-15-16-10-19(25-2)20(26-3)11-17(16)22-21(15)18(23)9-14(13)6-8-24/h10-11,13-14,18,22,24H,4-9,12H2,1-3H3/t13-,14-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	358.2256	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	37687-31-3	Mehdi Beniddir
Olivacine.mgf	*..*	Olivacine	247.123	qTof	LC-ESI	281	CC1=C(C=CN=C2C)C2=CC3=C1NC4=C3C=CC=C4	InChI=1S/C17H14N2/c1-10-12-7-8-18-11(2)14(12)9-15-13-5-3-4-6-16(13)19-17(10)15/h3-9,19H,1-2H3	N/A	1	Positive	N/A	Isolated	246.1157	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	484-49-1	Mehdi Beniddir
o-monoacetylseredine.mgf	*..*	O-monoacetylseredine	457.2395	qTof	LC-ESI	275	COC([C@@H]1[C@H](CC[C@]2([H])CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=C4C=C(OC)C(OC)=C5)OC(C)=O)=O	InChI=1S/C25H32N2O6/c1-13(28)33-20-6-5-14-12-27-8-7-15-17-10-21(30-2)22(31-3)11-18(17)26-24(15)19(27)9-16(14)23(20)25(29)32-4/h10-11,14,16,19-20,23,26H,5-9,12H2,1-4H3/t14-,16+,19+,20+,23+/m1/s1	N/A	1	Positive	N/A	Isolated	456.226	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
pachysiphine.mgf	*..*	Pachysiphine	353.1861	qTof	LC-ESI	285	CC[C@@]12CC(C(OC)=O)=C3NC4=C([C@@]35CCN([C@@]25[H])C[C@H]6O[C@@H]16)C=CC=C4	InChI=1S/C21H24N2O3/c1-3-20-10-12(18(24)25-2)16-21(13-6-4-5-7-14(13)22-16)8-9-23(19(20)21)11-15-17(20)26-15/h4-7,15,17,19,22H,3,8-11H2,1-2H3/t15-,17-,19+,20-,21+/m1/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Panarine.mgf	*..*	Panarine	323.1754	qTof	LC-ESI	286	[H][C@]([N+](C/C1=C/C)(C)[C@H]2C3)(C[C@@H]1C2(C([O-])=O)[H])C4=C3C5=C(N4)C=CC=C5	InChI=1S/C20H22N2O2/c1-3-11-10-22(2)16-9-14-12-6-4-5-7-15(12)21-19(14)17(22)8-13(11)18(16)20(23)24/h3-7,13,16-18,21H,8-10H2,1-2H3/b11-3-/t13-,16-,17-,18?,22?/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	119736-90-2	Mehdi Beniddir
Pandine.mgf	*..*	Pandine	353.1843	qTof	LC-ESI	287	CC[C@@](O)(C1)[C@H]2N3[C@@H]4[C@H]1[C@H]2C(C(OC)=O)=C([C@@]54CC3)NC6=C5C=CC=C6	InChI=1S/C21H24N2O3/c1-3-20(25)10-11-14-15(19(24)26-2)16-21(8-9-23(17(11)21)18(14)20)12-6-4-5-7-13(12)22-16/h4-7,11,14,17-18,22,25H,3,8-10H2,1-2H3/t11-,14+,17-,18+,20-,21-/m1/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
paucidactineC.mgf	*..*	Paucidactine C	471.176	qTof	LC-ESI	288	COC(N1C2=C([C@]34[C@H]5OC([C@@]6(C[C@]7(CC[C@]146)CCCN(C5=O)[C@]37[H])O)=O)C=CC(OC)=C2OC)=O	InChI=1S/C24H26N2O8/c1-31-13-6-5-12-14(15(13)32-2)26(20(29)33-3)23-9-8-21-7-4-10-25-17(27)16(24(12,23)18(21)25)34-19(28)22(23,30)11-21/h5-6,16,18,30H,4,7-11H2,1-3H3/t16-,18-,21+,22+,23+,24-/m0/s1	N/A	1	Positive	N/A	Isolated	470.1689	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
paucidactineD.mgf	*..*	Paucidactine D	337.1552	qTof	LC-ESI	289	O=C1O[C@@H]2[C@]34C(C=CC=C5)=C5N[C@@]36CC[C@]7(CCCN(C2=O)[C@]47[H])C[C@@H]16	InChI=1S/C20H20N2O3/c23-15-14-20-11-4-1-2-5-13(11)21-19(20)8-7-18(10-12(19)16(24)25-14)6-3-9-22(15)17(18)20/h1-2,4-5,12,14,17,21H,3,6-10H2/t12-,14-,17-,18+,19+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	336.1474	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
paucidactineE.mgf	*..*	Paucidactine E	323.1752	qTof	LC-ESI	290	O=C1[C@]2([H])[C@@]34NC5=CC=CC=C5[C@]36[C@]7([H])[C@@](CCCN7C[C@@H]6O1)(C2)CC4	InChI=1S/C20H22N2O2/c23-16-13-10-18-6-3-9-22-11-15(24-16)20(17(18)22)12-4-1-2-5-14(12)21-19(13,20)8-7-18/h1-2,4-5,13,15,17,21H,3,6-11H2/t13-,15+,17+,18-,19-,20+/m1/s1	N/A	1	Positive	N/A	Isolated	322.1681	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
paucidactinine.mgf	*..*	Paucidactinine	441.1657	qTof	LC-ESI	291	[H][C@]1([C@@]2([C@@H]3C4)C(C=CC5=C6OCO5)=C6N(C(OC)=O)[C@@]27CC8)N4CCC[C@@]18C[C@@]7(O)OC3=O	InChI=1S/C23H24N2O7/c1-29-19(27)25-15-12(3-4-14-16(15)31-11-30-14)23-13-9-24-8-2-5-20(18(23)24)6-7-21(23,25)22(28,10-20)32-17(13)26/h3-4,13,18,28H,2,5-11H2,1H3/t13-,18+,20-,21-,22-,23+/m1/s1	N/A	1	Positive	N/A	Isolated	440.1584	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Pauridianthinine.mgf	*..*	Pauridianthinine	316.1079	qTof	LC-ESI	292	O=C(C1)C2=CN=CC=C2C1(O)C3=NC=CC4=C3NC5=C4C=CC=C5	InChI=1S/C19H13N3O2/c23-16-9-19(24,14-6-7-20-10-13(14)16)18-17-12(5-8-21-18)11-3-1-2-4-15(11)22-17/h1-8,10,22,24H,9H2	N/A	1	Positive	N/A	Isolated	315.10078	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Pauridianthoside.mgf	*..*	Pauridianthoside	541.1817	qTof	LC-ESI	293	C=C[C@@H]1[C@H](C(C2=NC=CC3=C2NC4=C3C=CC=C4)=O)C(C(OC)=O)=CO[C@H]1O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O	InChI=1S/C27H28N2O10/c1-3-12-18(22(32)20-19-14(8-9-28-20)13-6-4-5-7-16(13)29-19)15(25(35)36-2)11-37-26(12)39-27-24(34)23(33)21(31)17(10-30)38-27/h3-9,11-12,17-18,21,23-24,26-27,29-31,33-34H,1,10H2,2H3/t12-,17-,18+,21-,23+,24-,26+,27+/m1/s1	N/A	1	Positive	N/A	Isolated	540.1744	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
perhentidineA.mgf	*..*	Perhentidine A	705.4008	qTof	LC-ESI	294	CC(C1=COC[C@]2([H])[C@@]1([H])C[C@@H]3C4=C(C5=C(N4C)C(C[C@H](C(C)=O)[C@]6([H])C[C@@H]7C8=C(C9=CC=CC=C9N8C)C[C@@H](N7C)C6CO)=C(OC)C=C5)C[C@H]2N3C)=O	InChI=1S/C43H52N4O5/c1-22(49)26(27-15-38-42-29(17-36(44(38)3)32(27)19-48)24-10-8-9-11-35(24)46(42)5)14-31-40(51-7)13-12-25-30-18-37-34-21-52-20-33(23(2)50)28(34)16-39(45(37)4)43(30)47(6)41(25)31/h8-13,20,26-28,32,34,36-39,48H,14-19,21H2,1-7H3/t26-,27+,28+,32?,34-,36-,37-,38-,39-/m1/s1	N/A	1	Positive	N/A	Isolated	704.3938	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
perhentidineB.mgf	*..*	Perhentidine B	705.3995	qTof	LC-ESI	295	CC(C1=COC[C@]2([H])[C@@]1([H])C[C@@H]3C4=C(C5=C(N4C)C(C[C@@H](C(C)=O)[C@]6([H])C[C@@H]7C8=C(C9=CC=CC=C9N8C)C[C@@H](N7C)C6CO)=C(OC)C=C5)C[C@H]2N3C)=O	InChI=1S/C43H52N4O5/c1-22(49)26(27-15-38-42-29(17-36(44(38)3)32(27)19-48)24-10-8-9-11-35(24)46(42)5)14-31-40(51-7)13-12-25-30-18-37-34-21-52-20-33(23(2)50)28(34)16-39(45(37)4)43(30)47(6)41(25)31/h8-13,20,26-28,32,34,36-39,48H,14-19,21H2,1-7H3/t26-,27-,28-,32?,34+,36+,37+,38+,39+/m0/s1	N/A	1	Positive	N/A	Isolated	704.3938	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
perhentinine.mgf	*..*	Perhentinine	705.3992	qTof	LC-ESI	296	CC([C@H]([C@]1([H])C[C@@H]2C3=C(C4=CC=CC=C4N3C)C[C@@H](N2C)[C@@H]1CO)CC5=CC(C6=C7[C@H]8C[C@@]9([H])C(C(C)=O)=COC[C@@]9([H])[C@H](N8C)C6)=C(N7C)C=C5OC)=O	InChI=1S/C43H52N4O5/c1-22(49)26(27-14-39-42-30(16-36(44(39)3)32(27)19-48)25-10-8-9-11-35(25)46(42)5)12-24-13-29-31-17-37-34-21-52-20-33(23(2)50)28(34)15-40(45(37)4)43(31)47(6)38(29)18-41(24)51-7/h8-11,13,18,20,26-28,32,34,36-37,39-40,48H,12,14-17,19,21H2,1-7H3/t26-,27+,28+,32-,34-,36-,37-,39-,40-/m1/s1	N/A	1	Positive	N/A	Isolated	704.3938	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Pericyclivine.mgf	*..*	Pericyclivine	323.176	qTof	LC-ESI	297	C/C=C(C1)\[C@]2([H])C[C@@](N1[C@@]([C@@H]2C(OC)=O)([H])C3)([H])C4=C3C5=CC=CC=C5N4	InChI=1S/C20H22N2O2/c1-3-11-10-22-16-9-14-12-6-4-5-7-15(12)21-19(14)17(22)8-13(11)18(16)20(23)24-2/h3-7,13,16-18,21H,8-10H2,1-2H3/b11-3-/t13-,16-,17-,18?/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	975-77-9	Mehdi Beniddir
Perivine.mgf	*..*	Perivine	339.1703	qTof	LC-ESI	298	C/C=C1C2CC(C3=C(C[C@]([C@@H]2C(OC)=O)([H])NC\1)C4=CC=CC=C4N3)=O	InChI=1S/C20H22N2O3/c1-3-11-10-21-16-8-14-12-6-4-5-7-15(12)22-19(14)17(23)9-13(11)18(16)20(24)25-2/h3-7,13,16,18,21-22H,8-10H2,1-2H3/b11-3-/t13?,16-,18?/m0/s1	N/A	1	Positive	N/A	Isolated	338.163	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2673-40-7	Mehdi Beniddir
Picraline.mgf	*..*	Picraline	411.1914	qTof	LC-ESI	299	C/C=C1[C@@H]2C[C@@]3([H])[C@@]([C@@]4(C(COC(C)=O)2C(OC)=O)C[C@H]5N3C\1)(O5)NC6=C4C=CC=C6	InChI=1S/C23H26N2O5/c1-4-14-11-25-18-9-16(14)21(20(27)28-3,12-29-13(2)26)22-10-19(25)30-23(18,22)24-17-8-6-5-7-15(17)22/h4-8,16,18-19,24H,9-12H2,1-3H3/b14-4-/t16-,18-,19-,21?,22-,23-/m0/s1	N/A	1	Positive	N/A	Isolated	410.1842	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2671-32-1	Mehdi Beniddir
picrinine.mgf	*..*	Picrinine	339.1705	qTof	LC-ESI	300	[H][C@](N1[C@@H]2C3)(C[C@H]4/C(C1)=C\C)[C@]5(O2)[C@]3(C4(C(OC)=O)[H])C6=CC=CC=C6N5	InChI=1S/C20H22N2O3/c1-3-11-10-22-15-8-12(11)17(18(23)24-2)19-9-16(22)25-20(15,19)21-14-7-5-4-6-13(14)19/h3-7,12,15-17,21H,8-10H2,1-2H3/b11-3-/t12?,15-,16-,17?,19?,20+/m1/s1	N/A	1	Positive	N/A	Isolated	338.163	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Pleiocarpamine.mgf	*..*	Pleiocarpamine	323.1754	qTof	LC-ESI	301	C/C=C(C1)\[C@]2([H])C[C@@](N1CC3)([H])C4=C3C5=C(N4[C@@H]2C(OC)=O)C=CC=C5	InChI=1S/C20H22N2O2/c1-3-12-11-21-9-8-14-13-6-4-5-7-16(13)22-18(14)17(21)10-15(12)19(22)20(23)24-2/h3-7,15,17,19H,8-11H2,1-2H3/b12-3-/t15-,17-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Alexander Fox Ramos	M+H	N/A	3	Gonioma	Gonioma malagasy	N/A	6393-66-4	Mehdi Beniddir
Pleiocarpine.mgf	*..*	Pleiocarpine	397.2122	qTof	LC-ESI	302	[H][C@]12[C@@]34CC[C@]5([C@H](C(OC)=O)C4)N(C(OC)=O)C6=CC=CC=C6C51CCN2CCC3	InChI=1S/C23H28N2O4/c1-28-18(26)16-14-21-8-5-12-24-13-11-22(19(21)24)15-6-3-4-7-17(15)25(20(27)29-2)23(16,22)10-9-21/h3-4,6-7,16,19H,5,8-14H2,1-2H3/t16?,19-,21+,22?,23+/m0/s1	N/A	1	Positive	N/A	Isolated	396.2049	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	559-52-4	Mehdi Beniddir
Pleiocarpinilam.mgf	*..*	Pleiocarpinilam	367.2016	qTof	LC-ESI	303	[H][C@]12[C@]3(CCCN24)CC[C@]5([C@H](C(OC)=O)C3)N(C)C6=CC=CC=C6C51CC4=O	InChI=1S/C22H26N2O3/c1-23-16-7-4-3-6-14(16)21-13-17(25)24-11-5-8-20(19(21)24)9-10-22(21,23)15(12-20)18(26)27-2/h3-4,6-7,15,19H,5,8-13H2,1-2H3/t15?,19-,20+,21?,22+/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	3703-93-3	Mehdi Beniddir
Pleiocarpinine.mgf	*..*	Pleiocarpinine	353.2224	qTof	LC-ESI	304	[H][C@]12C34CCC([C@]51CCN2CCC3)([C@H](C(OC)=O)C4)N(C)C6=C5C=CC=C6	InChI=1S/C22H28N2O2/c1-23-17-7-4-3-6-15(17)21-11-13-24-12-5-8-20(19(21)24)9-10-22(21,23)16(14-20)18(25)26-2/h3-4,6-7,16,19H,5,8-14H2,1-2H3/t16-,19-,20?,21+,22?/m0/s1	N/A	1	Positive	N/A	Isolated	352.2151	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	559-50-2	Mehdi Beniddir
Pleiocarpoline.mgf	*..*	Pleiocarpoline	413.2071	qTof	LC-ESI	305	[H][C@]12[C@@]34CC[C@]5([C@H](C(OC)=O)C4)N(C(OC)=O)C6=CC=CC=C6C51CC[N+]2([O-])CCC3	InChI=1S/C23H28N2O5/c1-29-18(26)16-14-21-8-5-12-25(28)13-11-22(19(21)25)15-6-3-4-7-17(15)24(20(27)30-2)23(16,22)10-9-21/h3-4,6-7,16,19H,5,8-14H2,1-2H3/t16?,19-,21+,22?,23+,25?/m0/s1	N/A	1	Positive	N/A	Isolated	412.1998	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	N/A	Mehdi Beniddir
Pleiokomenine_A.mgf	*..*	Pleiokomenine A	717.4374	qTof	LC-ESI	306	O=C(OC)C(C1)[C@]2(CC3)[C@@]4(C5=CC(CC6=CC=C(N(C)C7(C(C(OC)=O)C8)C9%10[C@@H](N(CCC%11)CC%10)[C@]8%11CC7)C9=C6)=CC=C5N2C)CCN%12CCC[C@@]31[C@H]%124	InChI=1S/C45H56N4O4/c1-46-34-9-7-28(24-30(34)42-17-21-48-19-5-11-40(38(42)48)13-15-44(42,46)32(26-40)36(50)52-3)23-29-8-10-35-31(25-29)43-18-22-49-20-6-12-41(39(43)49)14-16-45(43,47(35)2)33(27-41)37(51)53-4/h7-10,24-25,32-33,38-39H,5-6,11-23,26-27H2,1-4H3/t32-,33?,38+,39+,40-,41-,42+,43-,44-,45-/m1/s1	N/A	1	Positive	N/A	Isolated	716.4302	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	N/A	Mehdi Beniddir
Pleiokomenine_B.mgf	*..*	Pleiokomenine B	689.4061	qTof	LC-ESI	307	OC(C(C1)[C@]2(CC3)[C@@]4(C5=CC(CC6=CC=C(N(C)C7(C(C(OC)=O)C8)C9%10[C@@H](N(CCC%11)CC%10)[C@]8%11CC7)C9=C6)=CC=C5N2)CCN%12CCC[C@@]31[C@H]%124)=O	InChI=1S/C43H52N4O4/c1-45-33-8-6-27(23-29(33)41-16-20-47-18-4-10-39(37(41)47)12-14-43(41,45)31(25-39)35(50)51-2)21-26-5-7-32-28(22-26)40-15-19-46-17-3-9-38(36(40)46)11-13-42(40,44-32)30(24-38)34(48)49/h5-8,22-23,30-31,36-37,44H,3-4,9-21,24-25H2,1-2H3,(H,48,49)/t30?,31-,36+,37+,38-,39-,40-,41+,42-,43-/m1/s1	N/A	1	Positive	N/A	Isolated	688.3989	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	N/A	Mehdi Beniddir
Pleiomutine.mgf	*..*	Pleiomutine	631.4007	qTof	LC-ESI	308	C/C=C1[C@@]([H])([C@]2(C(OC)=O)[H])C[C@@]3([H])[C@@]([C@]4(C5)CCN3C\1)(C6=CC=CC7=C6N5[C@@]8([C@]9([H])C)[C@@]7%10[C@]%11([H])[C@@]9(CCCN%11CC%10)CC8)N2C%12=C4C=CC=C%12	InChI=1S/C41H50N4O2/c1-4-38-14-7-19-43-21-13-28-27-9-5-6-10-31(27)45(34(28)35(38)43)33(25-38)26-11-12-32-29(23-26)40-18-22-44-20-8-15-39(37(40)44)16-17-41(40,42(32)2)30(24-39)36(46)47-3/h5-6,9-12,23,30,33,35,37H,4,7-8,13-22,24-25H2,1-3H3/t30-,33-,35-,37-,38+,39+,40+,41+/m0/s1	N/A	1	Positive	N/A	Isolated	630.3934	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	N/A	Mehdi Beniddir
Pleiomutinine.mgf	*..*	Pleiomutinine	615.3694	qTof	LC-ESI	309	C/C=C1[C@@]([H])([C@]2(C(OC)=O)[H])C[C@@]3([H])[C@@]([C@]4(C5)CCN3C\1)(C6=CC=CC7=C6N5[C@@]8([C@]9([H])C)[C@@]7%10[C@]%11([H])[C@@]9(CCCN%11CC%10)CC8)N2C%12=C4C=CC=C%12	InChI=1S/C40H46N4O2/c1-4-25-22-42-19-16-37-23-43-33-28(38-17-20-41-18-8-13-36(35(38)41)14-15-39(38,43)24(36)2)10-7-11-29(33)40(37)31(42)21-26(25)32(34(45)46-3)44(40)30-12-6-5-9-27(30)37/h4-7,9-12,24,26,31-32,35H,8,13-23H2,1-3H3/b25-4-/t24-,26+,31+,32+,35+,36+,37+,38-,39+,40-/m1/s1	N/A	1	Positive	N/A	Isolated	614.3621	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	21400-49-7	Mehdi Beniddir
Polyneuridine.mgf	*..*	Polyneuridine	353.186	qTof	LC-ESI	310	C/C=C(C1)\[C@@H]2CC(N1[C@H](C2(C(OC)=O)CO)C3)C4=C3C5=C(N4)C=CC=C5	InChI=1S/C21H24N2O3/c1-3-12-10-23-17-9-15(12)21(11-24,20(25)26-2)18(23)8-14-13-6-4-5-7-16(13)22-19(14)17/h3-7,15,17-18,22,24H,8-11H2,1-2H3/b12-3-/t15-,17?,18-,21?/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	6872-44-2	Mehdi Beniddir
polyneuridine_aldehyde1.mgf	*..*	Polyneuridine Aldehyde	351.1703	qTof	LC-ESI	311	O=CC1([C@@H](N2C/C3=C/C)CC4=C(C2C[C@H]13)NC5=C4C=CC=C5)C(OC)=O	InChI=1S/C21H22N2O3/c1-3-12-10-23-17-9-15(12)21(11-24,20(25)26-2)18(23)8-14-13-6-4-5-7-16(13)22-19(14)17/h3-7,11,15,17-18,22H,8-10H2,1-2H3/b12-3-/t15-,17?,18-,21?/m0/s1	N/A	1	Positive	N/A	Isolated	350.163	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Protostrychnine.mgf	*..*	Protostrychnine	353.186	qTof	LC-ESI	312	O=C1C[C@@H](O)[C@@]([C@@](/C(C2)=C\CO)([H])C[C@@H]3N2CC4)([H])[C@@]5([H])[C@]34C6=CC=CC=C6N51	InChI=1S/C21H24N2O3/c24-8-5-12-11-22-7-6-21-14-3-1-2-4-15(14)23-18(26)10-16(25)19(20(21)23)13(12)9-17(21)22/h1-5,13,16-17,19-20,24-25H,6-11H2/b12-5-/t13-,16+,17-,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	71610-48-5	Mehdi Beniddir
prunifolineA.mgf	*..*	Prunifoline A	455.1846	qTof	LC-ESI	313	COC(N1C2=C([C@]34[C@@H]5CN6[C@@]3([H])[C@](CC[C@]14C(OC)=O)(CC5=O)CCC6=O)C=CC=C2OC)=O	InChI=1S/C24H26N2O7/c1-31-16-6-4-5-13-18(16)26(21(30)33-3)23(20(29)32-2)10-9-22-8-7-17(28)25-12-14(15(27)11-22)24(13,23)19(22)25/h4-6,14,19H,7-12H2,1-3H3/t14-,19+,22-,23-,24+/m1/s1	N/A	1	Positive	N/A	Isolated	454.174	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
prunifolineB.mgf	*..*	Prunifoline B	469.1968	qTof	LC-ESI	314	COC(N1C2=C([C@]34[C@@H]5CN6[C@@]3([H])[C@](CC[C@]14C(OC)=O)(CC5=O)C=CC6)C=CC(OC)=C2OC)=O	InChI=1S/C25H28N2O7/c1-31-17-7-6-14-18(19(17)32-2)27(22(30)34-4)24(21(29)33-3)10-9-23-8-5-11-26-13-15(16(28)12-23)25(14,24)20(23)26/h5-8,15,20H,9-13H2,1-4H3/t15-,20+,23-,24-,25+/m1/s1	N/A	1	Positive	N/A	Isolated	468.1897	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
prunifolineC.mgf	*..*	Prunifoline C	381.1833	qTof	LC-ESI	315	COC1=C2N[C@@]3(C(OC)=O)CC[C@](CC4=O)(C56)C=CCN6C[C@@H]4C35C2=CC=C1	InChI=1S/C22H24N2O4/c1-27-16-6-3-5-13-17(16)23-21(19(26)28-2)9-8-20-7-4-10-24-12-14(15(25)11-20)22(13,21)18(20)24/h3-7,14,18,23H,8-12H2,1-2H3/t14-,18?,20+,21+,22?/m0/s1	N/A	1	Positive	N/A	Isolated	380.1736	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
prunifolineD.mgf	*..*	Prunifoline D	369.1812	qTof	LC-ESI	316	O=C(OC)[C@]12CC[C@](CC3=O)(C45)[C@@H](O)CCN5C[C@@H]3C14C6=CC=CC=C6N2	InChI=1S/C21H24N2O4/c1-27-18(26)20-8-7-19-10-15(24)13-11-23(9-6-16(19)25)17(19)21(13,20)12-4-2-3-5-14(12)22-20/h2-5,13,16-17,22,25H,6-11H2,1H3/t13-,16-,17?,19+,20+,21?/m0/s1	N/A	1	Positive	N/A	Isolated	368.1736	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
prunifolineE.mgf	*..*	Prunifoline E	413.1729	qTof	LC-ESI	317	O=C(OC)[C@]12CC[C@](CC3=O)([C@@]45[H])[C@@H](O)CCN5C[C@@H]3C14C6=CC=C(OCO7)C7=C6N2	InChI=1S/C22H24N2O6/c1-28-19(27)21-6-5-20-8-13(25)12-9-24(7-4-15(20)26)18(20)22(12,21)11-2-3-14-17(16(11)23-21)30-10-29-14/h2-3,12,15,18,23,26H,4-10H2,1H3/t12-,15-,18-,20+,21+,22?/m0/s1	N/A	1	Positive	N/A	Isolated	412.1634	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
prunifolineF.mgf	*..*	Prunifoline F	399.1944	qTof	LC-ESI	318	O=C(OC)[C@]12CC[C@](CC3=O)([C@@]45[H])[C@@H](O)CCN5C[C@@H]3C14C6=CC=CC(OC)=C6N2	InChI=1S/C22H26N2O5/c1-28-15-5-3-4-12-17(15)23-21(19(27)29-2)8-7-20-10-14(25)13-11-24(9-6-16(20)26)18(20)22(12,13)21/h3-5,13,16,18,23,26H,6-11H2,1-2H3/t13-,16-,18-,20+,21+,22?/m0/s1	N/A	1	Positive	N/A	Isolated	398.1842	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Pseudostrychnine.mgf	*..*	Pseudostrychnine	351.1703	qTof	LC-ESI	319	O=C1CC2[C@@]([C@@]3([H])C[C@]4(O)N(CC3=CCO2)CC5)([H])[C@@]6([H])[C@]45C7=CC=CC=C7N61	InChI=1S/C21H22N2O3/c24-17-9-16-18-13-10-21(25)20(6-7-22(21)11-12(13)5-8-26-16)14-3-1-2-4-15(14)23(17)19(18)20/h1-5,13,16,18-19,25H,6-11H2/t13-,16?,18-,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	350.163	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	465-62-3	Mehdi Beniddir
Pseudoyohimbine.mgf	*..*	Pseudoyohimbine	355.2016	qTof	LC-ESI	320	[H][C@@](N1CC2)(C[C@@]([C@@H](C(OC)=O)[C@@H](O)CC3)([H])[C@]3([H])C1)C4=C2C5=C(N4)C=CC=C5	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17+,18-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	84-37-7	Mehdi Beniddir
pyrrovobasine.mgf	*..*	Pyrrovobasine	605.303	qTof	LC-ESI	321	C/C=C1CN(C2CC3=C(N([H])C4=C3C=CC=C4)C(C(N([H])C5=C6C=CC=C5)=C6CCN7C(C=O)=CC=C7CO)C[C@H]/1[C@@H]2C(OC)=O)C	InChI=1S/C37H40N4O4/c1-4-22-19-40(2)33-18-29-26-10-6-8-12-32(26)39-36(29)30(17-28(22)34(33)37(44)45-3)35-27(25-9-5-7-11-31(25)38-35)15-16-41-23(20-42)13-14-24(41)21-43/h4-14,20,28,30,33-34,38-39,43H,15-19,21H2,1-3H3/b22-4-/t28-,30-,33?,34+/m1/s1	N/A	1	Positive	N/A	Isolated	604.305	Mehdi Beniddir	M+H	N/A	3	Voacanga	Voacanga africana	N/A	N/A	Beniddir/Le Pogam
Quebrachamine.mgf	*..*	Quebrachamine	283.2169	qTof	LC-ESI	322	CC[C@]1(CCC2)CN2CCC3=C(CC1)NC4=C3C=CC=C4	InChI=1S/C19H26N2/c1-2-19-10-5-12-21(14-19)13-9-16-15-6-3-4-7-17(15)20-18(16)8-11-19/h3-4,6-7,20H,2,5,8-14H2,1H3/t19-/m1/s1	N/A	1	Positive	N/A	Isolated	282.2096	Alexander Fox Ramos	M+H	N/A	3	Gonioma	Gonioma malagasy	N/A	4850-21-9	Mehdi Beniddir
Quebrachidine.mgf	*..*	Quebrachidine	353.186	qTof	LC-ESI	323	C/C=C1[C@@H]2CC3[C@]([C@@]4([C@H](O)C52C(OC)=O)C[C@@H]5N3C\1)([H])NC6=C4C=CC=C6	InChI=1S/C21H24N2O3/c1-3-11-10-23-15-8-13(11)21(19(25)26-2)16(23)9-20(18(21)24)12-6-4-5-7-14(12)22-17(15)20/h3-7,13,15-18,22,24H,8-10H2,1-2H3/b11-3-/t13-,15?,16-,17-,18-,20+,21?/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	4835-69-2	Mehdi Beniddir
Quinidine.mgf	*..*	Quinidine	325.1911	qTof	LC-ESI	324	O[C@H]([C@]1([H])[N@@](CC2)C[C@H](C=C)[C@@H]2C1)C3=CC=NC4=C3C=C(OC)C=C4	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	324.1838	Alexander Fox Ramos	M+H	N/A	3	Cinchona	Cinchona rubra	N/A	56-54-2	Mehdi Beniddir
quinidinone.mgf	*..*	Quinidinone	323.1779	qTof	LC-ESI	325	COC1=CC2=C(N=CC=C2C([C@@]3([H])C[C@@H]4CCN3C[C@@H]4C=C)=O)C=C1	InChI=1S/C20H22N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19H,1,7,9-10,12H2,2H3/t13-,14-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
quinine.mgf	*..*	Quinine	325.1906	qTof	LC-ESI	326	COC1=CC2=C([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)C=CN=C2C=C1	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1	N/A	1	Positive	N/A	Isolated	324.18378	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Raubasine.mgf	*..*	Raubasine	353.186	qTof	LC-ESI	327	O=C(OC)C1=CO[C@@H](C)[C@](C2)([H])[C@]1([H])C[C@@](N2CC3)([H])C4=C3C5=C(N4)C=CC=C5	InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16+,19-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	483-04-5	Mehdi Beniddir
rauniticine-allo-oxindole-A.mgf	*..*	Rauniticine oxindole A	369.1809	qTof	LC-ESI	328	O=C(NC1=C2C=CC=C1)[C@@]32[C@]4([H])C[C@@]5([H])[C@@]([C@H](OC=C5C(OC)=O)C)([H])CN4CC3	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13+,14+,18+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	368.1736	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
rauniticine-epi-allo-oxindole-B.mgf	*..*	Rauniticine oxindole B	369.1833	qTof	LC-ESI	329	O=C(NC1=C2C=CC=C1)[C@]32[C@]4([H])C[C@@]5([H])[C@@]([C@H](OC=C5C(OC)=O)C)([H])CN4CC3	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13+,14+,18+,21-/m1/s1	N/A	1	Positive	N/A	Isolated	368.1736	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
rauvanine.mgf	*..*	Rauvavine	413.2068	qTof	LC-ESI	330	C[C@@H]1[C@@]2([H])CN3CCC(C4=CC(OC)=C(OC)C=C4N5)=C5[C@@]3([H])C[C@]2([H])C(C(OC)=O)=CO1	InChI=1S/C23H28N2O5/c1-12-16-10-25-6-5-13-15-8-20(27-2)21(28-3)9-18(15)24-22(13)19(25)7-14(16)17(11-30-12)23(26)29-4/h8-9,11-12,14,16,19,24H,5-7,10H2,1-4H3/t12-,14+,16-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	412.2998	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Rauvomitine.mgf	*..*	Rauvomitine	503.254	qTof	LC-ESI	331	C/C=C1[C@@H]2C[C@@]3([H])[C@]([C@@]4([C@H](OC(C5=CC(OC)=C(OC)C(OC)=C5)=O)[C@H]62)C[C@@H]6N3C\1)([H])N(C)C7=C4C=CC=C7	InChI=1S/C30H34N2O5/c1-6-16-15-32-21-13-18(16)25-22(32)14-30(19-9-7-8-10-20(19)31(2)27(21)30)28(25)37-29(33)17-11-23(34-3)26(36-5)24(12-17)35-4/h6-12,18,21-22,25,27-28H,13-15H2,1-5H3/b16-6-/t18-,21-,22-,25-,27-,28+,30+/m0/s1	N/A	1	Positive	N/A	Isolated	502.2468	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	466-57-9	Mehdi Beniddir
rauvoxinineiodomethylate.mgf	*..*	N4-methylrauvoxinine	443.2172	qTof	LC-ESI	332	O=C([C@@]1(C2=C3)[C@](C4)([H])[N+](CC1)(C)C[C@]5([H])[C@@]4([H])C(C(OC)=O)=CO[C@H]5C)NC2=CC(OC)=C3OC	InChI=1S/C24H30N2O6/c1-13-15-11-26(2)7-6-24(21(26)8-14(15)16(12-32-13)22(27)31-5)17-9-19(29-3)20(30-4)10-18(17)25-23(24)28/h9-10,12-15,21H,6-8,11H2,1-5H3/p+1/t13-,14-,15-,21+,24-,26?/m0/s1	N/A	1	Positive	N/A	Isolated	443.2177	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Rescinnamine.mgf	*..*	Rescinnamine	635.29598	qTof	LC-ESI	333	COC1=CC(N2)=C(C(CCN3C4)=C2[C@@]3([H])C[C@@]5([H])[C@]4([H])C[C@@H](OC(/C([H])=C([H])/C6=CC(OC)=C(OC)C(OC)=C6)=O)[C@H](OC)[C@H]5C(OC)=O)C=C1	InChI=1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1	N/A	1	Positive	N/A	Isolated	634.289	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Reserpiline.mgf	*..*	Reserpiline	413.207	qTof	LC-ESI	334	O=C(OC)C1=CO[C@@H](C)[C@@](C2)([H])[C@]1([H])C[C@](N2CC3)([H])C4=C3C5=C(N4)C=C(OC)C(OC)=C5	InChI=1S/C23H28N2O5/c1-12-16-10-25-6-5-13-15-8-20(27-2)21(28-3)9-18(15)24-22(13)19(25)7-14(16)17(11-30-12)23(26)29-4/h8-9,11-12,14,16,19,24H,5-7,10H2,1-4H3/t12-,14-,16-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	412.1998	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Reserpine.mgf	*..*	Reserpine	609.2807	qTof	LC-ESI	335	[H][C@@](N1CC2)(C[C@@]([C@H](C(OC)=O)[C@@H](OC)[C@H](OC(C3=CC(OC)=C(OC)C(OC)=C3)=O)C4)([H])[C@@]4([H])C1)C5=C2C6=C(N5)C=C(OC)C=C6	InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	N/A	1	Positive	N/A	Isolated	608.2734	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	50-55-5	Mehdi Beniddir
Retuline.mgf	*..*	Retuline	339.2067	qTof	LC-ESI	336	[H][C@]1([C@@H](CO)[C@H](/C(C2)=C\C)C[C@@H]3N2CC4)[C@]34C5=CC=CC=C5N1C(C)=O	InChI=1S/C21H26N2O2/c1-3-14-11-22-9-8-21-17-6-4-5-7-18(17)23(13(2)25)20(21)16(12-24)15(14)10-19(21)22/h3-7,15-16,19-20,24H,8-12H2,1-2H3/b14-3-/t15-,16-,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2616-16-2	Mehdi Beniddir
rhazimal.mgf	*..*	Rhazimal	351.1706	qTof	LC-ESI	337	C/C=C/1\CN2CC[C@@]34C5=CC=CC=C5N=C3[C@@H]2C[C@@H]1[C@]4(C=O)C(=O)OC	InChI=1S/C21H22N2O3/c1-3-13-11-23-9-8-20-14-6-4-5-7-16(14)22-18(20)17(23)10-15(13)21(20,12-24)19(25)26-2/h3-7,12,15,17H,8-11H2,1-2H3/b13-3+/t15-,17-,20+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	350.163	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
rhazimol.mgf	*..*	Rhazimol	353.186	qTof	LC-ESI	338	C/C=C1[C@H]2C(C(OC)=O)(CO)[C@@]34C([C@@](C2)([H])N(CC4)C\1)=NC5=CC=CC=C35	InChI=1S/C21H24N2O3/c1-3-13-11-23-9-8-20-14-6-4-5-7-16(14)22-18(20)17(23)10-15(13)21(20,12-24)19(25)26-2/h3-7,15,17,24H,8-12H2,1-2H3/b13-3-/t15-,17-,20+,21?/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
rhazinilam.mgf	*..*	Rhazinilam	295.181	qTof	LC-ESI	339	CC[C@]1(CCC2=O)CCCN3C=CC(C4=CC=CC=C4N2)=C13	InChI=1S/C19H22N2O/c1-2-19-10-5-12-21-13-9-15(18(19)21)14-6-3-4-7-16(14)20-17(22)8-11-19/h3-4,6-7,9,13H,2,5,8,10-12H2,1H3,(H,20,22)/t19-/m1/s1	N/A	1	Positive	N/A	Isolated	294.1732	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
sandwicine.mgf	*..*	Sandwicine	327.2062	qTof	LC-ESI	340	CC[C@@H]1[C@H](N2C3CC1C4C2CC5([C@H]4O)C3N(C6=CC=CC=C56)C)O	InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11?,14?,15?,16?,17?,18-,19+,20?/m0/s1	N/A	1	Positive	N/A	Isolated	326.1994	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
sempervirine-chlorhydrate.mgf	*..*	Sempervirine-chlorhydrate	273.1381	qTof	LC-ESI	341	C1CCC2=CN3C=CC4=C5C=CC=CC5=NC4=C3C=C2C1	InChI=1S/C19H16N2/c1-2-6-14-12-21-10-9-16-15-7-3-4-8-17(15)20-19(16)18(21)11-13(14)5-1/h3-4,7-12H,1-2,5-6H2	N/A	1	Positive	N/A	Isolated	272.1313	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
seredamine.mgf	*..*	Seredamine	339.2059	qTof	LC-ESI	342	O[C@H]1[C@@]23[C@@]([C@@](C[C@H]([C@@H]41)/C(C5)=C/C)([H])N5[C@H]4C3)([H])N(C)C6=C(OC)C=CC=C62	InChI=1S/C21H26N2O2/c1-4-11-10-23-14-8-12(11)17-15(23)9-21(20(17)24)13-6-5-7-16(25-3)18(13)22(2)19(14)21/h4-7,12,14-15,17,19-20,24H,8-10H2,1-3H3/b11-4+/t12-,14-,15-,17-,19-,20+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
seredine.mgf	*..*	Seredine	415.2254	qTof	LC-ESI	343	COC([C@@H]1[C@H](CC[C@]2([H])CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=CC(OC)=C(C=C45)OC)O)=O	InChI=1S/C23H30N2O5/c1-28-19-9-15-13-6-7-25-11-12-4-5-18(26)21(23(27)30-3)14(12)8-17(25)22(13)24-16(15)10-20(19)29-2/h9-10,12,14,17-18,21,24,26H,4-8,11H2,1-3H3/t12-,14+,17+,18+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	414.2155	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
seredone.mgf	*..*	Seredone	355.2003	qTof	LC-ESI	344	[H]C1C(CC[C@]2([H])CN3CCC4=C([C@]3([H])C[C@]12[H])NC5=CC(OC)=C(C=C45)OC)=O	InChI=1S/C21H26N2O3/c1-25-19-9-16-15-5-6-23-11-12-3-4-14(24)7-13(12)8-18(23)21(15)22-17(16)10-20(19)26-2/h9-10,12-13,18,22H,3-8,11H2,1-2H3/t12-,13+,18+/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Serpentine.mgf	*..*	Serpentine	349.1547	qTof	LC-ESI	345	C[C@@H]1OC=C(C(OC)=O)[C@@]([C@]1([H])C2)([H])CC3=[N+]2C=CC4=C3[N-]C5=C4C=CC=C5	InChI=1S/C21H20N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-8,11-12,15-16H,9-10H2,1-2H3/t12-,15-,16+/m0/s1	N/A	1	Positive	N/A	Isolated	348.1474	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	18786-24-8	Mehdi Beniddir
Silicine.mgf	*..*	Silicine	297.1964	qTof	LC-ESI	346	CC[C@H]1CN(C[C@@H]2[C@H]1CC(=O)C3=C(C2)C4=CC=CC=C4N3)C	InChI=1S/C19H24N2O/c1-3-12-10-21(2)11-13-8-16-14-6-4-5-7-17(14)20-19(16)18(22)9-15(12)13/h4-7,12-13,15,20H,3,8-11H2,1-2H3/t12-,13+,15-/m0/s1	N/A	1	Positive	N/A	Isolated	296.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Splendoline.mgf	*..*	Splendoline	371.1965	qTof	LC-ESI	347	C[C@H]1OC[C@@]2([H])[C@]3([H])N(C(CO)=O)C4=CC=CC=C4[C@]35[C@]6(O)C[C@@]2([H])[C@@]1([H])CN6CC5	InChI=1S/C21H26N2O4/c1-12-14-9-22-7-6-20-16-4-2-3-5-17(16)23(18(25)10-24)19(20)15(11-27-12)13(14)8-21(20,22)26/h2-5,12-15,19,24,26H,6-11H2,1H3/t12-,13+,14+,15-,19+,20+,21-/m1/s1	N/A	1	Positive	N/A	Isolated	370.1893	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	22152-58-5	Mehdi Beniddir
stemmadenine.mgf	*..*	Stemmadenine	355.2016	qTof	LC-ESI	348	COC([C@]1([C@@]2([H])CC[N@](CCc(c1[nH]3)c4c3cccc4)C/C2=C\C)CO)=O	InChI=1S/C21H26N2O3/c1-3-14-12-23-10-8-16-15-6-4-5-7-18(15)22-19(16)21(13-24,20(25)26-2)17(14)9-11-23/h3-7,17,22,24H,8-13H2,1-2H3/b14-3+	N/A	1	Positive	N/A	Isolated	354.1943	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
strictamine.mgf	*..*	Strictamine	323.1761	qTof	LC-ESI	349	COC([C@H]1[C@H]2C[C@]3([H])N(C/C2=C\C)CC[C@@]14C3=Nc5c4cccc5)=O	InChI=1S/C20H22N2O2/c1-3-12-11-22-9-8-20-14-6-4-5-7-15(14)21-18(20)16(22)10-13(12)17(20)19(23)24-2/h3-7,13,16-17H,8-11H2,1-2H3/b12-3+/t13-,16-,17+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	322.1681	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Strictosamide.mgf	*..*	Strictosamide	499.2075	qTof	LC-ESI	350	O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]([C@@H]([C@@]2(C[C@]34[H])[H])C=C)OC=C2C(N3CCC5=C4NC6=CC=CC=C65)=O)CO)O)O	InChI=1S/C26H30N2O8/c1-2-12-15-9-18-20-14(13-5-3-4-6-17(13)27-20)7-8-28(18)24(33)16(15)11-34-25(12)36-26-23(32)22(31)21(30)19(10-29)35-26/h2-6,11-12,15,18-19,21-23,25-27,29-32H,1,7-10H2/t12-,15+,18+,19-,21-,22+,23-,25+,26+/m1/s1	N/A	1	Positive	N/A	Isolated	498.2002	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	23141-25-5	Mehdi Beniddir
Strictosidine.mgf	*..*	Strictosidine	531.2337	qTof	LC-ESI	351	[H][C@]1(NCCC2=C1NC3=CC=CC=C23)C[C@]4([C@H]([C@@H](OC=C4C(OC)=O)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)CO)C=C)[H]	InChI=1S/C27H34N2O9/c1-3-13-16(10-19-21-15(8-9-28-19)14-6-4-5-7-18(14)29-21)17(25(34)35-2)12-36-26(13)38-27-24(33)23(32)22(31)20(11-30)37-27/h3-7,12-13,16,19-20,22-24,26-33H,1,8-11H2,2H3/t13-,16+,19+,20-,22-,23+,24-,26+,27+/m1/s1	N/A	1	Positive	N/A	Isolated	530.2264	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	20824-29-7	Mehdi Beniddir
strychnine.mgf	*..*	Strychnine	335.1754	qTof	LC-ESI	352	[H][C@]1([C@@]23[C@@H](N4CC3)C[C@](C(C4)=CCO5)([H])[C@@]1([H])[C@]5([H])CC6=O)N6C7=C2C=CC=C7	InChI=1S/C21H22N2O2/c24-18-10-16-19-13-9-17-21(6-7-22(17)11-12(13)5-8-25-16)14-3-1-2-4-15(14)23(18)20(19)21/h1-5,13,16-17,19-20H,6-11H2/t13-,16-,17-,19-,20-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	334.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	57-24-9	Mehdi Beniddir
Strychnofoline.mgf	*..*	Strychnofoline	483.2755	qTof	LC-ESI	353	O=C([C@]12[C@@](C[C@H](C[C@]3([H])N(C)CCC4=C3NC5=C4C=CC=C5)[C@@H](C=C)C6)([H])N6CC2)NC7=C1C=CC(O)=C7	InChI=1S/C30H34N4O2/c1-3-18-17-34-13-11-30(23-9-8-20(35)16-25(23)32-29(30)36)27(34)15-19(18)14-26-28-22(10-12-33(26)2)21-6-4-5-7-24(21)31-28/h3-9,16,18-19,26-27,31,35H,1,10-15,17H2,2H3,(H,32,36)/t18-,19-,26-,27-,30-/m0/s1	N/A	1	Positive	N/A	Isolated	482.2682	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	63408-17-3	Mehdi Beniddir
Strychnogucine_A.mgf	*..*	Strychnogucine A	651.333	qTof	LC-ESI	354	O=C1[C@]([C@@]2([H])C[C@]34C5=CC=CC=C5N6[C@@]3([H])C([C@H]7C[C@@H]4N2C/C7=C/C)=CCC6=O)([H])[C@@]8([H])[C@@]([C@H](C(C9)=CCO8)C[C@@H]%10N9CC%11)([H])[C@@]%12([H])[C@]%10%11C%13=CC=CC=C%13N%121	InChI=1S/C42H42N4O3/c1-2-22-21-44-31(19-42-28-8-4-5-9-29(28)45-34(47)12-11-24(38(42)45)25(22)17-33(42)44)36-37-35-26-18-32-41(14-15-43(32)20-23(26)13-16-49-37)27-7-3-6-10-30(27)46(39(35)41)40(36)48/h2-11,13,25-26,31-33,35-39H,12,14-21H2,1H3/b22-2-/t25-,26-,31+,32-,33-,35-,36-,37+,38-,39-,41+,42+/m0/s1	N/A	1	Positive	N/A	Isolated	650.3257	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	324519-12-2	Mehdi Beniddir
Strychnogucine_C.mgf	*..*	Strychnogucine C	651.333	qTof	LC-ESI	355	O=C1[C@]([C@@]2([H])C[C@]34C5=CC=CC=C5N(C(C=C6)=O)[C@@]3([H])C6[C@H]7C[C@@H]4N2C/C7=C/C)([H])[C@@]8([H])[C@@]([C@H](C(C9)=CCO8)C[C@@H]%10N9CC%11)([H])[C@@]%12([H])[C@]%10%11C%13=CC=CC=C%13N%121	InChI=1S/C42H42N4O3/c1-2-22-21-44-31(19-42-28-8-4-5-9-29(28)45-34(47)12-11-24(38(42)45)25(22)17-33(42)44)36-37-35-26-18-32-41(14-15-43(32)20-23(26)13-16-49-37)27-7-3-6-10-30(27)46(39(35)41)40(36)48/h2-13,24-26,31-33,35-39H,14-21H2,1H3/b22-2-/t24?,25-,26-,31+,32-,33-,35-,36-,37+,38-,39-,41+,42+/m0/s1	N/A	1	Positive	N/A	Isolated	650.3257	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	532971-12-3	Mehdi Beniddir
Strychnohexamine.mgf	*..*	Strychnohexamine	869.4901	qTof	LC-ESI	356	O=C1C([C@@]2([H])C[C@]34C5=CC=CC=C5N6[C@@]3([H])/C([C@H]7C[C@@H]4N2C/C7=C/C)=C\N8[C@]([H])([C@]9%10C%11=C8C=CC=C%11)/C([C@H](/C(C%12)=C\C)C[C@@H]9N%12CC%10)=C\6)=C[C@]([C@H](/C(C%13)=C\C)C[C@@H]%14N%13CC%15)([H])[C@@]%16([H])[C@]%14%15C%17=CC=CC=C%17N%161	InChI=1S/C59H60N6O/c1-4-33-28-61-22-20-58-45-15-9-12-18-48(45)65-55(58)39(36(33)24-51(58)61)23-40(56(65)66)49-27-59-44-14-8-11-17-47(44)64-31-41-37-25-50-57(19-21-60(50)29-34(37)5-2)43-13-7-10-16-46(43)63(53(41)57)32-42(54(59)64)38-26-52(59)62(49)30-35(38)6-3/h4-18,23,31-32,36-39,49-55H,19-22,24-30H2,1-3H3/b33-4-,34-5-,35-6-,41-31-,42-32-/t36-,37-,38-,39-,49+,50-,51-,52-,53-,54-,55-,57+,58+,59+/m0/s1	N/A	1	Positive	N/A	Isolated	868.4829	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	442123-70-8	Mehdi Beniddir
Strychnopentamine.mgf	*..*	Strychnopentamine	550.354	qTof	LC-ESI	357	[H][C@](N1CC2)(C[C@@](C[C@@]3([H])C4=C(C(C=CC=C5)=C5N4)CCN3C)([H])[C@](C=C)([H])C1)C6=C2C7=CC=C(O)C([C@]8([H])N(C)CCC8)=C7N6	InChI=1S/C35H43N5O/c1-4-21-20-40-17-14-26-24-11-12-31(41)32(28-10-7-15-38(28)2)35(24)37-34(26)30(40)19-22(21)18-29-33-25(13-16-39(29)3)23-8-5-6-9-27(23)36-33/h4-6,8-9,11-12,21-22,28-30,36-37,41H,1,7,10,13-20H2,2-3H3/t21-,22-,28+,29-,30-/m0/s1	N/A	1	Positive	N/A	Isolated	549.3468	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	63209-34-7	Mehdi Beniddir
Strychnophylline.mgf	*..*	Strychnophylline	566.349	qTof	LC-ESI	358	OC1=CC=C2C3([C@]4([H])C[C@@](C[C@@]5([H])C6=C(C(C=CC=C7)=C7N6)CCN5C)([H])[C@@H](C=C)CN4CC3)C(NC2=C1[C@]8([H])N(C)CCC8)=O	InChI=1S/C35H43N5O2/c1-4-21-20-40-17-14-35(25-11-12-29(41)31(33(25)37-34(35)42)27-10-7-15-38(27)2)30(40)19-22(21)18-28-32-24(13-16-39(28)3)23-8-5-6-9-26(23)36-32/h4-6,8-9,11-12,21-22,27-28,30,36,41H,1,7,10,13-20H2,2-3H3,(H,37,42)/t21-,22-,27+,28-,30-,35?/m0/s1	N/A	1	Positive	N/A	Isolated	565.3417	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	69306-88-3	Mehdi Beniddir
Sungucine.mgf	*..*	Sungucine	635.3381	qTof	LC-ESI	359	C/C=C(C1)\[C@H](C[C@@H]2N1CC3)C4[C@@]5([H])[C@]23C6=CC=CC=C6N5C(C([C@@]7([H])C[C@]89C%10=CC=CC=C%10N(C(C=C%11)=O)[C@@]8([H])[C@]%11([H])[C@H]%12C[C@@H]9N7C/C%12=C/C)=C4)=O	InChI=1S/C42H42N4O2/c1-3-23-21-43-16-15-41-30-9-5-8-12-33(30)46-39(41)28(27(23)18-35(41)43)17-29(40(46)48)34-20-42-31-10-6-7-11-32(31)45-37(47)14-13-25(38(42)45)26-19-36(42)44(34)22-24(26)4-2/h3-14,17,25-28,34-36,38-39H,15-16,18-22H2,1-2H3/b23-3-,24-4-/t25-,26-,27-,28?,34+,35-,36-,38-,39-,41+,42+/m0/s1	N/A	1	Positive	N/A	Isolated	634.3308	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	73020-53-8	Mehdi Beniddir
Tabernaemontanine.mgf	*..*	Tabernaemontanine	355.2016	qTof	LC-ESI	360	CN1C(C2([H])C(OC)=O)CC3=C(C(CC2[C@H](CC)C1)=O)NC4=C3C=CC=C4	InChI=1S/C21H26N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h5-8,12,14,17,19,22H,4,9-11H2,1-3H3/t12-,14+,17+,19+/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2134-98-7	Mehdi Beniddir
Tabernamine.mgf	*..*	Tabernamine	617.385	qTof	LC-ESI	361	O=C(OC)[C@@H]1[C@@H]2CC3=C(NC4=CC=CC=C43)[C@](c5cc6[nH]c([C@H]7[C@H]([C@H](C[C@H](C7)C8)CC)[N@]8CC9)c9c6cc5)([H])C[C@H]1/C(CN2C)=C\C	InChI=1S/C40H48N4O2/c1-5-23-15-22-16-32-37-28(13-14-44(20-22)39(23)32)27-12-11-25(17-34(27)42-37)30-18-29-24(6-2)21-43(3)35(36(29)40(45)46-4)19-31-26-9-7-8-10-33(26)41-38(30)31/h6-12,17,22-23,29-30,32,35-36,39,41-42H,5,13-16,18-21H2,1-4H3/b24-6-	N/A	1	Positive	N/A	Isolated	616.3777	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Mehdi Beniddir
Tabernanthine.mgf	*..*	Tabernanthine	311.2118	qTof	LC-ESI	362	CC[C@@H](C[C@H]1C2)C([N@](C1)CC3)[C@@H]2C4=C3C5=C(N4)C=C(OC)C=C5	InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-16(6-7-22(11-12)20(13)17)15-5-4-14(23-2)10-18(15)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13-,17-,20?/m0/s1	N/A	1	Positive	N/A	Isolated	310.2045	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	83-94-3	Mehdi Beniddir
Tabersonine.mgf	*..*	Tabersonine	337.192	qTof	LC-ESI	363	O=C(OC)C1=C([C@@]23[C@]4([H])[C@](C=CCN4CC3)(CC)C1)NC5=C2C=CC=C5	InChI=1S/C21H24N2O2/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2/h4-9,19,22H,3,10-13H2,1-2H3/t19-,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	336.1838	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	4429-63-4	Mehdi Beniddir
tabertinggine.mgf	*..*	Tabertinggine	293.1654	qTof	LC-ESI	364	CC(C1=C[C@@]23C[C@](C1)([H])CN2CCC4=C3NC5=C4C=CC=C5)=O	InChI=1S/C19H20N2O/c1-12(22)14-8-13-9-19(10-14)18-16(6-7-21(19)11-13)15-4-2-3-5-17(15)20-18/h2-5,10,13,20H,6-9,11H2,1H3/t13-,19-/m1/s1	N/A	1	Positive	N/A	Isolated	292.1576	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
tenuisineA.mgf	*..*	Tenuisine A	397.1762	qTof	LC-ESI	365	COC(N1C2=C([C@]34CCN5CC=C[C@]56CC[C@]13[C@@H](C(O4)=O)C6)C=C(OC)C=C2)=O	InChI=1S/C22H24N2O5/c1-27-14-4-5-17-15(12-14)22-9-11-23-10-3-6-20(23)7-8-21(22,24(17)19(26)28-2)16(13-20)18(25)29-22/h3-6,12,16H,7-11,13H2,1-2H3/t16-,20-,21-,22-/m1/s1	N/A	1	Positive	N/A	Isolated	396.1685	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
tenuisineB.mgf	*..*	Tenuisine B	427.1884	qTof	LC-ESI	366	COC(N1C2=C([C@]34CCN5CC=C[C@]56CC[C@]13[C@@H](C(O4)=O)C6)C=C(OC)C(OC)=C2)=O	InChI=1S/C23H26N2O6/c1-28-17-11-14-16(12-18(17)29-2)25(20(27)30-3)22-7-6-21-5-4-9-24(21)10-8-23(14,22)31-19(26)15(22)13-21/h4-5,11-12,15H,6-10,13H2,1-3H3/t15-,21-,22-,23-/m1/s1	N/A	1	Positive	N/A	Isolated	426.1791	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
tenuisineC.mgf	*..*	Tenuisine C	411.1584	qTof	LC-ESI	367	COC(N1C2=C([C@]34CCN5C(C=C[C@]56CC[C@]13[C@@H](C(O4)=O)C6)=O)C=C(OC)C=C2)=O	InChI=1S/C22H22N2O6/c1-28-13-3-4-16-14(11-13)22-9-10-23-17(25)5-6-20(23)7-8-21(22,24(16)19(27)29-2)15(12-20)18(26)30-22/h3-6,11,15H,7-10,12H2,1-2H3/t15-,20-,21-,22-/m1/s1	N/A	1	Positive	N/A	Isolated	410.1478	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
tetrahydro_alstonine.mgf	*..*	Tetrahydro-alstonine	353.186	qTof	LC-ESI	368	C[C@H]1[C@@H]2CN3CCC4=C([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)NC5=CC=CC=C45	InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16-,19-/m0/s1	N/A	1	Positive	N/A	Isolated	352.1786	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
tetraphyllicine.mgf	*..*	Tetraphyllicine	309.196	qTof	LC-ESI	369	CN1C2=CC=CC=C2[C@]34C[C@@H](C5C4O)N6[C@](C[C@H]5/C(C6)=C\C)([H])[C@@]31[H]	InChI=1S/C20H24N2O/c1-3-11-10-22-15-8-12(11)17-16(22)9-20(19(17)23)13-6-4-5-7-14(13)21(2)18(15)20/h3-7,12,15-19,23H,8-10H2,1-2H3/b11-3-/t12-,15-,16-,17?,18-,19?,20+/m0/s1	N/A	1	Positive	N/A	Isolated	308.1889	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Theionbrunonine_A.mgf	*..*	Theionbrunonine A	707.3645	qTof	LC-ESI	370	CN1C(C2C(OC)=O)CC3=C([C@@H](S[C@H](CC/4C5C(OC)=O)C6=C(CC5N(C)CC4=C\C)C7=C(N6)C=CC=C7)C[C@H]2/C(C1)=C\C)NC8=C3C=CC=C8	InChI=1S/C42H50N4O4S/c1-7-23-21-45(3)33-17-29-25-13-9-11-15-31(25)43-39(29)35(19-27(23)37(33)41(47)49-5)51-36-20-28-24(8-2)22-46(4)34(38(28)42(48)50-6)18-30-26-14-10-12-16-32(26)44-40(30)36/h7-16,27-28,33-38,43-44H,17-22H2,1-6H3/b23-7-,24-8-/t27-,28+,33-,34-,35-,36+,37?,38?/m0/s1	N/A	1	Positive	N/A	Isolated	706.3553	Alexander Fox Ramos	M+H	N/A	3	Mostuea	Mostuea brunonis	N/A	N/A	Mehdi Beniddir
Theionbrunonine_B.mgf	*..*	Theionbrunonine B	693.3509	qTof	LC-ESI	371	C/C=C1CNC2CC3=C([C@@H](S[C@H](CC/4C5C(OC)=O)C6=C(CC5N(C)CC4=C\C)C7=C(N6)C=CC=C7)C[C@@H]/1C2C(OC)=O)NC8=C3C=CC=C8	InChI=1S/C41H48N4O4S/c1-6-22-20-42-32-16-28-24-12-8-10-14-30(24)43-38(28)34(18-26(22)36(32)40(46)48-4)50-35-19-27-23(7-2)21-45(3)33(37(27)41(47)49-5)17-29-25-13-9-11-15-31(25)44-39(29)35/h6-15,26-27,32-37,42-44H,16-21H2,1-5H3/b22-6-,23-7-/t26-,27+,32-,33-,34-,35+,36?,37?/m0/s1	N/A	1	Positive	N/A	Isolated	692.3396	Alexander Fox Ramos	M+H	N/A	3	Mostuea	Mostuea brunonis	N/A	N/A	Mehdi Beniddir
Theionbrunonine_C.mgf	*..*	Theionbrunonine C	723.365	qTof	LC-ESI	372	[O-][N@@+](C1([H])CC2=C(NC3=C2C=CC=C3)C(SC4C(NC5=C6C=CC=C5)=C6C[C@@](N(C)C/C7=C/C)([H])[C@@H](C(OC)=O)[C@]7([H])C4)C[C@@]/8([H])[C@@H]1C(OC)=O)(C)CC8=C\C	InChI=1S/C42H51N4O5S/c1-7-23-21-45(3)33-17-29-25-13-9-11-15-31(25)43-39(29)35(19-27(23)37(33)41(47)50-5)52-36-20-28-24(8-2)22-46(4,49)34(38(28)42(48)51-6)18-30-26-14-10-12-16-32(26)44-40(30)36/h7-16,27-28,33-38,43-44,49H,17-22H2,1-6H3/t27-,28-,33-,34-,35+,36+,37+,38+/m1/s1	N/A	1	Positive	N/A	Isolated	722.358	Alexander Fox Ramos	M+H	N/A	3	Mostuea	Mostuea brunonis	N/A	N/A	Beniddir/Le Pogam
Trimethoxy_3_4_5_cinnamate_vincamajine.mgf	*..*	Trimethoxy-3,4,5-cinnamate-vincamajine	587.2752	qTof	LC-ESI	373	C/C=C1[C@@H]2C[C@@]3([H])[C@@]4([H])N(C)C5=CC=CC=C5C4([C@@H]6OC(/C=C/C7=CC(OC)=C(OC)C(OC)=C7)=O)C[C@@H](C26C(OC)=O)N3C\1	InChI=1S/C34H38N2O7/c1-7-20-18-36-24-16-22(20)34(32(38)42-6)27(36)17-33(21-10-8-9-11-23(21)35(2)30(24)33)31(34)43-28(37)13-12-19-14-25(39-3)29(41-5)26(15-19)40-4/h7-15,22,24,27,30-31H,16-18H2,1-6H3/b13-12+,20-7-/t22-,24-,27-,30+,31-,33?,34?/m0/s1	N/A	1	Positive	N/A	Isolated	586.2679	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia boulindaensis	N/A	57800-03-0	Mehdi Beniddir
Tubotaiwine.mgf	*..*	Tubotaiwine	325.192	qTof	LC-ESI	374	CC[C@H]1[C@@H]2CCN3[C@H]1[C@@]4(C5=CC=CC=C5NC4=C2C(OC)=O)CC3	InChI=1S/C20H24N2O2/c1-3-12-13-8-10-22-11-9-20(18(12)22)14-6-4-5-7-15(14)21-17(20)16(13)19(23)24-2/h4-7,12-13,18,21H,3,8-11H2,1-2H3/t12-,13-,18+,20+/m0/s1	N/A	1	Positive	N/A	Isolated	324.18378	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Uncarine_D.mgf	*..*	Uncarine D	369.1804	qTof	LC-ESI	380	C[C@H]1[C@@H]2CN3CC[C@]4(C5=CC=CC=C5NC4=O)[C@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14-,18+,21-/m0/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
UncarineA.mgf	*..*	Uncarine A	369.1804	qTof	LC-ESI	375	C[C@@H]1[C@H]2CN3CC[C@]4(C5=CC=CC=C5NC4=O)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13+,14-,18+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
UncarineB.mgf	*..*	Uncarine B	369.1804	qTof	LC-ESI	376	C[C@@H]1[C@H]2CN3CC[C@@]4(C5=CC=CC=C5NC4=O)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13+,14-,18+,21-/m1/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
UncarineC.mgf	*..*	Uncarine C	369.1804	qTof	LC-ESI	377	C[C@H]1[C@@H]2CN3CC[C@@]4(C5=CC=CC=C5NC4=O)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14-,18-,21+/m0/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
UncarineE.mgf	*..*	Uncarine E	369.1804	qTof	LC-ESI	378	C[C@H]1[C@@H]2CN3CC[C@]4(C5=CC=CC=C5NC4=O)[C@@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14-,18-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
UncarineF.mgf	*..*	Uncarine F	369.1804	qTof	LC-ESI	379	C[C@H]1[C@@H]2CN3CC[C@@]4(C5=CC=CC=C5NC4=O)[C@H]3C[C@@H]2C(C(OC)=O)=CO1	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14-,18+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	368.17361	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
undulifoline.mgf	*..*	Undulifoline	341.1856	qTof	LC-ESI	381	CN1CC[C@H]2[C@H]3[C@@H]1C4=C([C@@]2(COCC3)C(=O)OC)NC5=CC=CC=C54	InChI=1S/C20H24N2O3/c1-22-9-7-14-12-8-10-25-11-20(14,19(23)24-2)18-16(17(12)22)13-5-3-4-6-15(13)21-18/h3-6,12,14,17,21H,7-11H2,1-2H3/t12-,14-,17+,20-/m0/s1	N/A	1	Positive	N/A	Isolated	340.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Usambarensine.mgf	*..*	Usambarensine	433.2387	qTof	LC-ESI	382	[H][C@@]12C[C@@](CC3=NC=CC4=C3NC5=C4C=CC=C5)([H])/C(CN1CCC6=C2NC7=C6C=CC=C7)=C\C	InChI=1S/C29H28N4/c1-2-18-17-33-14-12-23-21-8-4-6-10-25(21)32-29(23)27(33)16-19(18)15-26-28-22(11-13-30-26)20-7-3-5-9-24(20)31-28/h2-11,13,19,27,31-32H,12,14-17H2,1H3/b18-2-/t19-,27-/m0/s1	N/A	1	Positive	N/A	Isolated	432.2314	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	36150-14-8	Mehdi Beniddir
Usambarine.mgf	*..*	Usambarine	451.2856	qTof	LC-ESI	383	[H][C@@]12C[C@@](C[C@]3([H])N(C)CCC4=C3NC5=C4C=CC=C5)([H])[C@@H](C=C)CN1CCC6=C2NC7=C6C=CC=C7	InChI=1S/C30H34N4/c1-3-19-18-34-15-13-24-22-9-5-7-11-26(22)32-30(24)28(34)17-20(19)16-27-29-23(12-14-33(27)2)21-8-4-6-10-25(21)31-29/h3-11,19-20,27-28,31-32H,1,12-18H2,2H3/t19-,20-,27-,28-/m0/s1	N/A	1	Positive	N/A	Isolated	450.2783	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	35226-29-0	Mehdi Beniddir
vallesamine.mgf	*..*	Vallesamine	341.186	qTof	LC-ESI	384	C/C=C1CN(CC2=C3NC4=CC=CC=C24)CC[C@]/1([H])[C@@]3(C(OC)=O)CO	InChI=1S/C20H24N2O3/c1-3-13-10-22-9-8-16(13)20(12-23,19(24)25-2)18-15(11-22)14-6-4-5-7-17(14)21-18/h3-7,16,21,23H,8-12H2,1-2H3/b13-3-/t16-,20-/m0/s1	N/A	1	Positive	N/A	Isolated	340.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
valparicine.mgf	*..*	Valparicine	277.1698	qTof	LC-ESI	385	C/C=C1CN2[C@@]3([H])C[C@]/1([H])C(C4=NC5=CC=CC=C5[C@@]43CC2)=C	InChI=1S/C19H20N2/c1-3-13-11-21-9-8-19-15-6-4-5-7-16(15)20-18(19)12(2)14(13)10-17(19)21/h3-7,14,17H,2,8-11H2,1H3/b13-3-/t14-,17+,19-/m1/s1	N/A	1	Positive	N/A	Isolated	276.1627	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vellosimine.mgf	*..*	Vellosimine	293.1648	qTof	LC-ESI	386	C/C=C(C1)\[C@@H]2C[C@@](N1[C@H](C2(C=O)[H])C3)([H])C4=C3C5=C(N4)C=CC=C5	InChI=1S/C19H20N2O/c1-2-11-9-21-17-8-14-12-5-3-4-6-16(12)20-19(14)18(21)7-13(11)15(17)10-22/h2-6,10,13,15,17-18,20H,7-9H2,1H3/b11-2-/t13-,15?,17-,18-/m0/s1	N/A	1	Positive	N/A	Isolated	292.1576	Alexander Fox Ramos	M+H	N/A	3	Geissospermum	Geissospermum laeve	N/A	6874-98-2	Mehdi Beniddir
venalstonine.mgf	*..*	Venalstonine	337.1911	qTof	LC-ESI	387	COC([C@@H]1C[C@@]2([C@@]34[H])C=CCN4CC[C@]53C6=CC=CC=C6N[C@]15CC2)=O	InChI=1S/C21H24N2O2/c1-25-17(24)15-13-19-7-4-11-23-12-10-20(18(19)23)14-5-2-3-6-16(14)22-21(15,20)9-8-19/h2-7,15,18,22H,8-13H2,1H3/t15-,18-,19+,20+,21+/m0/s1	N/A	1	Positive	N/A	Isolated	336.1838	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
venecurine.mgf	*..*	Venecurine	325.1906	qTof	LC-ESI	388	CC1(O)OCC2C3CC4c5[nH]c6ccccc6c5CC2[N+]4(C)CC13	InChI=1S/C20H25N2O2/c1-20(23)15-9-22(2)17-8-13-11-5-3-4-6-16(11)21-19(13)18(22)7-12(15)14(17)10-24-20/h3-6,12,14-15,17-18,21,23H,7-10H2,1-2H3/q+1	N/A	1	Positive	N/A	Isolated	325.1916	Sarah Szwarc	M+	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
villalstonidineB.mgf	*..*	Villalstonidine B	691.3835	qTof	LC-ESI	389	CN1[C@@H]2CC(C3=CC=CC=C3N4C)=C4[C@H]1C[C@@]5([H])[C@]([C@](C)(O6)OC[C@]52[H])([H])C[C@]78[C@@]6([C@@](C[C@@]9([H])/C(C%10)=C\C)([H])N%10CC8)N([C@@](CO)9C(OC)=O)C%11=CC=CC=C%117	InChI=1S/C42H50N4O5/c1-6-24-21-45-16-15-40-20-31-26-17-35-37-27(25-11-7-9-13-32(25)44(37)4)18-34(43(35)3)28(26)22-50-39(31,2)51-42(40)36(45)19-30(24)41(23-47,38(48)49-5)46(42)33-14-10-8-12-29(33)40/h6-14,26,28,30-31,34-36,47H,15-23H2,1-5H3/b24-6-/t26-,28-,30+,31+,34-,35-,36+,39+,40+,41?,42+/m1/s1	N/A	1	Positive	N/A	Isolated	690.3781	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Villalstonine.mgf	*..*	Villalstonine	661.3748	qTof	LC-ESI	390	C/C=C1[C@@H](C2C(OC)=O)C[C@H]3[C@@]4(O5)N2C6=CC=CC=C6[C@@]4(CC7[C@]5(C)OCC8C7CC9C%10=C(C(C=CC=C%11)=C%11N%10C)CC8N9C)CCN3C\1	InChI=1S/C41H48N4O4/c1-6-23-21-44-16-15-40-20-30-26-17-34-36-27(24-11-7-9-13-31(24)43(36)4)18-33(42(34)3)28(26)22-48-39(30,2)49-41(40)35(44)19-25(23)37(38(46)47-5)45(41)32-14-10-8-12-29(32)40/h6-14,25-26,28,30,33-35,37H,15-22H2,1-5H3/b23-6-/t25-,26?,28?,30?,33?,34?,35-,37-,39+,40-,41-/m0/s1	N/A	1	Positive	N/A	Isolated	660.3676	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia angustifolia	N/A	2723-56-0	Mehdi Beniddir
vinamidine.mgf	*..*	Vinamidine	825.4075	qTof	LC-ESI	391	CCC(=O)CC1CN(CCc2c([nH]c3ccccc23)C(C1)(C(=O)OC)c1cc2c(cc1OC)N(C)C1C22CCN3CC=CC(CC)(C23)C(OC(C)=O)C1(O)C(=O)OC)C=O|c:46|	InChI=1/C46H56N4O10/c1-8-29(53)21-28-24-45(41(54)58-6,37-31(15-19-49(25-28)26-51)30-13-10-11-14-34(30)47-37)33-22-32-35(23-36(33)57-5)48(4)39-44(32)17-20-50-18-12-16-43(9-2,38(44)50)40(60-27(3)52)46(39,56)42(55)59-7/h10-14,16,22-23,26,28,38-40,47,56H,8-9,15,17-21,24-25H2,1-7H3	N/A	1	Positive	N/A	Isolated	824.3996	Sarah Szwarc	M+H	N/A	3	Catharanthus	Catharanthus roseus	N/A	N/A	Beniddir/Le Pogam
Vinblastine.mgf	*..*	Vinblastine	811.4277	qTof	LC-ESI	392	O[C@@]1(CC)C[C@@](C[N@@](CC2)C1)([H])C[C@@](C3=C(OC)C=C(N(C)C4[C@@]56[C@]7([H])[C@](C=CCN7CC6)(CC)[C@@H](OC(C)=O)[C@]4(O)C(OC)=O)C5=C3)(C(OC)=O)C8=C2C9=CC=CC=C9N8	InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38?,39+,42-,43+,44+,45-,46-/m0/s1	N/A	1	Positive	N/A	Isolated	810.4204	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	865-21-4	Mehdi Beniddir
vincadifformine.mgf	*..*	Vincadifformine	339.2067	qTof	LC-ESI	393	CC[C@]1([C@@]23[H])CCCN3CC[C@]42C5=CC=CC=C5NC4=C(C(OC)=O)C1	InChI=1S/C21H26N2O2/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2/h4-5,7-8,19,22H,3,6,9-13H2,1-2H3/t19-,20-,21-/m0/s1	N/A	1	Positive	N/A	Isolated	338.1994	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vincamajine.mgf	*..*	Vincamajine	367.2016	qTof	LC-ESI	394	C/C=C1[C@@H]2C[C@@]3([H])[C@@]4([H])N(C)C5=CC=CC=C5C4([C@@H]6O)C[C@@H](C26C(OC)=O)N3C\1	InChI=1S/C22H26N2O3/c1-4-12-11-24-16-9-14(12)22(20(26)27-3)17(24)10-21(19(22)25)13-7-5-6-8-15(13)23(2)18(16)21/h4-8,14,16-19,25H,9-11H2,1-3H3/b12-4-/t14-,16-,17-,18+,19-,21?,22?/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Alexander Fox Ramos	M+H	N/A	3	Alstonia	Alstonia boulindaensis	N/A	2506-26-5	Mehdi Beniddir
vincamedine.mgf	*..*	Vincamedine	409.2125	qTof	LC-ESI	395	CN1C2=CC=CC=C2[C@]3(C(OC(C)=O)[C@]45C(OC)=O)C[C@@H]4N6[C@](C[C@H]5/C(C6)=C\C)([H])[C@H]31	InChI=1S/C24H28N2O4/c1-5-14-12-26-18-10-16(14)24(22(28)29-4)19(26)11-23(21(24)30-13(2)27)15-8-6-7-9-17(15)25(3)20(18)23/h5-9,16,18-21H,10-12H2,1-4H3/b14-5-/t16-,18-,19-,20+,21-,23+,24+/m0/s1	N/A	1	Positive	N/A	Isolated	408.2049	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vincamine.mgf	*..*	Vincamine	355.2016	qTof	LC-ESI	396	[H][C@@]12C3=C4C5=C(N3[C@@](O)(C(OC)=O)C[C@]1(CC)CCCN2CC4)C=CC=C5	InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	1617-90-9	Mehdi Beniddir
vincamone.mgf	*..*	Vincamone	295.1804	qTof	LC-ESI	397	CC[C@@]12CCCN3CCC4=C(N(C5=C4C=CC=C5)C(C2)=O)[C@]13[H]	InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4	N/A	1	Positive	N/A	Isolated	294.1732	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vincanidine.mgf	*..*	Vincanidine	309.1597	qTof	LC-ESI	398	C/C=C([C@@H](C(C=O)=C1N2)C[C@@H]34)/CN4CC[C@@]31C5=C2C(O)=CC=C5	InChI=1S/C19H20N2O2/c1-2-11-9-21-7-6-19-14-4-3-5-15(23)17(14)20-18(19)13(10-22)12(11)8-16(19)21/h2-5,10,12,16,20,23H,6-9H2,1H3/b11-2-/t12-,16-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	308.1525	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vincine.mgf	*..*	Vincine	385.2123	qTof	LC-ESI	399	CC[C@@]12CCCN3[C@]1([H])C4=C(C5=C(C=C(OC)C=C5)N4[C@](C(OC)=O)(O)C2)CC3	InChI=1S/C22H28N2O4/c1-4-21-9-5-10-23-11-8-16-15-7-6-14(27-2)12-17(15)24(18(16)19(21)23)22(26,13-21)20(25)28-3/h6-7,12,19,26H,4-5,8-11,13H2,1-3H3/t19-,21+,22+/m1/s1	N/A	1	Positive	N/A	Isolated	384.20491	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vincorine.mgf	*..*	Vincorine	369.216	qTof	LC-ESI	400	C/C=C([C@@H]([C@H]1C(OC)=O)CC[C@@]23N4C)/C[N@@]3CC[C@@]21C5=C4C=CC(OC)=C5	InChI=1S/C22H28N2O3/c1-5-14-13-24-11-10-21-17-12-15(26-3)6-7-18(17)23(2)22(21,24)9-8-16(14)19(21)20(25)27-4/h5-7,12,16,19H,8-11,13H2,1-4H3/b14-5-/t16-,19-,21-,22-/m0/s1	N/A	1	Positive	N/A	Isolated	368.21	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vincosamide.mgf	*..*	Vincosamide	499.2075	qTof	LC-ESI	401	[H][C@]12C[C@]3([C@H]([C@@H](OC=C3C(N1CCC4=C2NC5=CC=CC=C45)=O)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C=C)[H]	InChI=1S/C26H30N2O8/c1-2-12-15-9-18-20-14(13-5-3-4-6-17(13)27-20)7-8-28(18)24(33)16(15)11-34-25(12)36-26-23(32)22(31)21(30)19(10-29)35-26/h2-6,11-12,15,18-19,21-23,25-27,29-32H,1,7-10H2/t12-,15+,18-,19-,21-,22+,23-,25+,26+/m1/s1	N/A	1	Positive	N/A	Isolated	498.2002	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	23141-27-7	Mehdi Beniddir
vindoline.mgf	*..*	Vindoline	457.233	qTof	LC-ESI	402	CC[C@]12C=CCN3[C@H]1[C@]4(C(N(C)C5=C4C=CC(OC)=C5)[C@@](C(OC)=O)(O)[C@H]2OC(C)=O)CC3	InChI=1S/C25H32N2O6/c1-6-23-10-7-12-27-13-11-24(19(23)27)17-9-8-16(31-4)14-18(17)26(3)20(24)25(30,22(29)32-5)21(23)33-15(2)28/h7-10,14,19-21,30H,6,11-13H2,1-5H3/t19-,20?,21+,23+,24+,25-/m1/s1	N/A	1	Positive	N/A	Isolated	456.226	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vindolinine.mgf	*..*	Vindolinine	337.1911	qTof	LC-ESI	403	[H][C@]12[C@@]34[C@@H](C)[C@]5(C(C(OC)=O)C4)NC6=CC=CC=C6[C@@]51CCN2CC=C3	InChI=1S/C21H24N2O2/c1-13-19-8-5-10-23-11-9-20(18(19)23)14-6-3-4-7-16(14)22-21(13,20)15(12-19)17(24)25-2/h3-8,13,15,18,22H,9-12H2,1-2H3/t13-,15+,18+,19+,20-,21-/m1/s1	N/A	1	Positive	N/A	Isolated	336.1838	Alexander Fox Ramos	M+H	N/A	3	Pleiocarpa	Pleiocarpa mutica	N/A	N/A	Mehdi Beniddir
Voacalgine_A.mgf	*..*	Voacalgine A	475.1864	qTof	LC-ESI	404	O=C(OC)[C@H]1N2[C@@]3(OC(C4=C(O)C(O)=CC=C45)=O)[C@@]5(CCN(C/6)[C@@]3([H])C[C@@]1([H])C6=C/C)C7=C2C=CC=C7	InChI=1S/C27H26N2O6/c1-3-14-13-28-11-10-26-16-6-4-5-7-18(16)29-22(25(33)34-2)15(14)12-20(28)27(26,29)35-24(32)21-17(26)8-9-19(30)23(21)31/h3-9,15,20,22,30-31H,10-13H2,1-2H3/b14-3-/t15-,20-,22-,26-,27-/m0/s1	N/A	1	Positive	N/A	Isolated	474.1791	Alexander Fox Ramos	M+H	N/A	3	Voacanga	Voacanga grandifolia	N/A	N/A	Mehdi Beniddir
Voacamine.mgf	*..*	Voacamine	705.401	qTof	LC-ESI	405	O=C(OC)[C@@H]1[C@@H](CC2=C3NC4=C2C=CC=C4)N(C)C/C(C1CC3C5=CC(NC6=C7CC[N@@](C8)[C@]9([H])[C@@]6(C(OC)=O)C[C@H]8C[C@@H]9CC)=C7C=C5OC)=C/C	InChI=1S/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24+,28?,31?,35-,37+,40+,43-/m1/s1	N/A	1	Positive	N/A	Isolated	704.3938	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	3371-85-5	Mehdi Beniddir
Voacangine.mgf	*..*	Voacangine	369.2173	qTof	LC-ESI	406	CC[C@H]1C[C@@H]2C[C@@]([C@@]1([H])[N@](C2)CC3)(C(OC)=O)C4=C3C5=CC(OC)=CC=C5N4	InChI=1S/C22H28N2O3/c1-4-14-9-13-11-22(21(25)27-3)19-16(7-8-24(12-13)20(14)22)17-10-15(26-2)5-6-18(17)23-19/h5-6,10,13-14,20,23H,4,7-9,11-12H2,1-3H3/t13-,14+,20+,22?/m1/s1	N/A	1	Positive	N/A	Isolated	368.21	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	510-22-5	Mehdi Beniddir
Voachalotine.mgf	*..*	Voachalotine	367.2016	qTof	LC-ESI	407	C/C=C(C1)\[C@@H]2CC(N1[C@H](C2(C(OC)=O)CO)C3)C4=C3C5=C(N4C)C=CC=C5	InChI=1S/C22H26N2O3/c1-4-13-11-24-18-10-16(13)22(12-25,21(26)27-3)19(24)9-15-14-7-5-6-8-17(14)23(2)20(15)18/h4-8,16,18-19,25H,9-12H2,1-3H3/b13-4-/t16-,18?,19-,22?/m0/s1	N/A	1	Positive	N/A	Isolated	366.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	664-25-5	Mehdi Beniddir
VOACORINE.mgf	*..*	Voacorine	721.3964	qTof	LC-ESI	408	C/C=C1CN(C)[C@@]2([H])CC3=C(NC4=CC=CC=C34)C(C5=C(OC)C=C6C7=C(NC6=C5)[C@]8(C(OC)=O)C[C@@]9([H])C[C@@]([C@@H](O)C)([H])[C@]8([H])N(CC7)C9)C[C@@]\1([H])C2C(OC)=O	InChI=1S/C43H52N4O6/c1-7-24-21-46(3)35-17-32-25-10-8-9-11-33(25)44-38(32)31(15-28(24)37(35)41(49)52-5)30-16-34-29(18-36(30)51-4)26-12-13-47-20-23-14-27(22(2)48)40(47)43(19-23,39(26)45-34)42(50)53-6/h7-11,16,18,22-23,27-28,31,35,37,40,44-45,48H,12-15,17,19-21H2,1-6H3/b24-7-	N/A	1	Positive	N/A	Isolated	720.3887	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
voatriafricanine_A.mgf	*..*	Voatriafricanine A	1027.53	qTof	LC-ESI	409	OC12N3C4=C(O)C([C@H]C[C@H]/5[C@@H]6C(OC)=O)C(N([H])C7=C8C=CC=C7)=C8CC6N(C)CC5=C\C)=CC=C4[C@@]19CCN%10C9[C@@]%11(C[C@H]2C[C@H]%12[C@H]%13[C@@]%14(CC(C(OC)=O)=C%15NC%16=CC=CC=C%16[C@@]%15%17CCN([C@@H]%123)C%14%17)CCO%13)CCO[C@H]%11CC%10	InChI=1S/C62H70N6O8/c1-5-32-31-65(2)45-28-38-34-10-6-8-12-43(34)63-48(38)37(27-36(32)47(45)55(71)74-4)35-14-15-42-49(50(35)69)68-53-39(26-33-29-58-19-24-75-46(58)16-21-66-22-18-61(42,57(58)66)62(33,68)72)52-59(20-25-76-52)30-40(54(70)73-3)51-60(17-23-67(53)56(59)60)41-11-7-9-13-44(41)64-51/h5-15,33,36-37,39,45-47,52-53,56-57,63-64,69,72H,16-31H2,1-4H3/b32-5-/t33-,36?,37+,39+,45+,46+,47+,52?,53-,56+,57+,58-,59-,60+,61-,62-/m1/s1	N/A	1	Positive	N/A	Isolated	1026.53	Mehdi Beniddir	M+H	N/A	3	Voacanga	Voacanga africana	N/A	N/A	Beniddir/Le Pogam
voatriafricanine_B.mgf	*..*	Voatriafricanine B	1057.54	qTof	LC-ESI	410	OC12N3C4=C(O)C([C@H]C[C@H]/5[C@@H]6C(OC)=O)C(N([H])C7=C8C=CC=C7)=C8CC6N(C)CC5=C\C)=CC=C4[C@@]19CCN%10C9[C@@]%11(C[C@H]2C[C@H]%12[C@H]%13[C@@]%14(CC(C(OC)=O)=C%15NC%16=C(OC)C=CC=C%16[C@@]%15%17CCN([C@@H]%123)C%14%17)CCO%13)CCO[C@H]%11CC%10	InChI=1S/C63H72N6O9/c1-6-32-31-66(2)44-28-38-34-10-7-8-12-43(34)64-48(38)37(27-36(32)47(44)56(72)76-5)35-14-15-42-50(51(35)70)69-54-39(26-33-29-59-19-24-77-46(59)16-21-67-22-18-62(42,58(59)67)63(33,69)73)53-60(20-25-78-53)30-40(55(71)75-4)52-61(17-23-68(54)57(60)61)41-11-9-13-45(74-3)49(41)65-52/h6-15,33,36-37,39,44,46-47,53-54,57-58,64-65,70,73H,16-31H2,1-5H3/b32-6-/t33-,36?,37-,39+,44-,46+,47+,53?,54-,57+,58+,59-,60-,61+,62-,63-/m1/s1	N/A	1	Positive	N/A	Isolated	1056.54	Mehdi Beniddir	M+H	N/A	3	Voacanga	Voacanga africana	N/A	N/A	Beniddir/Le Pogam
Vobasine.mgf	*..*	Vobasine	353.186	qTof	LC-ESI	411	O=C(CC/1C2([H])C(OC)=O)C3=C(C[C@@]2([H])N(C)CC1=C\C)C4=C(N3)C=CC=C4	InChI=1S/C21H24N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h4-8,14,17,19,22H,9-11H2,1-3H3/b12-4-/t14-,17+,19?/m0/s1	N/A	1	Positive	N/A	Isolated	352.1787	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	2134-83-0	Mehdi Beniddir
vobatensineA.mgf	*..*	Vobatensine A	663.3896	qTof	LC-ESI	412	O[C@H](C)[C@@]([C@@]12[H])([H])C[C@@H]3C[C@@]1([H])C4=C(C5=CC(OC)=C([C@H]6C[C@@H]([C@H]7C(OC)=O)/C(CN([C@@H]7CC8=C6NC9=CC=CC=C89)C)=C\C)C=C5N4)CCN2C3	InChI=1S/C41H50N4O4/c1-6-23-20-44(3)35-17-31-24-9-7-8-10-33(24)42-39(31)30(15-27(23)37(35)41(47)49-5)29-16-34-28(18-36(29)48-4)25-11-12-45-19-22-13-26(21(2)46)40(45)32(14-22)38(25)43-34/h6-10,16,18,21-22,26-27,30,32,35,37,40,42-43,46H,11-15,17,19-20H2,1-5H3/b23-6-/t21-,22-,26-,27-,30-,32+,35-,37-,40+/m1/s1	N/A	1	Positive	N/A	Isolated	662.3832	Le Pogam	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vobatensineB.mgf	*..*	Vobatensine B	665.4045	qTof	LC-ESI	413	CN1[C@@]([C@]2(C(OC)=O)[H])([H])CC3=C([C@@]([H])(C4=C(OC)C=C5C(NC6=C5CCN7[C@]8([H])[C@@]6([H])C[C@@H](C7)C[C@]8([H])[C@H](O)C)=C4)C[C@]2([H])[C@@](CC)([H])C1)NC9=CC=CC=C93	InChI=1S/C41H52N4O4/c1-6-23-20-44(3)35-17-31-24-9-7-8-10-33(24)42-39(31)30(15-27(23)37(35)41(47)49-5)29-16-34-28(18-36(29)48-4)25-11-12-45-19-22-13-26(21(2)46)40(45)32(14-22)38(25)43-34/h7-10,16,18,21-23,26-27,30,32,35,37,40,42-43,46H,6,11-15,17,19-20H2,1-5H3/t21-,22+,23-,26-,27-,30-,32+,35+,37?,40+/m1/s1	N/A	1	Positive	N/A	Isolated	664.3989	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vobatensineC.mgf	*..*	Vobatensine C	665.406	qTof	LC-ESI	414	CN1[C@@]([C@]2(C(OC)=O)[H])([H])CC3=C([C@@]([H])(C4=C(OC)C=C5C(N[C@]6(CCN7[C@]8([H])[C@@]6([H])C[C@@H](C7)C[C@]8([H])CC)C5=O)=C4)C[C@]2([H])C(CC)C1)NC9=CC=CC=C93	InChI=1S/C41H52N4O4/c1-6-23-14-22-15-31-38(23)45(20-22)13-12-41(31)39(46)30-19-35(48-4)27(17-33(30)43-41)28-16-26-24(7-2)21-44(3)34(36(26)40(47)49-5)18-29-25-10-8-9-11-32(25)42-37(28)29/h8-11,17,19,22-24,26,28,31,34,36,38,42-43H,6-7,12-16,18,20-21H2,1-5H3/t22-,23-,24?,26+,28+,31+,34-,36?,38-,41-/m0/s1	N/A	1	Positive	N/A	Isolated	664.3989	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vobatensineD.mgf	*..*	Vobatensine D	663.3886	qTof	LC-ESI	415	CN1[C@@]([C@]2(C(OC)=O)[H])([H])CC3=C([C@@]([H])(C4=C(OC)C=C5C(N=C6[C@]5(O)CCN7[C@]8([H])[C@@]6([H])C[C@@H](C7)C[C@]8([H])CC)=C4)C[C@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C41H50N4O4/c1-6-23-14-22-15-30-38(23)45(20-22)13-12-41(47)31-19-35(48-4)27(17-33(31)43-39(30)41)28-16-26-24(7-2)21-44(3)34(36(26)40(46)49-5)18-29-25-10-8-9-11-32(25)42-37(28)29/h7-11,17,19,22-23,26,28,30,34,36,38,42,47H,6,12-16,18,20-21H2,1-5H3/b24-7-/t22-,23-,26+,28+,30+,34-,36?,38-,41-/m0/s1	N/A	1	Positive	N/A	Isolated	662.3832	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vobatensineE.mgf	*..*	Vobatensine E	647.394	qTof	LC-ESI	416	CN1[C@@]([C@]2(C(OC)=O)[H])([H])CC3=C([C@@]([H])(C4=C5C(NC6=C5CCN7[C@]8([H])[C@@]6([H])C[C@@H](C7)C[C@]8([H])CC)=CC=C4OC)C[C@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C41H50N4O3/c1-6-23-16-22-17-30-38-26(14-15-45(20-22)40(23)30)35-32(43-38)12-13-34(47-4)37(35)29-18-27-24(7-2)21-44(3)33(36(27)41(46)48-5)19-28-25-10-8-9-11-31(25)42-39(28)29/h7-13,22-23,27,29-30,33,36,40,42-43H,6,14-21H2,1-5H3/b24-7-/t22-,23-,27+,29+,30-,33-,36?,40-/m0/s1	N/A	1	Positive	N/A	Isolated	646.3883	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
vobatensineF.mgf	*..*	Vobatensine F	663.3887	qTof	LC-ESI	417	C[N+]1([O-])[C@@]([C@]2(C(OC)=O)[H])([H])CC3=C([C@@]([H])(C4=C(OC)C=C5C(NC6=C5CCN7[C@]8([H])[C@@]6([H])C[C@@H](C7)C[C@]8([H])CC)=C4)C[C@]2([H])/C(C1)=C\C)NC9=CC=CC=C93	InChI=1S/C41H50N4O4/c1-6-23-14-22-15-32-38-26(12-13-44(20-22)40(23)32)28-19-36(48-4)29(17-34(28)43-38)30-16-27-24(7-2)21-45(3,47)35(37(27)41(46)49-5)18-31-25-10-8-9-11-33(25)42-39(30)31/h7-11,17,19,22-23,27,30,32,35,37,40,42-43H,6,12-16,18,20-21H2,1-5H3/b24-7-/t22-,23-,27+,30+,32-,35-,37?,40-,45?/m0/s1	N/A	1	Positive	N/A	Isolated	662.3832	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam
Vobtusine.mgf	*..*	Vobtusine	719.3803	qTof	LC-ESI	418	O[C@]12[C@]3(CC4)C5=CC=CC(OC)=C5N1C[C@@]6(CN(CC7)C([C@@]7(C(C=CC=C8)=C8N9)C9=C(C(OC)=O)C%10)[C@]%11%10[C@H]6OCC%11)C[C@]2([H])C[C@@]%12%13[C@]3([H])N4CC[C@@H]%12OCC%13	InChI=1S/C43H50N4O6/c1-50-30-9-5-7-28-32(30)47-24-38(20-25-21-39-13-18-52-31(39)10-15-45-17-12-42(28,36(39)45)43(25,47)49)23-46-16-11-41-27-6-3-4-8-29(27)44-33(41)26(34(48)51-2)22-40(35(41)46)14-19-53-37(38)40/h3-9,25,31,35-37,44,49H,10-24H2,1-2H3/t25-,31+,35?,36+,37+,38+,39-,40+,41+,42-,43-/m1/s1	N/A	1	Positive	N/A	Isolated	718.373	Alexander Fox Ramos	M+H	N/A	3	Callichilia	Callichilia inaequalis	N/A	19772-79-3	Mehdi Beniddir
Vomicine.mgf	*..*	Vomicine	381.1809	qTof	LC-ESI	419	O=C1C[C@@](OCC=C2CN(C)CC3)([H])[C@@]([C@@]2([H])CC4=O)([H])[C@@]5([H])[C@]43C6=CC=CC(O)=C6N51	InChI=1S/C22H24N2O4/c1-23-7-6-22-14-3-2-4-15(25)20(14)24-18(27)10-16-19(21(22)24)13(9-17(22)26)12(11-23)5-8-28-16/h2-5,13,16,19,21,25H,6-11H2,1H3/t13-,16-,19-,21-,22+/m0/s1	N/A	1	Positive	N/A	Isolated	380.1736	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	125-15-5	Mehdi Beniddir
Wieland_Gumlich_aldehyde.mgf	*..*	Wieland-Gumlich aldehyde	311.1754	qTof	LC-ESI	420	O[C@H](OCC=C1C2)[C@@]([C@H]1C[C@@H]3N2CC4)([H])[C@@]5([H])[C@]34C6=CC=CC=C6N5	InChI=1S/C19H22N2O2/c22-18-16-12-9-15-19(6-7-21(15)10-11(12)5-8-23-18)13-3-1-2-4-14(13)20-17(16)19/h1-5,12,15-18,20,22H,6-10H2/t12-,15-,16+,17-,18+,19+/m0/s1	N/A	1	Positive	N/A	Isolated	310.1681	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	466-85-3	Mehdi Beniddir
Yohimbine.mgf	*..*	Yohimbine	355.2016	qTof	LC-ESI	421	[H][C@](N1CC2)(C[C@@]([C@@H](C(OC)=O)[C@@H](O)CC3)([H])[C@]3([H])C1)C4=C2C5=C(N4)C=CC=C5	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1	N/A	1	Positive	N/A	Isolated	354.1943	Alexander Fox Ramos	M+H	N/A	3	N/A	N/A	N/A	146-48-5	Mehdi Beniddir
yunnanensine.mgf	*..*	Yunnanensine	329.1854	qTof	LC-ESI	422	COC([C@](C1=CC2=CC=CC=C2N1)([C@@]3([H])/C(CNCC3)=C\C)CO)=O	InChI=1S/C19H24N2O3/c1-3-13-11-20-9-8-15(13)19(12-22,18(23)24-2)17-10-14-6-4-5-7-16(14)21-17/h3-7,10,15,20-22H,8-9,11-12H2,1-2H3/b13-3-/t15-,19+/m1/s1	N/A	1	Positive	N/A	Isolated	328.1787	Sarah Szwarc	M+H	N/A	3	N/A	N/A	N/A	N/A	Beniddir/Le Pogam